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V01.1
Brown pigment gallstones and cholesterol precipitation
L Vitetta1,A Sali, J Little and T Jones
1Swinburne University, Graduate School of Integrative Medicine, Melbourne,
Australia
The time frame of gallstone formation is largely unknown,with cholesterol pre-
cipitation the primary pronucleating event in the majority of gallstones from
patients in western countries. Brown pigment gallstones from patients (N=44)
who underwent a cholecystectomy, were investigated in terms of bactibilia,
gross chemical compositions, bile analyses and bile microscopy. The results
showed that the most common post surgery pathology report on the gallblad-
der was of chronic cholecystitis. Gallbladder fluids aspirated [24/41 (58.5%)]
from the gallbladders at surgery for microbiological investigations, showed a
bactibilia of 100%.At least one organism was cultured that was positive for the
enzyme b-glucuronidase (promoter of calcium bilirubinate precipitation). Bile as
a viscous or semi viscous - watery mucoid fluid was frequently observed and
only in a subgroup of 11 patients was a total bile salt, cholesterol and phos-
pholipid analysis of the gallbladder bile possible.The mean (SD) bile saturation
index calculated for these samples was 1.6 (0.2) [95%CI: 1.30, 1.88].The mean
(SD) % dry weight of cholesterol, bilirubin and calcium content of gallstones
from 9 patients from this subgroup was cholesterol 40.8 (3.5)% [95%CI: 34.0,
47.6]; bilirubin 13.9 (2.2)% [95%CI: 9.7, 18.1]; and calcium 6.0 (1.0)% [95%CI:
4.0, 7.9]. IR spectra showed that calcium bilirubinate (CaB) and calcium palmi-
tate were present. Brown pigment gallstones from a further 33 patients showed
similar chemical compositions and not different from the subgroup (P>.05).
Light microscopy of gallbladder fluids irrespective of consistency (N=38)
showed all to have abundant CaB. Light microscopy showed cholesterol mono-
hydrate crystals in approximately 70% of the bile samples. We propose that
brown pigment gallstone formation in the gallbladder is subject to multiple aeti-
ological mechanisms that involve cholesterol.Cholesterol deposits in the stone,
cholesterol monohydrate crystal precipitates in bile and a moderately high bile
cholesterol saturation index, would support this hypothesis.
V01.2
Cholesterol ‘solitaire’ gallstones and bacteria
L Vitetta L1,B Paspaliaris,A Sali, P Little and T Jones
1Swinburne University, Graduate School of Integrative Medicine, Melbourne,
Australia
The aetiology of cholesterol gallstone formation has largely concentrated on
the cholesterol crystal pronucleation - bile salt micelle insolubility mechanism.
Recently bacteria have been implicated as an additional mechanism that may
well further enhance multiple cholesterol gallstone nidation and growth. We
investigated gallbladder bile with single cholesterol gallstones from 27 patients.
Gallbladder bile samples were aspirated from the gallbladder at the time of sur-
gery from each patient and immediately cultured for aerobic and anaerobic bac-
terial growth. All samples tested returned a result of no growth after 5 days
incubation. Subsequent total bile salts, cholesterol and phospholipid analysis of
a sample of the gallbladder bile confirmed that the bile samples were supersat-
urated with cholesterol. The mean (SD) bile saturation index was 1.82 (0.21)
[95%CI: 1.41, 2.22]. Microscopic examination of bile under direct and polarized
light confirmed abundant cholesterol precipitation as cholesterol monohydrate
crystals. Chemical analysis of the gallstones showed a mean (SD) % dry weight
of cholesterol of 87.5 (1.81)% [95%CI: 84.0, 91.1]. IR spectra confirmed cho-
lesterol as the principal structural component. Employing the polymerase chain
reaction technique coupled with a primer set universal for bacterial species,
bacterial DNA was detected in the nidus area of 5 single cholesterol gallstones
from 5 separate patients.As no bacterial growth was cultured we suspect the
bacterial DNA detected were most probably from dead organisms preserved
within the gallstone matrix from a time pertaining to gallstone nidation.
Bacterial DNA sequences were consistent with those from enterobacterial
species. Pathology reports concerning the gallbladder consisted of acute chole-
cystitis (37%) and chronic cholecystitis (63%). Gallstones found to have bacte-
rial DNA sequences within their central matrix structure were all from the
group of chronic cholecystitis.We postulate that bacteria may colonize choles-
terol ‘rich’ gallstones, a gallstone type previously thought not to be associated
with bacterial infections. Bacterial colonization of the gallbladder may be a tran-
sient event. Hence, bacteria if present in bile in conjunction with bile supersat-
urated with cholesterol would enhance gallstone nidation.
V01.3
Gallstones in cirrhotic patients: criteria of evaluation of the surgical risk
G Zotti,A Balsamo, C Piccolo and G Salvo
Department of General Surgery, University of Naples “Federico II” 
Gallstones in cirrhotics are present in a significant number of cases. The low
concentration of lecithin and neutrofat acids decreases the solubility of cho-
lesterol leads to gallstone formation. In these patients the hepatic disease
increases remarkably the morbidity and the surgical mortality, mostly due to
the haemorrhagic risk. For these reasons are necessary careful evaluation, a
precise therapeutica1 indication and the choice of the best surgical procedure,
laparoscopic approach included. In our retrospective study we review the
results in order to verify the usefulness of in vivo tests and mininvasive surgi-
cal approaches upon the morbility and mortality of the cirrhotic patients oper-
ated for gallstones. Our experience , in the years 1990-2000, consists of 2749
gallstones observed, of these 2365 (86%) have been operated. 248/2749
patients (9%) had a cirrhosis, mostly (221 = 89%) post-hepatitis. Of these 248
patients, 171 (69%) were submitted to the surgical treatment (150 cholecys-
tectomies and 21 cholecystotomies), 50 (20%) did not undergo to the opera-
tion, 36 because of the high risk checked out by the coagu1ation “in vivo” tests,
and 14 for a poor or absent symptomatology. In the operated group (171), 25
(15%) needed severa1 (two or more) blood units transfusions due to an extant
haematic loss, 7 (4%) required the admission in intensive care unit (ICU) where
four out of seven died for hepatic, rena1 and respiratory failure post-haemor-
rhagic shock.We consider that the standard preoperatory criteria used for the
operability are not adequate to settle an exact appraisal of the haemorrhagic
operatory risk and further eva1uations, as the coagulation “in vivo” tests, in
addition to mininvasive procedures, as the videolaparoscopic approach, are
necessary.
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V01.4
Management of acute cholecystitis in elderly patients
L Lapidakis, B Gougoutas B, G Kyratzis, G Papoutsis, N Theakos and C Lapidaki 
KAT Hospital, 2nd Dept of General Surgery,Athens, Greece
Acute cholecystitis is one of the most common emergency surgical problems
for the elderly. During the last 15 years, 212 patients over 70 years of age (mean
77,4yrs), presenting pain, nausea, fever and/or jaundice were admitted. Seldom,
symptomatology was mild not corresponding to the true gravity of the disease
and its complications.The time from the onset of symptoms to admission was
3.7 days. Emergency surgery within the first 24 hours from admission was
applied on 168 patients Group A. Another 36 patients -Group B- underwent
semi urgent surgery within one week of presentation, after intensive treatment
of coexistent diseases, or deterioration of the clinical picture,which obliged the
removal of any reservations for surgery. Finally only 8 patients were treated
conservatively and 5 of them underwent an elective operation. Operative find-
ings revealed gallbladder complications, while a pancreatic reaction was present
in 19 patients. Operative policy comprised, in addition to gallbladder resection,
exploration of the ducts when necessary and T- tube or choledochoduodenos-
tomie. Five patients died due to acute respiratory (3) and multi-system organ
failure (2). Postoperative morbidity was noted on 21 patients mostly concern-
ing thoracic complications conservatively treated, whereas two patients were
submitted to an early relaparotomy because of bleeding, treated successfully. It
is concluded that emergency surgery for acute cholecystitis or at least semi
urgent operation have the best results in elderly population, in spite of any
major coexistent problems. Intensive management of these disorders reduces
the perioperative risk in this, anyway, high-risk group of elderly patients.
V01.5
Acute cholecystitis in the elderly - prognostic factors
V Ovejero, L Sanz, E Azcano, CS Laso, E Barbón, JJ González and E Martínez
Hospital Central, University of Oviedo, Surgery B, Oviedo, Spain
INTRODUCTION:Acute cholecystitis in the elderly is common, and associat-
ed diseases may result in high morbidity and mortality after treatment. We
investigated possible factors related with the evolution of this group of patients.
MATERIAL AND METHODS: In a 10-year period (January 89 - April 99) 306
patients with biliary lithiasis, aged 80 year and older, were treated in our
Department. In 161 (52.6%) of them a diagnosis of acute cholecystitis was
obtained.Their mean age was 84.8 (80-95) years and the majority were women,
107 (66.5%). 129 (80.1%) had associated diseases.Median time of complaint was
2 months. We investigated factors related with morbidity and mortality (epi-
demiological, clinical, laboratory and modality of treatment). RESULTS: Sixty-
three patients (39.1%) were considered for surgery. In this group there pre-
dominated younger people (p<0.001) with associated diseases (p=0.05) com-
mon bile duct stones on ultrasound (p=0.002) and the highest values of direct
bilirubin (p=0.01). Overall complication rates were 33.5%, mainly in the surgi-
cal group, 35/63 vs 19/98 (p<0.001). Jaundice (p=0.002), fever (p<0.001) and
prothrombin time (p=0.003) on arrival were independent factors of morbidity.
Twenty-two patients (13.7%) died independently of the modality of treatment
carried out: 8/63 vs 14/98, surgical vs conservative management. In the regres-
sion model, only creatinine level (p=0.05) and prothrombine time (0.05)
retained their influence . CONCLUSIONS: Medical and surgical management
are effective modalities of treatment, but must be tailored to each patient. It is
possible to identify patients with high risk of morbi/mortality.
V01.6
Role of jaundice in patients with biliary lithiasis 80 years and older
C Laso1,V Ovejero, L Sanz, E Azcano, E Barbón, JJ González and E Martínez
1Hospital Central, University of Oviedo, Surgery, Oviedo, Spain
INTRODUCTION: Biliary lithiasis is very common, mainly in old people, and
jaundice is frequent in this group of patients.We investigated treatment options
and the influence of jaundice on clinical behaviour.
MATERIAL AND METHODS: Between January 1989 and April 1999, 306
patients with gallstone disease, aged 80 years and older, were treated in our
Unit. 125 (41.7%) of them had jaundice. Mean age was 84.6 (80-94) years, and
women predominated, 79 (63.2%). 103 (82.4%) patients had associated dis-
eases, 46 (36.8%) had acute cholecystitis and 19 (15.2%) acute pancreatitis.We
studied modalities of treatment and factors with influence on morbidity and
mortality (epidemiological, clinical, and laboratory factors). RESULTS: Forty-six
patients (36.8%) were treated medically, 45 (36%) surgically and in 24 an ERCP
was performed. 54 patients (43.2%) had complications, abdominal 28 (22.4%)
and systemic 40 (32%). Twenty-five patients (20%) died, mainly from sepsis
and/or related conditions (MOF). Complications predominated in cases with a
higher direct bilirubin level (p=0.004) or lower prothrombin time (p=0.04).
Also, patients treated by surgery or ERCP had more morbidity (p=0.001).
Mortality was related with bilirubin rates (p=0-03) and prothrombin time
(p=0.03), and also with serum creatinine level (p<0.001).The highest mortality
was obtained in patients treated by medical means, and the lowest in the group
of ERCP (p=0.05). CONCLUSIONS: Jaundice in patients with biliary lithiasis
has a direct influence on results.The best results in relation with mortality are
obtained with ERCP or surgery, isolated or in combination.
V01.7
Incidence and consequence of arterial injuries in patients with injuries of the
common bile duct after cholecystectomy
O Farges,A Alves, J Nicolet,T Watrin,A Sauvanet and J Belghiti
Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
The incidence of arterial injuries during cholecystectomies is 7 %.The incidence
and type of these lesions, when there is an associated injury of the common
bile duct is unknown. It has however been suggested that they changed the clin-
ical presentation and complicated the treatment of the biliary injury (Arch Surg
1998; 133: 176). Since 1990, 54 patients who had sustained a bile duct injury
during cholecystectomy were prospectively evaluated by angiography.
Angiography demonstrated a vascular injury in 25 patients (46 %).This includ-
ed an interruption of the right branch of the hepatic artery in 19 patients, asso-
ciated with a pseudoaneurysm in 1 patient, to an injury of the portal vein in 3
patients and an isolated injury to the portal vein in 2 patients. The latter 6
patients, with complex vascular injuries were treated by arterial embolisation
(n = 1) and liver resection (n = 5) respectively.A liver resection was performed
in 3 of the 19 other patients with an arterial injury and in 5 of the 29 patients
without vascular injuries.A Roux-en-Y biliary repair was performed in the 40
other patients (mean 49 +/- 16 years), including 16 with an arterial injury
(group 1) and 24 without arterial injury (group 2). Initial biliary symptoms,
severity and stage of the biliary injury, duration of surgery, postoperative mor-
bidity and duration of in-hospital stay were comparable in the two groups.All
patients are alive with a mean follow-up of 18 months (6 - 77 months). In both
groups, 90 % of the patients are symptom-free. Incidence of arterial injuries in
patients who have sustained a common bile duct injury during cholecystecto-
my is 43. In 18 % of the cases, these arterial injuries are complex (associated
with portal vein injuries or arterial pseudoaneurysm) and change the treatment
approach of the biliary injury. In contrast, simple interruption of the right
branch of the hepatic artery does not change the clinical presentation, man-
agement and outcome of the biliary injury.
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V01.8
Management of high hepatic duct stricture
E Galperin, N Kuzovlev and A Chevokin
Moscow Medical Academy, Department of Hepatic Surgery, Moscow, Russia
Data were collected prospectively on 149 patients with benign bile duct
(Bismuth Types 3 - 5) in 1988 - 1999. 47% of our patients suffered from long-
term jaundice, 43% - cholangitis, 30% - external biliary fistula, 6% - abscesses
and biliary sepsis. In patients with an extended hepatic duct stricture we per-
formed fenestration of the liver parenchyma in Segment 4 up to the portal
plate.The anastomosis was performed as an end-to-side hepaticojejunostomy
using interrupted sutures with the knots outside without stenting. In 14
patients with high-extended right hepatic duct stricture we used the
Exchangeable Transhepatic Drainage.The length of postoperative stenting was
1,5 - 2 years.There were 2 (1.3%) deaths in the postoperative period second-
ary to a sharp intestinal ileus and intra-abdominal bleeding.There were 28 com-
plications: abscess - 8, temporary biliary fistulae - 16, intra-abdominal bleeding
- 3, intestinal ileus - 1. 3 patients were operated on to stop the intra-abdomi-
nal bleeding. Follow-up was conducted in 130 patients by medical record
review or telephone interview. 4 patients died of reasons unrelated to biliary
tract disease. The overall outcome of 130 with surgical reconstruction who
completed treatment was good in 115 (90,7%). Development restrictures
observed at 4 (3,07 %) patients, which were repeatedly operated. The bad
results (15 patients) were caused, besides restrictures, accompanying HBV and
HCV infection (6 patients), biliary cirrhosis (5 patients).
V01.9
Post cholecystectomy symptoms
K Søndenna and T Berhane
Department of Surgery, Rogaland Central Hospital, Stavanger, Norway
OBJECTIVE: After gallbladder removal for stone disease 20% of the patients
remain symptomatic.The aim of our study was to evaluate the magnitude and
quality of such post cholecystectomy symptoms. METHODS: During the two-
year period 1998-2000 we prospectively examined 172 consecutive patients
with characteristic symptoms (pain attacks only, n=143) of gallbladder stone
disease or acute cholecystitis (n=29) and positiv finding at ultrasonography.The
patients were interviewed before and 3-18 months after removal of the gall-
bladder. Pain specifics and dyspepsia, a pain visual analogue scale (pVAS), quali-
ty of life measurements and psycometric analyses were used. 125 patients have
been operated on so far, and 90 of these followed-up to date, 66 women and
24 men with a median age 48-years, range 22-77. FINDINGS:Typical gallstone
related pain persisted in 4 patients (4.4%) while 5 (5.5%) had diffuse type aching
pain. Another patient had CBD stones. Dyspepsia and other gastrointestinal
complaints disappeared in 74%, 14% improved, and 12% remained unchanged.
Food intolerance was cured in 73% of patients, improved in 10%, and persisted
in 17%. Diarrhoea or loose stools were experienced by 9% of the patients post-
operatively. CONCLUSIONS: Nearly all patients were cured of their pain
attacks by cholecystectomy. Dyspepsia and food intolerance was mostly cured
or improved.We attribute our results to strict patient selection for cholecys-
tectomy based on the typical pain pattern of gallstone disease.
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V03.1
The additional value of FDG-PET during follow-up of patients with colorectal
liver metastases after radiofrequency ablation or cryosurgery
BS Langenhoff1,WJG Oyen2,T Wobbes1 and TJM Ruers1
1Department of Surgery and 2Department of Nuclear Medicine, University
Medical Centre Nijmegen, Nijmegen,The Netherlands
INTRODUCTION: After local ablative therapy (radiofrequency ablation or
cryosurgery) for irresectable colorectal liver metastases, follow-up is difficult as
CT scans show normally postoperative treatment affects that can hardly be dif-
ferentiated from residual or recurrent tumour. The current study was per-
formed to determine the utility of 18F-FDG-PET-scanning for follow-up.
METHODS: All patients included in this prospective study were subjected to
conventional diagnostic methods (CT scan and CEA) and FDG-PET. FDG-PET
and CDM were obtained within three weeks after surgery, at six weeks and
then every three months. Outcomes were verified with true lesion status,
obtained by histopathology or clinical follow-up of at least nine months.
RESULTS: 23 patients have been followed up after cryosurgery (n=17) and
radiofrequency ablation (n=6). All preoperatively made FDG-PET-scans were
positive. Directly postoperative, FDG-PET was positive in three patients treat-
ed with cryosurgery and in two patients treated with RF. Four of these patients
developed a local recurrence at the site treated with cryosurgery/RF. One
patient appeared to have an abscess. During nine months of follow-up, five
patients appeared to have recurrences at the liver at a different site of the liver.
Three patients had a positive FDG-PET and one patient had a false-negative
FDG-PET. CEA, a tumour marker, appeared to be not a sensitive indicator of
tumour recurrence, nine patients being non-CEA secretors. Furthermore,
FDG-PET shows local tumour recurrence three months earlier than CT scans.
CONCLUSIONS: FDG-PET has an important additional value in follow-up of
patients after local ablative therapy.
V03.2
Liver regeneration is impaired in mice deficient for urokinase plasminogen acti-
vator (uPA) but not tissue plasminogen activator (tPA).
JM Vogten1, TA Drixler1, MFBG Gebbink2, EE Voest2, P Carmeliet3, ThJMV van
Vroonhoven1 and IHM Borel Rinkes1
1University Medical Centre Utrecht, Surgery, Utrecht,The Netherlands
2University Medical Centre Utrecht, Oncology, Utrecht,The Netherlands
3KU Leuven, Centre for transgene technology and gene therapy, Leuven,
Belgium
INTRODUCTION:Plasminogen activators are important in matrix remodeling,
which occurs during liver regeneration and angiogenesis. Our previous studies
have suggested a role for angiogenesis in liver regeneration. In this study we
analysed liver regeneration in mice deficient for urokinase plasminogen activa-
tor (uPA) and tissue plasminogen activator (tPA). We hypothesized that defi-
ciency of uPA or tPA leads to impaired liver regeneration. MATERIALS AND
METHODS: Mice deficient for uPA (uPA-/-), tPA (tPA-/-), or wild type (uPA+/+,
tPA+/+) were subjected to 70% partial hepatectomy (PH). Liver regeneration
was measured as wet liver weight (WLW) and by bromodeoxyuridine (BrdU)
incorporation. Microvessel density (MVD) determined angiogenesis in the liver.
Also, the angiogenic capacity of these mice was analysed in the cornea neovas-
cularisation assay. RESULTS: All strains showed similar angiogenic responsive-
ness in the cornea assay. Liver regeneration after PH was inhibited in uPA-/-
mice by 44.9% and 21.5% (day 7 and 14, respectively) compared to wild type.
There was no difference in liver regeneration between tPA-/- and tPA+/+ mice.
BrdU incorporation was delayed and reduced in uPA -/- mice (peak at 96 hrs
post PH, 8.2% ± 1.6 labelled cells) compared to wild type (peak at 48 hrs post
hepatectomy, 22.83% ± 3.0 labelled cells). No differences in MVD were
observed between any of the phenotypes. CONCLUSION: Deficiency for uPA
(but not tPA) delays murine liver regeneration, as measured by liver mass and
BrdU labelling.This effect is not due to inhibition of microvessel growth during
physiological angiogenesis.
V03.3
Hepatocellular carcinoma: early mortality by recurrence after partial liver
resection: results of a multi-centre study
J Regimbeau1, GY Lauwers2, DM Nagorney3, I Ikai4,Y Yamaoka4, JN Vauthey5 and
J Belghiti1
1Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
2Massachusetts Hospital, Pathology, Boston, United States
3Mayo Clinic, Digestive Surgery, Rochester, United States
4Kyoto School of Medicine, Digestive Surgery, Kyoto, Japan
5Anderson Cancer Centre, Digestive Surgery, Houston, United States
Recurrence after partial liver resection for hepatocellular carcinoma (HCC) is
common and represents a major cause of death. For some patients the death
by recurrence occurred less than 1 year after liver resection.The aim of this
study was to identify potential risk factors of early death after partial liver
resection for HCC.Among 591 patients who underwent partial liver resection
for HCC between 1980 and 1999 at hepatobiliary centres in Japan, France, and
the United States, 473 patients with more than one-year follow up and for
whom the cause of the death was known were included. Of these 47 (8%)
patients died by recurrence less than 1 year after partial liver resection and 426
were alive after one year of follow up (mean follow up 55±32 months). After
multivariate analysis a tumour > 5 cm (p<0.02 ; Odds Ratio 3), more than 1
tumour (p<0.01 ; Odds Ratio 3.3), the presence of more than 5 mitosis per 10
high power field (p<0.03 ; Odds Ratio 2.9) and of active hepatitis [activity
degree > 5] (p<0.04 ; Odds Ratio 3.2), were associated with a higher risk of
early death by HCC recurrence. Conversely, origin, age, gender of the patients,
Child score, etiology of the hepatopathy (virus B or C), level of alfa-fetoprotein,
presence of uni or bilateral tumours or of a main portal trunk thrombosis,
nature of the liver resection, presence and the degree of fibrosis on non
tumourous liver, presence of microscopic vascular embols, degree of
tumourous necrosis, presence of a peritumourous capsule, presence of nuclear
pleomorphisms, pathologic type of the HCC and degree of differentiation were
not found to be associated with a higher risk of early death by HCC recur-
rence.This study allowed us to identify patients with HCC at high risk of early
death by recurrence. For these patients, early prevention of recurrence by
aggressive medical therapy should be envisaged.
V03.4
N-acetylcysteine modulates the late phase of liver ischemia-reperfusion injury
G Glantzounis1,W Yang1, R Kotir1,A Seifalian1 and B Davidson1
1Royal Free Hospital, University Department of Surgery, London, UK
It has been suggested that N-acetylcysteine (NAC) may modulate the initial
phase (<2 hrs of reperfusion) of liver ischemia-reperfusion injury (I/R), but its
effect in the late phase remains unclear.The aim of the present study was to
investigate the role of NAC in liver I/R injury in a rabbit model.Three groups
of New Zealand white rabbits were used (n=6 each). In the first group, NAC
(150 mg/kg/hr) was administered 15 minutes before reperfusion and main-
tained at dose of 10 mg/kg/hr during reperfusion period. In the second group
(placebo), 20 ml of 5% D/W was infused 15 minutes before reperfusion and
continued at a rate of 10ml/kg/hr. In the third group, animals were sham-oper-
ated and no ischemia was induced. In the first and second group, median and
left lobe hepatic ischemia was induced for 60 minutes, followed by 7 hrs of
reperfusion. Bile flow, hepatic microcirculation and hepatic tissue oxygenation
were continuously recorded. Indocyanine green (ICG) clearance was measured
directly by near infrared spectroscopy (NIRS) 6 hours after reperfusion. NAC
produced significant improvement in flow in the hepatic microcirculation after
the 5th hr, improved tissue oxygenation after the 2nd hr and improved liver
function significantly, as indicated by ICG clearance (all p<0.05). In conclusion,
NAC seems to ameliorate the liver injury after warm I/R in a rabbit model.This
protective effect is only after the initial phase of I/R.
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V03.5
Critical graft size in adult-to-adult living donor liver transplantation: the impact
of the severity of the recipient’s disease.
M Ben-Haim1, S Emre2,T Fishbein2, P Sheiner2, ME Schwartz2 and CM Miller2
1The Chaim Sheba Medical Centre, Surgery B and Transplantation, Tel-
Hashomer, Israel
2The Mount Sinai Medical Centre, The Recanati / Miller Transplantation
Institute, New-York, United States
INTRODUCTION: A limiting factor in the use of adult-t- adult living donor
liver transplantation (A-ALDT) has been the adequacy of graft size. Previous
series suggested minimal graft: recipient weight ratio (GRWR) of 0.8-1%, but
without accounting for recipients disease. METHODS: Forty adults (mean age,
52±14; mean weight, 72±14kg) underwent liver transplantation using left lobes
(n=10, mean weight, 481±83g) or right lobes (n=30, mean weight, 845±182g).
Outcomes were evaluated with emphasis on graft size, using GRWR, and on
severity of disease, using Child-Turcotte-Pugh (CTP) score. Small-for-size syn-
drome was defined clinically, by poor graft function without ischemia markers.
RESULTS:There were 6 recipients’ early deaths (early patient survival, 85%) and
2 late deaths to tumour recurrence.Among recipients with normal liver func-
tion or CTP class A, there was no significant difference when small grafts
(GRWR<0.85, n=6) or large grafts (GRWR>0.85, n=9) were transplanted (graft
survival, 83% vs. 88% respectively, p=0.65). In CTP class B or C recipients of
large grafts (GRWR>0.85, n=19) the graft survival was 74%. Five of 6 CTP class
B or C patients who received small grafts (GRWR<0.85%), developed small-for-
size syndrome: 2 died (one after re-transplantation), 4 survived (2 after re-
transplantation). The graft survival was only 33%, p=0.023. CONCLUSIONS:
Graft function and survival are influenced not only by graft size, but also by pre-
transplant disease severity. GRWR as low as 0.6% can be used safely in non-cir-
rhotics or CTP class A patients. CTP class B and C recipients require
GRWR>0.85 to prevent small-for-size syndrome and related morbidity.
V03.6
Moderate hypothermia prevents increases in intracranial pressure and cerebral
hyperemia in patients undergoing liver transplantation for acute liver failure
S Olde Damink1,A Lee2, N Deutz3, P Hayes4 and R Jalan5
1Maastricht University Hospital, Surgery, Maastricht,The Netherlands
2Royal Infirmary Edinburgh, Liver Unit, Edinburgh, United Kingdom
3Maastricht University Hospital, Surgery, Maastricht,The Netherlands
4Royal Infirmary Edinburgh, Liver Unit, Edinburgh, United Kingdom
5UCL, Liver Institute, London, United Kingdom
During liver transplantation (OLT) for acute liver failure (ALF), some patients
develop acute increases in intracranial hypertension (ICP). We tested the
hypothesis that increases in ICP during OLT for ALF can be prevented by mod-
erate hypothermia.16 patients with ALF were studied (age 29 (28-54), 12
females). Patients were monitored using an ICP monitor and cerebral blood
flow (CBF) was determined. Group I (n=6) comprised of patients that did not
require treatment for increased ICP (ICP<15mmHg) and underwent OLT with
body temperature at 35.9°C (1.3). Group II (n=5) comprised of patients who
had episodes of increased ICP that was controlled on treatment with mannitol
to <15mmHg and underwent OLT with temperature at 36.4°C (1.1). Group III
(n=5) comprised of patients who had uncontrolled increased ICP prior to OLT
for which they had been cooled (temperature maintained at 33.4°C (0.8).
RESULTS:Group I had significant increase in ICP (p<0.01) during dissection and
reperfusion phases (p<0.05). Group II also had significant increase in ICP dur-
ing dissection (p<0.001) and reperfusion phases (p<0.01). Group III had no sig-
nificant increase in ICP during the OLT.The increase in ICP during dissection
and reperfusion was greater in groups II and I compared with group III.The rise
in ICP in groups I and II were associated with increased CBF which was not
observed in Group III. The increase in ICP was corrected by clamping the
suprahepatic vena cava (anhepatic phase). CONCLUSIONS: Moderate
hypothermia successfully prevents increases in ICP during OLT for ALF.
V03.7
Liver transplantation for hepatitis-B: long term results and therapeutic progress
N Rayes1, D Seehofer1,T Steinmüller1,T Berg2, U Hopf2, R Neuhaus1,AR Müller1
and P Neuhaus1
1Charitè Campus Virchow, Department of General, Visceral- and Transplant-
Surgery, Berlin, Germany
2Charité Campus Virchow, Department of Gastroenterology and Hepatology,
Berlin, Germany
Since passive immunoprophylaxis and new antiviral agents are thought to
improve survival rates in liver transplantation for hepatitis B, we performed a
long-term retrospective analysis of our hepatitis-B patients in different periods.
PATIENTS: In total 206 hepatitis-B patients were liver transplanted at our cen-
tre. 55% were transplanted for HBV-cirrhosis, 10% for ALF and 14% due to HBV
plus HCC, the remaining 21% for HBV cirrhosis plus HDV or HCV.
Management included long-term passsive Immunoprphylaxis (>100 U/l) and in
addition since 1993 HBV-DNA positive patients were treated pre-and postop-
eratively with famciclovir, since 1996 with lamivudine. HBV-recurrence was
treated likewise. RESULTS: Overall 1-, 5- and 10-year patient survival rate was
95%, 80% and 75%, respectively. Survival was significantly impaired in patients
with HCC or with HBV-recurrence. However HBV-recurrence revealed excel-
lent survival rates (100%) in patients with either HDV-or HCV-coinfection.
Preoperative viral replication slightly impaired long-term survival (95%, 78% and
61%). Under newer antiviral options survival was improved, although not yet
statistically significant. Graft losses due to reinfection were most frequently
seen in patients transplanted in era I, and up to now not at all in era III.
era I (1988-93) era II (1994-1996) era III (1997-2000)
1/2 year reinfection rate: 34%/42% 37%/46% 15%/15%
1/2 year patient survival: 89%/84% 89%/83% 96%/93%
CONCLUSION: Liver transplantation for hepatitis-B patients with adequate
prophylaxis and antiviral treatment reveals excellent survival rates, not inferior
to other indications. In the future new problems might evolve due to broader
antiviral pre-treatment and evolution of multiresistant strains prior transplan-
tation.
V03.8
Effects of bioartificial liver support treatment on coagulation in anhepatic pigs.
MN Sosef1 SL Abrahamse1, M-P van de Kerkhove1, MN Levi2, TM van Gulik1 and
RAFM Chamuleau3
1Departments of Surgery, 2Hematology, and 3Exp. Hepatology, Academic
Medical Centre,Amsterdam,The Netherlands
INTRODUCTION: The function of a bioartificial liver (BAL) based on viable
porcine hepatocytes has been evaluated in anhepatic pigs.The purpose of the
present study was to assess the contribution of BAL treatment to blood coag-
ulation. METHODS: Pigs (40-55 kg) were anaesthetized and a total hepatecto-
my was performed (n=14).The infrahepatic caval vein and the portal vein were
connected to the subdiaphragmatic caval vein using a 3-way prosthesis.Animals
received standard intensive care (group I, n=5), treatment with an empty BAL
(group II, n=4) or with a cell-loaded BAL (group III, n=5) for a period of 24
hours starting 24 hours after hepatectomy. Main parameters were prothrom-
bin time (PTT), antithrombin III (AT III) and thrombin-antithrombin (TAT) com-
plexes. RESULTS: PTT, factor II, factor V,AT III and fibrinogen rapidly decrease
after total hepatectomy in pigs, reflecting the anhepatic state of the animals.
Numbers of platelets also decrease, especially during connection to the extra-
corporeal circuit (groups II and III). Treatment of anhepatic pigs with the BAL
containing hepatocytes does not improve PTT, factor II, factor V,AT III and fib-
rinogen levels. This is explained by the direct complexation of newly synthe-
sised coagulation factors in anhepatic pigs, as demonstrated by increased TAT
and F1+2 complexes in BAL-treated animals (group III). Levels of fibrinogen, t-
PA and PAI-1 are not influenced by BAL-treatment. CONCLUSIONS:
Treatment of anhepatic pigs with the BAL containing hepatocytes does not
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improve PT times and AT III levels.This can be explained by a direct complex-
ation of newly synthesised ATIII in anhepatic pigs.
V03.9
Could biological markers influence prognosis and treatment strategies of
patients affected by colorectal cancer with or without liver metastases?
M Ravaioli1, C Barozzi2, M Bonoli2, A d’Errico2, GL Grazi1, G Poggioli1, G
Ercolani1,WF Grigioni2 and A Mazziotti1
1Liver Transplantation, Surgery, Bologna, Italy
2Pathology, Oncohematology, Bologna, Italy
BACKGROUND: Biological markers enabling prediction of behaviour of col-
orectal cancer (CRC) are debated. Local and systemic extents of tumour
spread are the most widely prognostic indicators, but aren’t sufficient always to
predict the clinical course of the disease. PATIENTS AND METHODS:To iden-
tify biological markers,which may improve clinical staging,we analysed the influ-
ence on CRC prognosis of TGF-alpha, Her-2/neu, MMP-2, VEGF, IGF-II and
microvessel density. Surgical specimens were obtained from 60 patients with
CRC of whom 31 developed liver metastases (CRC-M1) and 29 had a mean
disease-free survival of 11 years (CRC-M0). Protein expression of TGF-alpha,
Her/neu, VEGF and IGF-II was detected by immunohistochemistry; mRNA
expression of MMP-2 by in situ hybridization; and microvessel density (MVD)
by computer-assisted image analysis after immunostaining with anti-CD34 anti-
body. Chi-square analysis was performed to evaluate the differences between
the two groups and logistic regression was used to assess associations among
biological variables and depth of invasion of CRC (T) and lymph node involve-
ment (N). RESULTS: Chi-square analysis showed that expression of TGF-alpha,
Her-2, MMP-2,VEGF, IGF-II and MVD, was significantly higher in CRCs-M1 than
in CRCs-M0 (p=0.001, p=0.026, p=0.006, p=0.005, p=0.001, p=0.008, respec-
tively). Logistic regression indicated that TGF-alpha, MMP-2 and IGF-II were
more highly expressed in CRC-M1 tumours, independently of T and N. CON-
CLUSIONS: This study suggests that TGF-alpha, MMP-2 and IGF-II could be
related to CRC progression and provide useful information to stratify patients
at high risk of developing distant metastases independently of T and N.
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V04.1
Negative prognostic factors in iatrogenic bile duct injuries
M Erkan, K Acarli, I Ozden,A Emre,A Alper, O Bilge,Y Tekant, O Ariogul
University of Istanbul, Istanbul Medical Faculty, HPB Surgery, Istanbul,Turkey
177 patients with iatrogenic bile duct injuries, treated between 1978-2000 were
reviewed to find negative prognostic factors.The initial operation was chole-
cystectomy in 75% (88 open, 44 laparoscopic). Between 1990-1995, laparo-
scopic injury rate was 28% among all cholecystectomies.This ratio rose to 42%
from 1995 to 2000 and it was 50% in 2000. 65% of patients had previous oper-
ations before referral. It was either reconstruction (86%) or drainage (14%).
Average time elapsed from initial operation to referral was 732 days. 32
angiographies were made on 70 patients (available after 1998), and 16 vascular
injuries have been detected. Surgical and non-surgical treatments were used in
86% and 14% respectively. Roux-Y hepaticojejunostomy was the most pre-
ferred method (80%). 27 patients were septic on admission. Excluding the 7
patients who were in extremely poor condition on admission, the mortality
rate was 5%. 142 patients were followed up for an average of 42 months (1-
180). Outcome was excellent in 63% (no symptoms-normal biochemistry),
good in 22% (no symptoms-elevated cholestasis enzymes), fair in 6% (improve-
ment in cholangitis), poor in 1% (persistent cholangitis). 11 patients died on fol-
low up (6 unrelated causes).There were 15 restenosis cases. 11 were treated
surgically and 4 with PTC-balloon dilatation.We concluded that restenosis was
significantly more common among patients who had previous reconstruction
(13 vs. 2, p=0.02), mortality rate was significantly higher among patients who
were septic on admission (9 vs. 7, p<0.0001) and vascular injury had no signifi-
cant effect on either restenosis or mortality.
V04.2
Long-term outcome of hepaticojejunostomy with routine access loop forma-
tion following bile duct injury at cholecystectomy
R Al-Ghnaniem and IS Benjamin
King’s College Hospital, Academic Department of Surgery, London, United
Kingdom
AIM:To examine the long-term outcome following hepatico-jejunostomy (HJ)
for iatrogenic bile duct injury and the utility of routine construction of an
access loop (AL). PATIENTS AND METHODS: Patients with iatrogenic biliary
injuries were treated with HJ and AL. Injuries were classified according to
Bismuth level (BL).An ‘excellent ’ outcome was achieved if the patient did not
experience jaundice or cholangitis in the follow up period and ‘good’ if the
patient had required radiological intervention but has been asymptomatic for
longer than 12 months. RESULTS: Forty-eight patients underwent such opera-
tion.There was one (2%) operative death.The mean follow up period was 67
months [range 6-118]. Sixteen (35%) injuries were BL II, 20 (43%) BL III and 10
(22%) BL IV. Outcome was dependent on the BL (P < 0.001). It was excellent
in all BL II patients, excellent in 13 (65%) and good in 7 (35%) in BL III and excel-
lent in 2 (20%), good in 6 (60%) and poor in 2 (20%) patients with BL IV injuries.
Moreover, the need for AL intervention was dependent on the BL (P<0.001).
None of the BL II patients required intervention compared to 6 (30%) of BL III
and 8 (80%) of BL IV. CONCLUSION: Biliary reconstruction affords satisfacto-
ry long-term outcome.The likelihood of needing the AL for radiological inter-
vention is dependent on the BL.We recommend that AL should be construct-
ed in all BL III and IV injuries and selectively in BL II injuries.
V04.3
Complicated Choledochal Cysts
A Agarwal,A Chaudhary and AK Sachdev
GB Pant Hospital & MAM College, GI Surgery, Delhi, India
Choledochal Cysts are now being diagnosed more often all over the world
both because of an increased awareness and better diagnostic modalities.The
complication potential of the choledochal cysts is well known but there are
very few reports addressing the issue.This study was aimed to ascertain the
incidence , the type of complication and their presentation in-patients with
Choledochal cysts and the results of surgery in these patients. 81 patients of
Choledochal Cysts were operated on between January 1988 and June 1999. Of
these 16 (20%) patients were found to have a complicated Choledochal Cyst.
There were 15 adults and one child. 11 of these patients were female and 5
male. Complications include acute cholangitis (5), Liver abscess (2),
Spontaneous perforation (1), and Malignancy (1). 5 of these patients had under-
gone a previous cyst-enteric drainage prior to referral.All patients underwent
surgery at our centre with the aim of excision of the Cyst. Of the 81 patients
with CDC, 53(65%) had Todani type I and 26(32%) type IVa and one each type
II and IV b cysts. Six (11%) patients with type I cysts and 10 (38%) with type IV
a cysts had complications (p<0.5%).While all patients with uncomplicated CDC
underwent a one stage complete excision of the extra hepatic bile duct and a
wide hilar anastomosis with a roux loop of jejunum.The surgical excision was
technically more difficult in-patients with complicated CDC. Excision was pos-
sible in 14 of 16 patients and of these 2 patients needed staged surgery. In one
patient each with portal hypertension and malignancy, only a wide cyst-enteric
drainage was possible. Complications in Choledochal cysts were seen in 20% of
patients. Complications develop more commonly in adult patients and those
with type IVa Cysts. Despite the presence of complications, the Choledochal
Cysts in a majority of patients can be safely excised. However the best treat-
ment of complications of Choledochal Cysts remains prevention and excision
of all choledochal cysts is recommended as soon they are diagnosed.
V04.4
Is aggressive surgical approach justified for BDC and CCC?
T Lorf, L Moreno, U Hanack, R Canelo and B Ringe
Georg August Universität, Klinik für Transplantationschirurgie , Göttingen,
Germany
INTRODUCTION: According to their different location, clinical feature and
prognosis, intrahepatic cholangiocarcinoma (CCC) should well be differentiat-
ed from proximal bile duct carcinoma (BDC).We retrospectively reviewed the
clinical course of 32 consecutive patients in the viewpoint of an aggressive sur-
gical approach in both diseases. PATIENT AND METHODS: During the period
from 1994 to 2000 we operated on 16 patients (male = 9;female = 7) with BDC
(UICC I = 1; II = 3; IVA = 12) and 16 patients (male = 12;female = 4) with CCC
(UICC II = 2; III = 5; IVA = 9). 15/16 patients with BDC underwent liver and/or
bile duct resection. In 6 cases additional portal vein resection was necessary to
achieve resectability. 12/16 patients with CCC underwent major liver resec-
tions, in 2 cases in combination with partial resection of inferior caval vein
(IVC). RESULTS: Achieved resectability rate for BDC and CCC was 94% and
75%, respectively. Curative resection (R0) could be obtained in 13/16 BDC and
in 9/16 CCC. In patients with BDC median survival was after R1-resection 12.1
[0.2-15], and R0-resection 14.5 [1.5-56] months. Median survival in CCC was
R1: 3.9 [1.3-7] and R0: 10.4 [1.2-51] months, respectively. The nonresectable
patients had a median survival of 2.7 [0.17-3.4] months. CONCLUSIONS: We
advocate an aggressive approach utilizing an extended resection if necessary
including vascular replacement in patients with BDC and CCC. Selected
patients seem to have benefit with prolonged survival and even cure.
IHPBA Abstracts, Monday, May 28, 2001
34
V04.5
Hilar cholangiocarcinoma involving the portal bifurcation: long-term results
after resection
L Muã‘Oz,T Fishbein, P Sheiner, S Emre, C Miller and M Schwartz
The Mount Sinai Hospital, R/M Transplantation Institute, New York, United
States
INTRODUCTION: Resection offers the only potential for cure of hilar cholan-
giocarcinoma (CCA). Involvement of portal bifurcation is often thought to con-
traindicate resection.We have reviewed our experience to determine whether
aggressive surgical management improves survival. METHODS: Of 137 patients
with CCA evaluated between 1/90 and 1/01, 63 (45.9%) were resected.Tumour
location was distal in 13, intrahepatic in 22, and hilar in 28; this report concerns
the latter group. All 28 patients underwent hepatectomy and bile duct resec-
tion with hepaticojejunostomy. In 10 cases (Group 1) the portal bifurcation was
involved, necessitating portal resection and reconstruction; 18 (Group 2) had
no portal involvement . Frozen section of duct margins was done routinely.
Survival was estimated using the Kaplan-Meier method, and compared between
groups with the log-rank test. RESULTS: Portal reconstruction in Group 1 was
by graft interposition (1), venoplasty using the posterior wall of the right por-
tal vein (2), or end-end anastomosis (7). Hepatectomies included R trisegmen-
tectomy (8), R lobectomy (4), and L lobectomy (16); 20 (71%) had concomitant
caudate resection. No statistical differences were found in terms of tumour
size, perineural invasion, or need for blood transfusion. Mortality within 60 days
was 7.1%.At mean 32 months follow-up, 4 patients in Group 1 and 6 in Group
2 remained alive and free of disease. One, 2, and 4-year survivals were 60%, 45%
and 23% in Group 1, and 77%, 62% and 37% in Group 2 (p = ns). CONCLU-
SIONS: Portal involvement by CCA is not a contraindication to resection.
V04.6
Transforming growth factor beta1 (TGF-beta1) induces the expression of vas-
cular endothelial growth factor (VEGF) in human cholangiocellular carcinoma
(CCC)
C Benckert1, S Jonas2, T Cramer, Z von Marschall, B Wiedenmann, S Rosewicz
and P Neuhaus
1General, Visceral, and Transplantation Surgery, General, Visceral and
Transplantation Surgery, Berlin, Germany
2Hepatology and Gastroenterology, Hepatology and Gastroenterology, Berlin,
Germany
BACKGROUND: VEGF is a well-established proangiogenic factor, which has
been shown to be regulated by TGF-beta1. Our aim was to examine the
expression of VEGF and TGF-beta1 in CCC and to analyze the regulation of
both at the molecular level. METHODS:VEGF,TGF-beta1 and their receptors
were examined by immunohistochemistr y, in situ-hybridisation, RT-PCR and
ELISA, respectively.VEGF-regulation by TGF-beta1 was assessed in transactiva-
tion assays using a series of 5-deletion reportergene-constructs of the VEGF
promoter. RESULTS: VEGF-mRNA and protein were over expressed in all
tumour cells when compared to non-transformed surrounding tissue. VEGF-
receptors Flt-1 and KDR/flk-1 were detected in 15/19 and in 10/19 samples in
tumourendothelium.TGF-beta1 and TGF-beta-receptors were present in 19/19
CCC´s.TGF-beta1 treatment significantly increased VEGF-protein levels in two
representative CCC cell lines. Analysis of VEGF promoter constructs in tran-
sient transfection experiments confirmed a substantial up-regulation of VEGF
promoter activity in response to TGF-beta1 treatment. Utilizing deletion con-
structs of the 5 ´flanking region of the VEGF promoter (-2018 to +50), the
region 85 to -50 was shown to be necessary and sufficient for both TGF-beta1
inducible and basal VEGF expression. This region contains potential SP-1 and
EGR-1 binding sites.Mutational analysis revealed that SP-1, but not EGR-1 bind-
ing sites were necessary for basal expression as well as TGF-beta1 responsive-
ness. CONCLUSION: Our data characterize TGF-beta1 as a potent stimulus of
VEGF in CCC via SP-1 mediated transactivation of the 85 to-50 region of the
VEGF promoter. Disruption of TGF-beta1/VEGF interaction may provide tar-
gets for suppression of tumourneovascularization in CCC.
V04.7
To drain or not to drain: a meta-analysis on the efficacy of preoperative biliary
drainage for tumours causing obstructive jaundice
T Karsten1, ME Sewnath1, MH Prins2 and DJ Gouma1
1Departments of Surgery and 2Clinical Epidemiology,Academic Medical Centre,
Amsterdam
To review the effectiveness of preoperative biliary drainage (PBD) in patients
with suspected malignant tumours causing jaundice, a systematic review and
meta-analysis was performed of randomized controlled trials (RCT) and com-
parative cohort studies (CCS) conducted world-wide and published between
1981 and 2000, classified on methodological strength and subdivided in level I:
RCT, and level II: CCS. Comparison was made of PBD vs no PBD (immediate
surgery) in jaundiced patients undergoing tumour resection. For qualitive
review, relative differences (%) were calculated to compare effects on overall
outcome. Outcomes were in-hospital mortality, overall morbidity due to the
treatment modality (drainage and operation related complications) and hospi-
tal stay. For qualitative data, effect sizes were calculated and combined in meta-
analyses. Five RCTs, including 302 patients, met the inclusion criteria for level I
type studies, and 13 CCSs, including 2195 patients, met the criteria for level II
type studies. Meta-analysis of level I studies showed no difference in mortality
between patients who had PBD and those who had immediate surgery, Peto
odds ratio (OR)[95% Confidence Interval (CI)]: 1.19 [0.63-2.23] . Overall mor-
bidity however, was significantly adversely affected by PBD compared with
immediate surgery, Peto OR [95% CI]: 1.99 [1.25-3.16].At level II, there was no
difference in mortality between the 2 treatment modalities, Peto OR [95% CI]:
1.01 [0.64-1.57] . Also for the overall morbidity, there was no benefit of PBD,
Peto OR [95% CI]: 1.07 [0.82-1.40] . If PBD had been without complications,
morbidity would be in favour of drainage, Peto OR [95%CI]: for level I: 0.59
[0.37-0.94] and for level II: 0.61 [0.49-0.75] . Furthermore, PBD was not able to
reduce the length of postoperative hospital stay compared with immediate sur-
gery; instead, it prolonged the total length of hospital stay (level I: 42 ± 5 days
vs. 24 ± 4 days, resp.; level II: 33 ± 5 days vs. 18 ± 5 days, resp.). CONCLU-
SIONS: PBD for patients with suspected malignant tumours causing jaundice
carries no benefit . Only if PBD related complications could be reduced with at
least 27% and consequently diminish hospital stay, than PBD might be benefi-
cial.
V04.8
Thoracoscopic splanchnicectomy for intractable pain in patients with unre-
sectable pancreatic cancer
J Kuriansky, M Ben-Haim, D Rosin, M Shabtai and A Ayalon
The Chaim Sheba Medical Centre, Surgery B and Transplantation,Tel-Hashomer,
Israel
INTRODUCTION: Intractable pain is the most distressing and disabling prob-
lem in patients with unresectable pancreatic cancer (PC).AIM:The study was
conducted to evaluate the efficacy and the safety of Thoracoscopic
Splanchnicectomy (TS) for pain control in patients with unresectable PC.
METHODS: Patients with PC,who were Opiate-dependent and/or incapable to
perform daily activities were included. Subjective evaluation of pain with visual
analogue scoring system (0 to 10 scale) was performed before and after TS.
RESULTS: Between May 1995 and April 2000, 34 patients (19 men and 15
women, mean age, 65) underwent 55 TSs (some underwent unilateral TS fol-
lowed by a second contralateral TS).All procedures were completed in a tho-
racoscopic fashion and there were no procedure related complications. The
mean operative time was 38 minutes for unilateral-, and 65 minutes for bilat-
eral TS.The mean pain score decreased from 8.5 (range, 8-10) preoperatively
to 3 (range 0-5) after the TS, p<0.05. All patients reported reduction in anal-
gesic usage. Complete pain relief until death to PC, was achieved in 84% of the
patients. CONCLUSIONS:TS is safe and very effective for intractable pain relief
in patients with PC.
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V04.9
Colonic involvement in acute pancreatitis – an 11 year retrospective study of
16 patients
P Van Minnen1, K Bosscha1, M Besselink1, M Schipper2 and H Gooszen1
1University Medical Centre Utrecht, Surgery, Utrecht,The Netherlands
2University Medical Centre Utrecht, Pathology, Utrecht,The Netherlands
Colonic necrosis in acute pancreatitis is a severe and potentially lethal compli-
cation. Resection of the affected segment is the treatment of choice. In this ret-
rospective study of the period from 1990 until 2001, the location, pathology
and treatment of colonic involvement in acute pancreatitis were reviewed to
evaluate the current theories on pathogenesis, and treatment of this complica-
tion. All 16 patients had severe acute pancreatitis (Ranson score 3 or greater,
mean SAP score = 12). In 13 patients colonic involvement was suspected dur-
ing surgery, one had intramural gas on CT, two had colonic haemorrhage. 21
segments were removed in 16 patients for suspected imminent perforation
based on the aspect of the outer surface of the colon. 16 segments were sent
for pathologic review; three of the other five segments that were disposed of
had a macroscopic perforation. 11 patients died, 8 due to multiple organ fail-
ure. All 16 specimens showed necrosis and pericolitis in the pericolic fat, of
these 4 had ischaemia on microscopic examination, 5 showed subserosal haem-
orrhage. The right hemicolon was involved most frequently, in 12 cases.
Secondary anastomosis did not induce further mortality. CONCLUSION:
spread of pancreatic enzymes and inflammation is a major cause for colonic
involvement . Special attention should be paid to detect early colonic involve-
ment. Outside-inspection of the colon during surgery is unreliable to detect
ischaemia or imminent perforation. In case of no evident perforation, intra-
operative colonoscopy is advised to avoid unnecessary resection.An aggressive
surgical approach seems to be justified.
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V05.1
The value of laparoscopy and laparoscopic ultrasound in determining
resectability of colorectal hepatic metastases
JNM IJzermans1, M Gholghesaei1, JM van Muiswinkel2, G Kazemier1 and HW
Tilanus1
1University Hospital Rotterdam - Dijkzigt, Surgery, Rotterdam,The Netherlands
2University Hospital Rotterdam - Dijkzigt, Radiology, Rotterdam, The
Netherlands
OBJECTIVE:To assess the value of laparoscopy and laparoscopic ultrasound in
the selection of patients for resection of colorectal hepatic metastases.
METHOD: 58 patients considered to have potentially resectable colorectal
hepatic metastases after helical CT were subjected to laparoscopy and laparo-
scopic ultrasound were retrospectively reviewed. Primary outcome measure-
ment was the number of cases in which laparoscopy and laparoscopic ultra-
sound resulted in the finding of contraindications for resection and therefore
leading to a change in therapeutic approach. FINDINGS: Out of 58 patients 57
patients were analysed using laparoscopy and laparoscopic ultrasound. In one
patient iatrogenic perforation of the small intestines necessitated a conversion
to open exploration. In 19 patients (33%) the procedure yielded a result pro-
hibiting resection.The main findings were extrahepatic spread and a close rela-
tion of metastases to major vessels. 3 patients were ruled out for resection on
other grounds. 35 patients went on to open exploration leading to resection in
30 cases. The combined laparoscopy and laparoscopic ultrasound procedure
predicted resectability correctly in 79% of the cases.The sensitivity of CT com-
pared with the resected specimen regarding the number of lesions detected
was 89%.The sensitivity of laparoscopic ultrasound was also 89%. CONCLU-
SIONS: Laparoscopy and laparoscopic ultrasound contribute significantly to the
selection of patients for resection of metastases preventing open exploration
in a substantial number of patients. Laparoscopic ultrasound does not seem to
detect more metastases than CT but its value lies in establishing the relation of
tumour to vascular structures.
V05.2
Biopsy of Colorectal Liver Metastases and the risk of dissemination
MS Rodgers1, R Cannan2, R Collinson, S Desai, RS Stubbs2 and JL McCall1
1University of Auckland, Surgery,Auckland, New Zealand
2Wakefield Centre,Wellington, New Zealand
INTRODUCTION: It is generally accepted by liver surgeons that biopsy of col-
orectal liver metastases is seldom necessary and can result in dissemination,
which risks rendering the patient incurable.To date the magnitude of this risk
has not been documented. This study is an attempt to quantify this risk.
METHOD:A multicentre retrospective review was undertaken of cases of col-
orectal liver metastases presenting for surgery. The patients who had under-
gone biopsy of the lesion preoperatively were identified and analysed with a
standard proforma. Documented evidence was sought of dissemination caused
by the biopsy. Particular note was made of cases in which dissemination pre-
cluded curative surgery. RESULTS: Forty-five cases of colorectal liver metas-
tases that were biopsied prior to curative surgery were identified.Twenty-one
biopsies were performed at open surgery at the time of their colon resection,
2 were done as laparoscopic procedures, and twenty-two were performed
radiologically. Nine of the cases (20%) had evidence of spread related to the
biopsy. Four had spread to the parietal peritoneum, 4 had local invasion of the
diaphragm, 1 had invasion of small bowel adherent to the liver and 1 had intra-
hepatic spread.The median time between biopsy and definitive surgery was 64
days. Notably only 2 of these 9 cases did not proceed to liver resection and
only 1 because of biopsy related spread. CONCLUSION: Biopsy of colorectal
liver metastases carries a substantial risk of spreading disease. However it is not
clear if this has a significant impact on resectability or patient survival.
V05.3
Analysis of allelic imbalance in colorectal cancer patients according to stage and
presence of synchronous liver metastatic lesions
JC Weber1, P Oudet2, A Schneider2, MP Gaub2, H Nakano2, Ph Bachellier1, A
Mustun1, Ph Wolf1, C Meyer1 and D Jaeck1
1Hopitaux Universitaires de Strasbourg, Department of Digestive Surgery,
Strasbourg, France
2Hopitaux Universitaires de Strasbourg, Department of molecular Biology,
Strasbourg, France
Spontaneous errors in DNA replication, i.e., allelic imbalance (AI) or
microsatellite instability (MSI), have been suggested to play an important role in
neoplastic transformation and to explain the chromosomal alterations in can-
cer cells. The present study investigates the relationship between AI and local
tumour progression or liver metastatis. MATERIALS AND METHODS: 102
patients with colorectal carcinoma undergoing surgical resection were includ-
ed.Among them, ten patients with synchronous liver metastases were includ-
ed. Patients were distributed following Astler-Coller classification as stage A
(n=6), stage B1 (n=11), stage B2 (n=31), stage C (n=29), and stage D (n=25).
The extracted DNA samples were amplified with PCR using primers for 35
polymorphic microsatellites markers targeting 17 chromosomes. Loss of het-
erozygosity between the normal tissue ant the tumour was diagnosed as AI and
frequency of AI (%AI) was compared with tumour progression. RESULTS: % AI
was significantly higher in stage D patients (63.7 ± 5.7%) than in the stage A-B1
(37.9 ± 5.1% ; p<0.01) and stage B2 (41.3 ± 4.2% ; p<0.01,ANOVA) . In addition,
%AI was significantly higher in the synchronous liver metastases (61.0 ± 7.1%)
than in the stage A-B1 cancer (p<0.05) and stage B2 cancer (p<0.05,ANOVA).
A stepwise regression analysis showed that %AI of certain microsatellites,
which are D18S61, D11S916 and D15S127, present significantly positive corre-
lations with Astler-Coller stage. CONCLUSION: The frequency of AI signifi-
cantly correlates with tumour progression of colorectal cancer. Primary
tumours with synchronous liver metastases also showed higher %AI, suggest-
ing that %AI indicates local progression and development of metastases.
V05.4
Liver resections for colorectal metastases: does aggressive policy improve long
term results?
G Ercoliani, GL Grazi, M Ravaioli, M Cescon,A Gardini, F Pierangeli,A Mazziotti
Surgical Unit, Surgery and Trasplantation, Bologna, Italy
AIM: Liver resection is the treatment of choice for colorectal metastases. An
aggressive policy for advanced cases has been proposed with controversial ben-
efit. We analysed results and long term prognosis obtained before and after
1992 when a more aggressive strategy was applied. METHODS: Of 256 liver
resections performed for colorectal hepatic metastases from 1984, 70 were
carried out before 1992 (group A) and 186 after 1992 (Group B).There were
38 male and 32 female in group A, 113 and 73 in group B, respectively. Mean age
was 59.1±9.2 years, and 59.8±10.1 years, respectively, (range 32-81 years). Mean
diameter of the largest lesion was 5.1±3.1 cm (range 0.4-20 cm), and 4.8±2.9
cm (range 1.5-18 cm), respectively. Mean number of nodules was 1.4±0.8 (range
1-5), and 1.8±1.3 (range 1-10), respectively (p=0.05). One or 2 nodules were
present in 92.9% of pts. operated on the first period, and in 78.3% of patients
in group B (p<0.01) . RESULTS:A wedge resection was performed in 12 (17.1%)
pts. in the first period and 30 (16.1%) pts. in the second period, respectively; a
segmentectomy (1-3 segments) in 45 (64.3%) and 88 (47.3%), an extended
hepatectomy (> 3 segments) in 13 (18.6%) and 68 (36.5%), respectively (p <
0.002).Among 60 pts. with multiple metastases, 71.7% were operated on in the
second period; similarly among 42 pts. with multiple bilobar lesions, 81% were
resected after 1992. Only in group B, 11 liver resection with inferior vena cava
(IVC) resection and reconstruction were performed for advanced cases with
IVC involvement. Furthermore, in .. pts a partial resection of diaphragm was
performed to achieve curative procedures. In 4 pts with bilobar metastases,
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two stage hepatectomy was performed after 1992. Intraoperative transfusion
was administered in 77.1% of pts. in the first period, and 30.1% in the second
(p<0.04). Operative mortality was 1.4% (1/70 pts.) and 0.5% (1/186 pts.),
respectively.The postoperative morbidity was 20% (14 out of 70 pts) and 17.7%
(33 out of 186 pts.), respectively. Mean postoperative stay was 13.1±12.3 days
and 9.1±11.7, respectively (p<0.001).The 1, 3 and 5 year actuarial survival was
84.2%, 45.7% and 28.5 in group A, and 90.5%, 57.9% and 38.3% in group B,
respectively (p<0.05). CONCLUSIONS: Since 1992, improved prognosis was
obtained even if a more surgical aggressiveness was applied for colorectal liver
metastases. This policy increased the operability rate, and satisfactory long-
term results with comparable morbidity and mortality could be achieved even
in advanced cases. Liver resection should be advised in every patient with col-
orectal hepatic metastases, whenever curative procedures can be performed.
V05.5
Vascular density and metabolic activity of liver metastases increase after
removal of primary colorectal tumours in humans
CFJM Peeters1,2, JR Westphal2,WJG Oyen3, DJ Ruiter2, Th Wobbes1, RMW de
Waal2 and TJM Ruers1
Departments of 1Surgery, 2Pathology, and 3Nuclear Medicine, University
Medical Centre Nijmegen, the Netherlands
Explosive growth of metastases after removal of the primary tumour has been
related to abolishment of angiogenesis inhibition in mouse models.We investi-
gated the influence of the primary colorectal tumour on vascularization and
metabolic activity of liver metastases in human patients. First, we analysed the
vascular density in liver metastases from three patient groups:
Patients with synchronous metastases and primary tumour in situ (n=24)
Patients with synchronous metastases and primary tumour resected (n=18)
Patients with metachronous metastases (n=13)
Vascular density was assessed by staining for CD31, and was scored as minimal,
moderate, high and very high. In synchronous metastases, vascular density was
highest when the primary tumour had been removed.A further increase in vas-
cular density was observed in metachronous metastases. From 5 patients, liver
biopsies taken both before and after resection of the primary tumour were
available. In four out of these five patients, vascular density after removal of the
primary tumour was increased. Second, we assessed the metabolic activity of in
total 13 liver metastases by using FDG-PET before and 2 months after resec-
tion of the primary tumour.As a control, FDG-PET scans were performed from
three synchronous metastases without surgical intervention, applying the same
time interval. A significant increase in metabolic activity was observed after
resection of the primary tumour, which failed to appear in the control group.
Our data show for the first time that also in humans, a primary tumour may
inhibit vascularization of its distant metastases.
V05.6
Adenovirus mediated TIMP-3 prolongs survival from colorectal carninoma liver
metastases.
JM Vogten1, TA Drixler1, EA te Velde1, MFB Gebbink2, EE Voest2, ThJMV van
Vroonhoven1 and IHM Borel Rinkes1
1University Medical Centre Utrecht, Surgery, Utrecht,The Netherlands
2University Medical Centre Utrecht, Medical Oncology, Utrecht, The
Netherlands
INTRODUCTION: Tissue inhibitors of metalloproteinases (TIMPs) are pro-
tease inhibitors that act to limit extracellular matrix (ECM) degradation by
metalloproteinases (MMPs), a process necessary for tumour invasion and
angiogenesis.TIMPs have been shown to limit local tumour invasion and growth
of hepatic metastases. Also,TIMP-3 inhibits angiogenesis in vitro.We hypothe-
size that TIMP-3 can prolong survival by inhibition of growth of colorectal car-
cinoma hepatic metastases.MATERIALS AND METHODS:A TIMP-3 adenovirus
was constructed by combining a cytomegalo virus (CMV) promotor and TIMP-
3 cDNA insert.The adenoviral TIMP-3 construct was tested in our mouse col-
orectal carcinoma hepatic metastasis model: nude mice received intrasplenic
injection of 10exp5 LS-174T colorectal carinoma cells to induce hepatic metas-
tases.Tumour bearing mice then received the adenoviral TIMP-3 construct or
empty virus or saline. Survival of tumour bearing mice was recorded. RESULTS:
Transfection efficiency of adenovirus into hepatocytes was 33%.No hepatocyte
toxicity was observed. Survival of mice with hepatic metastases was significantly
prolonged by transfection with TIMP-3, as compared to saline treated mice
(mean survival 63 days ± 6.5 vs 29 days ± 1.7; n=5 and 4, respectively) and
empty virus mice (29 ± 1.1 days; n=5 and 4, respectively). CONCLUSION:
Bolus transfection with our adenoviral TIMP-3 construct resulted in a signifi-
cant prolongation of survival in a murine model of colorectal carcinoma liver
metastasis. The most likely explanation for these observations, limitation of
hepatic metastatic growth, is currently under investigation.
V05.7
The effect of targeted therapy with radiolabelled octreotide on colon carcino-
ma cells transfected with a somatostatin receptor in a rat liver metastasis
model.
A Mearadji1, WAP Breeman2, LJ Hofland3, PM van Koetsveld3, RL Marquet1, J
Jeekel1, CHJ van Eijck1
1 Erasmus Medical University Centre Rotterdam, Surgery, Rotterdam, The
Netherlands
2 Erasmus Medical University Centre Rotterdam,Nuclear Medicine,Rotterdam,
The Netherlands
3 Erasmus Medical University Centre Rotterdam, Internal Medicine, Rotterdam,
The Netherlands
INTRODUCTION: Somatostatin receptors (SSRs) are expressed in most
neuro-endocrine tumours and various other tumours, like breast cancer and
malignant lymphoma. In previous studies we showed that in vivo targeted ther-
apy with radiolabelled octreotide is highly effective for tumours expressing SSR
The aim of this study was to transfect SSR negative tumour cells with a SSR-
gene in order to make them also feasible for targeted therapy with radiola-
belled octreotide. METHODS: CC531 colon carcinoma cells (SSR negative)
were transfected in vitro with a SSR (type2)-gene. Hereafter an in vivo study
was performed in rats. On day 0 normal CC531 cells or transfected CC531
cells (CC531/SSR) were injected into the portal vein. Rats were divided in 4
groups: CC531 treated, CC531 control, CC531/SSR treated and CC531/SSR
control.Treatment with radiolabelled octreotide was given i.v. on day 1 and 8.
Tumour colonies in the liver were counted on day 28.A biodistribution study
was performed in 12 rats in order tot test functionality of the transfected SSR.
RESULTS: Tumourscores in the CC531 treated group did not differ from
CC531 controls (p>0.05). Surprisingly, tumourscores in the CC531/SSR treat-
ed group also did not differ from CC531/SSR controls (p>0.05).
Austoradiography showed high expression of SSRs in CC531/SSR tumour, in
contrast to CC531 The biodistribution study showed high uptake of radioac-
tivity in the transfected tumour, which was comparable with our positive con-
trol CA20948. CONCLUSIONS: Although no effect of targeted therapy with
radiolabelled octreotide was seen in transfected tumours, we measured a high
uptake of radioactivity in these tumours, comparable with CA20948.
Apparently, the transfected colon carcinoma cells are radioresistant to our
given dosages. In future experiments higher and/or fractionated dosages of radi-
olabelled octreotide will be given in an attempt to make this treatment
effective.
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V05.8
The effects of octreotide on rats experimental liver tumour after partial hepa-
tectomy
GL Xu1
1Anhui Provincial Hospital, General Surgery, Hefei, China
OBJECTIVE: To investigate the effects of octreotide (OCT) on rats experimen-
tal live tumour after partial hepatectomy (PH) and its intrinsic mechanism.
METHODS: Sixty-four rats were divided into four groups and underwent a
laparotomy.Walker-256 tumour was implanted in the liver (IH), group B, C and
D had a left lobe PH and group A was control. Octreotide 50ug/kg was admin-
istered intraperitoneally (IP) twice a day to group C and D (OCT).The time of
first administered to group C was 12 hours after PH and to group D was 72
hours after PH. Group A and B received a similar volume of saline (NS). OCT
and the control group was evaluated for tumour volume, metastases and liver
function. Flow cytometry (FCM) was used to detect apoptot tumour cell DNA
content and the remaining normal regenerative hepatic cell DNA content.
RESULTS: group A (control+IH+NS) show a significant reduction of IH tumour
volume at 7days versus group B (PH+IH+NS) (p<0.01). Group C and D
(PH+IH+OCT) show a significant reduction of IH tumour volume at 7days and
15days versus group B (p<0.01).The tumour cell apoptotic rate of groupC and
D was significantly higher than those of group A and B at 7and 15 days
(p<0.01) the liver function at 7days of all group had no difference (p>0.05),
while at 15days, group B deteriorated significantly (p<0.01).The renain normal
regenerative hepatic cell DNA content of group B, C and D had no difference
at 7days (p>0.05). CONCLUSIONS: (1) growth of experimental liver tumour is
enhanced after PH and inhibited by OCT. (2) the antitumour mechanism of
OCT may mainly be inducing liver tumour cells to apoptosis. (3) OCT has no
significant suppression on hepatic cell regeneration. The rat has good drug
durability. [Index words] octreotide liver tumour hepatectomy.
V05.9
Extended hepatoduodenal lymph node dissection in hpb malignancies
P Kupcsulik1,A Szijjarto1 and O Hahn1
1Semmelweis University, 1st. Dept. of Surgery, Budapest, Hungary
Prospective studies are failing concerning the significance of extended lymph
node dissection containing the hilar, hepatoduodenal suprapancreatic left gas-
tric and paraaortic nodes in hepatobiliary malignancies. There is no validated
lymph node mapping on the above-mentioned region. Since 1995 a prospective
trial was conducted on extended lymphadenectomy in primary biliary, primary
and secondary hepatic tumours. In a consecutive series of 112 patients with
extended hepatoduodenal lymph node dissection (EHDLD), no mortality
occurred. One patient underwent US guided drainage of postoperative sub-
phrenic abscess. In all operated cases radical removal of the tumour was per-
formed. Out of 36 biliary tract cancer (BT) 54%, of 54 colorectal liver metas-
tases (CLM) 29 %, of 16 HCC 50% showed lymph node metastasis.Six further
cases of different metastatic or primary tumours regarding the low number of
patients were not involved in the study. CLM, HCC and BT have characteristic
lymph node metastasis picture. CLM metastases occurred in 42% in the coeli-
ac trunk nodes. Nodes around the pancreatic head were tumour free in 100%.
Metastases of HCC are predominantly present in the hepatoduodeal ligament
with no involvement of pancreatic and coeliac nodes. Klatskin tumour gave
metastasis in 100 percent to coeliac nodes.3 year survival of CLM patients with
EHDLD is significantly better than those without (77% vs 52%). Conclusions:
EHBDL is indicated in cases of HCC, BT and especially of CLM. Different
tumours have typical lymph node metastasis picture. EHBDL significantly
enhances late survival after surgical removal of colorectal liver metastases.
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V06.1
Ct-severity index as prognostic tool for conservative treatment of acute 
Pancreatitis
P van de Linde1, PW Vriens1, PE Warmerdam2 and PJ Breslau1
1Rode Kruis Ziekenhuis, Surgery, Den Haag,The Netherlands
2Rode Kruis Ziekenhuis, Radiology, Den Haag,The Netherlands
Acute pancreatitis is a severe disease with unpredictable outcome that may
vary from rapid recovery to death. Treatment of acute pancreatitis is still a
source of controversy. We describe the value of CT-scanning as a prognostic
tool in the maximally conservative treatment of acute pancreatitis at the
department of surgery in a peripheral hospital. From 1994 to 2000, 56 patients
were admitted with the diagnosis acute pancreatitis, as defined by clinical find-
ings and raised serum amylase. The average age was 60, 46% were males. All
patients underwent CT-scanning with i.v. contrast within 48 hours. Balthazar
score as well as amount of necrosis was assessed to define the CT Severity
Index (CTSI). All patients were managed in a standardized fashion: Treatment
was maximally conservative with antacids, nasogastric decompression, and i.v.
fluid administration. Enteral tube feeding was initiated as soon as possible.
Antibiotics and surgery were reserved for treatment of septic complications
and hemodynamic instability only. The overall complication rate was 59% and
in-hospital mortality was 9%. In patients with a CTSI<5, these rates were 50%
and 2% (n=43), in patients with a CTSI=>5, 92% and 31% respectively (n=13).
CTSI correlated well with the incidence of complications (R2=0.91), mortality
(R2=0.91), and days admitted in the hospital (R2=0.98) . Conclusion:Acute pan-
creatitis is associated with significant morbidity and mortality. Maximal conser-
vative treatment with rapid enteral tube feeding and reserved antibiotic thera-
py results in an acceptable mortality rate. CTSI is an excellent prognostic tool
for complications and mortality.
V06.2
Treatment of infected pancreatic necrosis
V Glabai, R Temirsultanov,V Makarova,A Sharov And A Abramov
Department of Surgery, Moscow Medical Academy, Moscow, Russia
During the period from 1991 until 2000, 1890 patients with acute pancreatitis
were observed.Among them - 486 patients with pancreatic necrosis, 192 were
operated for infected pancreatic necrosis treated in the course of 3-20 days
from the onset of the disease. From the operated patients, 134 suffered from
alcoholism, 34 - gallstone disease; there was 3 post-ERCP patient; 5 had trau-
matic pancreatitis; and in 6 patients the cause is unknown.The general signs of
this complication were palpable mass in the upper abdomen (in 90% pts), fever
(in all) and intra- and/or peripancreatic cavities and fluid collections in US and
CT examinations (in all). The diagnosis of infectious complications of pancre-
atitis was considered as a strict indication to surgery.Also, revealed were: acute
necrotising pancreatitis without any signs of improvement, despite the intensive
treatment (24 pts); pancreatic abscess (30 pts); acute infected pseudocyst (56
pts); infected pancreatic and parapancreatic necrosis (106 pts). In 86 patients
with acute infected pancreatic pseudocyst and abscesses transcutaneous
drainage was applicated in 26 (failured in 8). 30 were operated for pancreatic
abscesses, one had distal resection of pancreas, 21 had their abscess cavities
gauzed. 8 transcutaneous there were 4 mortalities. For 56 patients with infect-
ed pancreatic pseudocyst, external drainage was performed in 41 cases, 10
transcutaneous, in 4 - the combination of external and internal drainage, and
one patient required distal resection. 7 died. In 24 patients who had acute
necrotising pancreatitis without any signs of improvement, despite the intensive
treatment, abdominal and retrocolic spaces drainage was used. Failured in 2. In
106 patients with the widespread infected pancreatic and peripancreatic tissues
necrosis ventral open packing was used. 17 patients died.In conclusion, we
believe that the ventral open packing appears to be the operation of choice in
the treatment of wide-spread infected and peripancreatic necrosis.
V06.3
Surgical treatment of necrotic pancreatitis
T Dyuzheva, E Galperin, K Dokuchaev, G Pogosyan, A Chevokin and G
Akhaladze
Moscow Medical Sechenov Academy, Department of Liver Surgery, Moscow,
Russia
METHODS: 113 patients (76 males, 37 females) underwent surgery for necrot-
ic pancreatitis. Group 1 (n = 81) presented noninfected pancreonecrosis (in
phase of intoxication): 39 underwent laparoscopy and 42 laparotomy followed
by drainage of the abdominal cavity. Group 2 (n = 47) revealed infected pan-
creonecrosis (in phase of suppurative complications): in 31 patients necrse-
questrectomies were performed by relaparotomies, in 16 via the stomas of the
retroperitoneal space formed during the first laparotomy.The interval between
the necrsequestrectomies was 10 days.The gravity was assessed by Apache-II.
RESULTS: Group 1. Suppurative complications developed in 1 out of 39 patients
after laparoscopy, compared to 13 out of 42 after laparotomy, p < 0.05. Died of
polyorganic insufficiency 6 of the 39, versus 20 of the 42 (p < 0.05). Group 2.
18 out of 31 patients died after relaparotomy, versus 1 out of 16 during treat-
ment through the stomas of the retroperitoneal space, p < 0.05. Before surgery
gravity according to Apache-II was 14.0 ± 3.2 and 12.0 ± 4.6 points (p > 0.05),
after surgery 13.5 ± 0.5 and 7.0 ± 2.0 points (p < 0.05) respectively. CON-
CLUSION: During the phase of intoxication laparoscopy should be carried out
with the evacuation of the exudate. In the phase of suppurutive complications
the best results were obtained with repeated necrsequestrectomies through
the bursoomentostoma and the stoma of the retroperitoneal space.
V06.4
The role of bacterial translocation (BT) in affecting pancreatic infection during
experimental acute pancreatitis
ID van Felius1, K Bosscha1, A Verheem1, MR Visser2, W Harmsen2, LMA
Akkermans1 and HG Gooszen1
1University Medical Centre Utrecht, Surgery, Utrecht,The Netherlands
2University Medical Centre Utrecht, Microbiology, Utrecht,The Netherlands
Enteral nutrition decreases BT to mesenteric lymph nodes (MLN) during
experimental acute pancreatitis. Contrary, oral parenteral nutrition increases
BT rate to MLN.The pathway of pancreatic infection is unknown. Aim of this
study is to investigate the influence of BT in affecting pancreatic infection dur-
ing acute pancreatitis. Fourty rats were divided in 4 groups: 1. Control (saline,
iv); 2. Mild pancreatitis (caerulein, iv); 3. Control (saline, iv and intraductal); 4.
Moderate pancreatitis (caerulein, iv and intraductal glyco-deoxycholic acid).All
groups received oral parenteral nutrition during one week. Three days after
induction of pancreatitis samples from abdominal organs were harvested for
quantitative microbial culturing. No difference in BT to MLN between group 1
(8/10), 2 (9/10), 3 (9/10) and 4 (10/10) was observed. In all groups, MLN were
infected mainly by E. coli (>103CFU/gr). Seventy percent of group 4 had pan-
creatic bacterial infection of mainly gram-positive cocci, whereas group 1, 2 and
3 had no pancreatic infection. Bacterial counts (>103CFU/gr) and species cul-
tured in the duodenum of group 4 were positively correlated to bacterial
counts and species in the pancreas (r=0.73) (p<0.01). No correlation was
observed in bacterial counts and species between MLN and pancreas.There is
no relation between BT to the MLN and the infection of the acute necrotizing
pancreas. There is a positive correlation between the bacterial species and
counts in the duodenum and the infected pancreas.This might imply that the
infection pathway of the pancreas does not take place by the MLN.
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V06.5
The cause of failures in surgical treatment of pancreatic necrosis
W Otto, J Jeziorek, R Paluszkiewicz and M Krawczyk
Department of General & Liver Surgery, Medical University of Warsaw, Poland
The aim of study was to evaluate the cause of failures in surgical treatment of
pancreatic necrosis. There were 37 patients (m.21, f.16, ma.63) treated in the
Department since 1996. All were presented on admittance with organ failure
but 35% of them developed also shock. All required surgery. Twelve patients
required emergency operation due to acute peritonitis: 6 of them (50%) died
soon due to shock and multiple organ failure, 3 (25%) recovered, 3 (25%)
developed suppurative complications. Twenty-five patients required after sur-
gery due to exudative peritonitis and intraabdominal or pancreatic abscesses:
10 of them (40%) recovered but 15 (60%) developed suppurative complica-
tions.Thus, there were 18 patients treated for suppurative complications, such
as recurrent intraabdominal and pancreatic abscesses, septic bleeding, ileus and
pancreatic fistula. Four of them required one additional operation: 3 (75%)
recovered, 1 (25%) died due to septic bleeding. Six of them required two-three
additional operations: 3 (50%) recovered, 3 (50%) died due to sepsis and mul-
tiple organ failure. Eight of them required more then three additional opera-
tions: 2 (25%) recovered, 6 (75%) died due to septic bleeding and/or sepsis and
multiple organ failure.We conclude that suppurative complications are the main
cause of failures in surgical treatment of pancreatic necrosis. However, surgical
approach in these cases is justified as the only method that is potent to inter-
rupt the self-expanding process of the disease.
V06.6
The effect of oral l-glutamine insuline and laxative on the severity of acute pan-
creatitis
F Avsar1, M Sahin2, O Saygun3, SN Aydin4, S Hengirmen5, H Vatansev6 and O
Yálmaz7
1State hospital, general surgery,Ankara,Turkey
2Selcuk University, general surgery, Konya,Turkey
3State hospital, general surgery,Ankara,Turkey
4State hospital, general surgery,Ankara,Turkey
5State hospital, general surgery,Ankara,Turkey
6State hospital, biochemistry, Konya,Turkey
AIM:The purpose of this study is to investigate the effect of oral L-Glutamine,
Laxative on the severity of acute pancreatitis. MATERIAL AND METHODS: 40
Sprague-Dawley rats were included in this study and divided into four groups.
Experimental pancreatitis was performed by ligating the main biliopancreatic
duct on the rats.The rats were fed with standart rat diet and top water. Group
I: Control, Group II: 15 mg/kg/day L-Glutamine, Group III: 3ml./day fleet enema,
Group IV: 3IU/kg/day Insuline were given via an orogastric catheter.All the rats
were sacrificed at 96th hour after the operation. Blood and tissue samples from
pancreas and lung were taken. RESULTS:Amylase levels were increased signifi-
cantly after the procedure. Five parameters in L-Glutamine Group (BUN,
Glucose, Leucocyte, PO2 and SGOT),5 parameters in Laxative Group
(Amylase, BUN, Glucose, LDH and SGOT) and 2 parameters in Insuline Group
(BUN and SGOT) were better than Control Group. In the histopathological
evaluation of pancreas tissue; necrosis was seen in 3 rats in control group and
3 rats in insuline group, in one rat in laxative group, and none in L-Glutamine
group.The severity of pancreatitis was heavier in control and insuline groups
(p< 0.05). CONCLUSION:Application of L-Glutamin during acute pancreatitis
does not increase the severity of the disease, and acts as an energy sources.
Laxative may given to reduce fecal mass from colon.
V06.7
Surgical treatment of purulent lesions of retroperitoneal fat in necrotizing pan-
creatitis
FV Galimzyanov and MI Proudkov
Surgery Department, Ural State Medical Academy, Russia
We offer a work classification of the volume of retroperitoneal fat lesions: ocal
forms – parapancreatitis, parapancreonecrosis, infiltrate and phlegmon, para-
pancreatic fat abscess.Total forms – retroperitoneocellulitis, infiltrates, phleg-
mons, and abscesses of D1, D2, S1, S2 spaces of retroperitoneal fat. Detailed
elaboration of the volume of fat lesions is performed with the use of the fol-
lowing research methods: ideolaparoscopy, ultrasound examination, computer
tomography, magnetoresonant tomography. In accordance with the volume of
lesions, accesses to all 4 fat spaces have been worked out as well as methods
of their sanitation with the use of special instruments. Results of treatment of
76 patients with retroperitoneal fat lesions in necrotizing pancreatitis during
purulent complications have been analysed. 26 patients were subjected to mid-
dle median laparotomy, cholecystostomy and marsupialization. 50 patients were
operated and in the postoperative period were treated only with the use of
minimally-invasive and endoscopic technologies.Average period of hospital stay
in traditional method of operative treatment without programmed revisions
and sanitations was 52 days, with the use of minimally-invasive technologies –
40 days. In traditional method of retroperitoneal space drainage lethality was
38.5%, whereas in retroperitoneal fat drainage from one or several mini-access-
es it was 14%.
V06.8
Abdominal infectious complications after surgical treatment for acute necro-
tizing pancreatitis
J De Waele1, U Hesse1, E Hoste2, P Pattyn1 and B de Hemptinne1
1 University Hospital Ghent, Surgery, Ghent, Belgium
2 University Hospital Ghent, Intensive Care, Ghent, Belgium
INTRODUCTION: The use of debridement and postoperative continuous
peritoneal lavage (PCPL) has emerged as a valuable tool in the treatment of
acute necrotizing pancreatitis.Abdominal complications are frequent, and often
require reoperation. OBJECTIVE: To study the incidence and characteristics of
abdominal infectious complications associated with PCPL, and microorganisms
associated with it. METHODS: Retrospective analysis of all patients treated
with debridement and PCPL for acute necrotizing pancreatitis in a tertiary cen-
tre during a 7-year period (1993-2000) . RESULTS: Thirty-eight patients were
treated surgically for acute necrotizing pancreatitis. Thirty (78%) patients sur-
vived the first two weeks, and were the subject of our analysis. In 24 patients
(80%), bacterial or fungal surinfection occurred during treatment. Nineteen
abdominal abscesses occurred in 15 patients (50%): twelve patients developed
intraabdominal abscesses and there were 7 wound abscesses; 2 intraabdominal
abscesses were drained percutaneously, and 10 required reoperation. In seven
patients, pancreatic necrosis became surinfected with Candida species; other
microorganisms frequently involved included Pseudomonas (n=8),
Staphylococci (n=8), MRSA (n=3) and Enterobacter areogenes (n=3). Lavage
duration was significantly longer in patients with abdominal abscesses (36 vs. 19
days, p=0,03).The occurrence of intraabdominal infections did not affect mor-
tality, but we observed a higher incidence of organ failure in these patients.The
use of prophylactic antibiotics did not decrease the rate of bacterial surinfec-
tion. CONCLUSION:The incidence of abdominal abscesses and surinfection of
pancreatic necrosis is high. Organ failure occurs more often in patients with
abdominal abscesses. Gram-negative bacteria and Candida spp. are most often
involved.
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V06.9
Acute pancreatic duct (PD) obstruction decreased pancreatic perfusion (PP)
which was partially reversed by early decompression and L-arginine adminis-
tration in Australian possums
JWC Chen1, CX Shi1, CJ Carati2, GTP Saccone1 and J Toouli1
1Flinders Medical Centre, Department of Surgery,Adelaide,Australia
2Flinders Medical Centre, Department of Anatomy and Histology, Adelaide,
Australia
Alteration in PP occurs during acute pancreatitis and can result in pancreatic
ischaemia and necrosis.The relationship between PD obstruction and PP, how-
ever, has not been studied.AIMS:To evaluate the effects of PD obstruction and
subsequent PD decompression on PP and to determine if L-arginine can mod-
ify these effects. METHODS:Anaesthetised Australia possums were assigned to
2 groups (A and B) which were subjected to a 30-minute (n=6) and a 120-
minute (n=9) PD ligation respectively followed by a 60-minute PD decompres-
sion. A subset of the group B (n=6) were subjected to intravenous L-arginine
(100mcg/kg) during PD ligation and PD decompression.The PP (laser Doppler
fluxmetry via a fibreoptic probe), PD pressure and blood pressure were con-
tinuously monitored. RESULTS: The PD pressure increased from 2.9 ±2.5
mmHg to 18.1±4.9 mmHg following PD ligation. PP was reduced to 67.1±4.5%
(P<0.01) and 46.2±7.5% (P<0.001) of baseline following 30 min and 120 min of
PD ligation respectively. Following 60 minutes of PD decompression, PP was
restored to 89.1±13.4% (P<0.02) of the baseline in the 30 min PD ligation
group. However, in the 120 min PD ligation group, the PP remained low at
47.9±8.5% (P=0.6) of baseline. L-arginine administration after 120 min of PD lig-
ation transiently increased PP from 46.2±7.5% to 81.1±8.6% (P<0.03) of base-
line. CONCLUSION:Acute PD obstruction resulted in a significant decrease in
PP, which was restored if decompression of PD was carried out within 30 min-
utes. L-arginine transiently improved PP. Early PD decompression following PD
obstruction may prevent pancreatic ischaemia.
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V07.1
The contribution of preoperative ultrasonography in the surgical treatment of
hepatic cysts
G Illomei1, C Murru1, M Mocci1, O Nardello1 and M Cagetti1
1Clinica Chirurgica, Scienze Mat,-Infantili e Diagnostica per Immagini, Cagliari,
Italy
AIM: Improvement of diagnostics and results of surgical treatment in patients
with a liver echinococcosis . MATERIAL AND METHODS: Between January
1980 and December 1999, 221 patients, 105 male and 116 female, aged 15 to
85 years with hydatid liver disease, were treated surgical in our
department.Diagnosis was made using clinical criteria, serology and imaging
techniques liver ultrasound and CT. Ultrasonography demonstrated that the
right lobe of the liver was affected in 124, the left lobe in 58 and both lobes in
39. Patients with hydatid cysts in other sites than liver were excluded from the
study. RESULTS: In 176 patients we perform a complete pericystectomy, in 14
with associated liver resection, in 45 a subtotal pericystectomy. Fatal complica-
tion did not occur.The medium hospitalisation was 8.8 days. CONCLUSIONS:
Ultrasonography still represent a sensitive and specific imaging technique in
detecting hepatic cysts. Because her accuracy is about 100%, this guiding tech-
nique can improve the safety and the efficacy in surgery for hepatic cysts.
V07.2
Activation of plasma proteolytic cascades during severe hip ato-pancreato-bil-
iary infections
A Karamarkovic1, M Sukalo and V Djukic
1 University Centre for Emergency Surgery, Dpt. for Surgical Infections and
Sepsis, Belgrade,Yugoslavia,Argentina
Severe Hepato-Pancreato-Biliary infections with septic syndrome are still asso-
ciated with high mortality rate (20-40%). Plasma proteolytic involvement in the
severe HPB infections, due to activation of the Coagulation, Fibrinolytic,
Kallikrein-Kinin and Complement systems, play a significant role in the patho-
physiological changes seen in HPB sepsis. In the competition among laboratory
tests and modern imaging techniques, early detection of the plasma cascade
systems disturbances, is a very important diagnostic step. In the prospective
study we investigated plasma proteolytic activity in severe HPB infections (22
pts. with perforative Cholecystitis, Cholangitis, Hepatic abscess, Infected
necrotic pancreatitis),and also in the control group (20 pts. with inguinal her-
nia) by daily avaluation of aPTT,Antithrombin III, Protein C, Plasminogen,Aplha
2 antiplasmin, C5-a and C5-B9 complements, C1 esetarse Inhibitor, Alpha 2
macroglobulin and HMWK. Median APACHE II score was 17, with predictable
mortality of 37%, vs. 23% of registered.All evaluated parameters were different
between HPB and Control group, with high significance (p<0.001). Analysed
parameters were entered into a model for multivariate regression analysis. Six
factors (At III, Protein C, HMWK, C5-B9, C1 Inhibitor,Alpha 2 macroglobulin)
proved independently significant (p<0.0001-0.026) . In order to incorporate the
concept of generalized proteolytic activation in the evaluation of patients with
severe HPB infections , the predictive Plasma Scoring System (PSS) was estab-
lished.The PSS is defined as the sum of deviations from the normal plasma pool
values for proenzymes and functional inhibition values of the coagulation, fibri-
nolytic, kallikrein-kinin and complement systems.
V07.3
Surgical approaches to the liver hydatid cysts: comparison of different surgical
techniques, preliminary results
F Avsar, S Hengirmen, IH Ozel, O Saygun, SN Aydán and B Yálmaz
Numune State Hospital, general surgery,Ankara,Turkey
PURPOSE:Retrospective evaluation of the patients who had been operated for
liver hydatid cysts, and discussion of the findings under the literature were
aimed in this study. MATERIALS AND METHODS: 61 patients who had been
operated in 1st Surgical Clinic of Ankara Numune Education and Research
Hospital were covered by the study. History records of the patients were first
examined. RESULTS: It was determined that 31 patients had undergone partial
cystectomy + open drainage to peritoneum, 14 patients partial cystectomy +
capitonage, 11 patients partial cystectomy + omentoplasty, 4 patients pericys-
tectomy and 1 patient partial cystectomy + cystojejunostomy. It was found that
frequencies of postoperative complications and periods of stay in hospital were
similar in all patients. CONCLUSION: In the end of the study, it was conclud-
ed that not one single method would be applicable for all cyst hydatids, but
rather a separate suitable one for each cyst hydatid must be selected.
V07.4
Biliary Duct Confluence Injuries and hydatid disease; a twenty years experience
JC Meneu-Diaz1, E Vicente-Lopez, OJ Nuão,Y Quijano, P Lopez Hervas and J
Die-Trill
1University Hospital Ramon y Cajal, Hepatobiliary and Transplantation Unit,
Madrid, Spain
From 1978 to 1999, 850 patients underwent surgical treatment for hydatid dis-
ease of the liver at our Surgical Department. Biliary duct confluence injuries
produced by hepatic hydatidosis (HH) were founded in 6 patients (0.7%).
Surgical intervention was performed in order to relieve the obstructive jaun-
dice and the clinical manifestations of cholangitis as well as to treat the hydatid
cyst. Partially opened cystopericystectomy technique was performed in 3
patients with a double bilio-enteric Roux-en-Y reconstruction. In the remain-
ing 3 patients, 2 with a prehepatic portal hypertension, and 1 with a triple
hepatic duct confluence , a cystojejunostomy was performed.There was no hos-
pital mortality. Two anastomotic leakeage following high bilio-enteric anasto-
mosis occured but did not require surgical treatment. During the follow-up (5
to 19 years), 1 patient suffered a local recurrence of the hydatid disease seven
years after cystojejunostomy was performed.The site of intrahepatic biliary and
vascular involvement, the presence of biliary duct anomalies and the presence
of portal hypertension are decisive factors in the election of the ideal proce-
dure of reconstruction. Conservative surgical approaches (partial cystectomy
and cystojejunostomy) occupy a first class place. Radical surgery is often a very
serious matter.
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V07.5
Surgical tactics in the treatment of multiple large hydatid cysts of the liver
G Papoutsis, N Theakos, G Kyratzis, B Gougoutas and L Lapidakis
KAT Hospital, 2nd Dept of General Surgery,Athens, Greece
The choice of the most convenient treatment of multiple large hydatid cysts of
the liver (LHC), especially in the presence of complications or diffuse abdomi-
nal echinococcosis is rather difficult.This is a retrospective study of 37 patients,
with LHC over than 10cm diameter (12-28 cm) treated during the last 15
years. In 5 of them multiple abdominal, after recurrence, hydatid cysts and in 2
generalized echinococcosis were present. Only in 8 patients LHC was solitary.
Operative tactics comprised all types of surgical interventions: Liver resection,
radical cysto-pericystectomy, total or partial cystectomy, unroofing, drainage
and omentoplasty. In 22 out of the 29 patients with multiple LHC, more than
one procedure were applied. A large spectrum of surgical procedures to face
extrahepatic cysts was used, biliary decompression being the most often.Three
patients with extended recurrence of the disease were finally considered as
inoperable. A long mean hosp. time of 23 days (16-108), low mortality
(2p=5.4%) and high morbidity rates (19p= 51.3%) resulted the study. It is con-
cluded that extended-complicated liver hydatid disease, especially after recur-
rence, consists a major operative problem with no standard surgical method-
ology.
V07.6
Hepatic hydatid disease: report of 59 cases
MR Diaconescu, I Costea, M Glod, R Terinte and R Chiriac
IV Surgical Clinic University of Medicine and Pharmacy “Gr.T.Popa” Iasi,
Romania
INTRODUCTION: The high prevalence of hepatic hydatid disease (HHD)
remains one of the major public health problems in our country. PATIENTS
AND METHODS: In the last 15 years, 59 patients with HHD have been oper-
ated on in our clinic. There were 35 male (59,3%) and 24 female (40,7%)
patients with a mean age of 44 years (range 8-72 years). Diagnosis was princi-
pally made by ultrasonography and computed tomography scanning. RESULTS:
Cysts were found in the right lobe in 46 patients, in the left lobe in 6 patients
and bilateral in 7 patients.Twelve patients had multiple hepatic cysts and three
patients had co-existing cysts with different abdominal locations.There were 5
cases of recurrent disease.The diameter of the cysts were larger then 10 cm
in 37 patients and the majority of our cases present complications: infection
(n=17), rupture in the biliary tree with obstructive jaundice (11), rupture in the
peritoneum with acute abdomen (n=2), another co-morbidity (n=5). Surgical
procedures were total cystectomies in 15 cases, partial cystectomies with
external (n=32) or internal (n=2) drainage in 34 cases combined methods
(including suture of biliary communications (n=5) and left hepatic (atypical or
segmentary) resections in 5 patients.The common bile duct was explored in 15
patients and it was drained by a T-tube in 10 patients and by a choledocoduo-
denostomy in 5 others. Cholecistectomy was performed in 30 patients (4 with
cholelitiasis).We have no deaths but a high percentage of morbidity rate (ten
patients developed chronic biliary fistula) with a long hospitalization period
(average 33 days). CONCLUSION:The location, large volume and great num-
ber of complicated cysts together with co-existing pathology obliged us to a
more conservative approach in the surgical treatment of HHD.
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V08.1
ERCP/ES in acute gallstone pancreatitis: stick to the protocol
M Besselink 1, L Van Minnen1, K Bosscha1, J Bogaard2 and HG Gooszen1
1University Medical Centre Utrecht, Surgery, Utrecht,The Netherlands
2University Medical Centre Utrecht, Gastroenterology, Utrecht, The
Netherlands
Early ERCP/ES is accepted in acute gallstone pancreatitis (AGP) patients with 3
or more Ranson criteria positive on admission. In clinical practice acute
ERCP/ES is not always feasible. We have compared patients subjected to
ERCP/ES with those who qualified based on their Ranson score, but did not
undergo the procedures. Between 1995 and 2001, 37 patients with AGP and
Ranson >= 3 were admitted.Twenty-four (65%) underwent ERCP/ES (median
age 68 yrs). Interval between the onset of symptoms and ERCP/ES was 72 hrs
in 14 patients. In the remaining 10 patients the interval was more than 3 days.
In 10 patients stones or sludge were removed. In the remaining patients the
passage of stones was suspected. There were no major complications in the
ERCP/ES group; 5 patients deteriorated into severe necrotizing pancreatitis, 2
(9%) of them died (89 and 90 years of age). In this group the median hospital
stay was 13 days (range 4-108).Thirteen patients were treated conservatively,
7 were admitted to the ICU, 4 (31%) died, all because of severe necrotizing pan-
creatitis. Median hospital stay was 18 days (range 7-78). Cholecystectomy was
performed in 22 patients, after a median period of 10 weeks. During this peri-
od, in the ERCP/ES group, 2 patients developed recurrent acute cholecystitis
and 2 patients developed recurrent AGP.All with uneventful recovery.
CONCLUSIONS: This study confirms that early ERCP/ES is effective to
decrease mortality caused by AGP. Early cholecystectomy is preferable to pre-
vent symptomatic gallstone disease. ERCP/ES does not prevent recurrent AGP.
V08.2
New approach on the definition and treatment of local complications in acute
pancreatitis
MA Secchi,W Sanchi, L Quadrelli, F Serra, J Forte, M Pollastri, E Tagliaferri and
L Rossi
Surgical Division. Italian, Provincial and HECA Hospital, Rosario,Argentina
BACKGROUND: In our experience local complications of acute pancreatitis
(AP) are the major cause of death within the second week after the onset of
the disease. OBJECTIVE: To consider a new agreed definition for AP as well as
a treatment approach of its local complications. DESIGN: Retrospective (1987-
1997) and prospective (1998- 2000) study. POPULATION: 703 patients having
AP between April 1987, and April 2000. METHOD: Lesions and local complica-
tions were defined according to the Pancreas Club, República Argentina, 1998.
All patients had AP of any etiology confirmed by morphological methods.A CT
Scan performed after the 4th day of the onset of AP showed an AP local involve-
ment. The clinical therapy was to treat local lession, and a combination of clin-
ical, percutaneous, laparoscopic or conventional surgery was performed to
treat local complications. 46 patients (6.5%) had local lesions, 16 had acute fluid
collections > 5 cm. in diameter (6 underwent percutaneous punction and
drainage), and 30 had pancreatic necrosis (with no complications at all). 78
patients (11.1%) showed local complications from which 90 of them had to be
treated (10 patients had 2 or more complications) Abscesses of any size and
pseudocysts > 5 cm of diameter were treated. Second surgical procedures for
treating infected necrosis were not taken into account.
RESULTS OF TREATMENT:
AP local Complic.n = 90 Medical Percutaneous Surgical Mortality n =
complications
Abscesses 18 2 10 6 1
Acute pseudocyst 19 4 4 11 1
Infected acute 2 0 1 1 0
pseudocyst
Infect.necrosis 51 5 1 45 12
CONCLUSION: An agreed definition of local complication (L.C) of AP and a
combined, selective and multidisciplinary approach is mandatory to obtain
lower rates of L.C. mortality: 2 % (14 / 703)
V08.3
Surgical treatment of acute pancreatitis in a specialized pancreatitis referral
centre - a 70 month retrospective study
L Van Minnen, M Besselink, B Bosscha and HG Gooszen
University Medical Centre Utrecht, Surgery, Utrecht,The Netherlands
Acute pancreatitis (AP) can present from a self-limiting illness to a highly lethal
disease.The applied treatment and outcome of patients with primary AP were
reviewed. Between 1995 and 2001, 200 patients with primary AP were admit-
ted to our hospital. Ethiology was biliary in 79 patients (40%), excessive alco-
hol consumption in 21 (11%) and other in 26 (12%). 74 cases were non-classi-
fied (37%). 94 patients had mild AP (Ranson < 3), 106 patients suffered from
severe AP. In the group with mild pancreatitis mortality was 3% and in the group
with severe AP 25%.Of the patients with severe AP, 35 (33%) underwent necro-
sectomy (NS) of pancreatic necrosis, 17 of these patients died (49%). After
necrosectomy, continuous postoperative lavage (CPL) was installed in 16
patients, 7 of these patients died (41%).After necrosectomy 10 patients under-
went open management of the abdomen (OMA) with regular inspection and
lavage, 7 patients died (70%). Nine patients underwent NS only, 3 patients died
(33%). Four times CPL was converted to OMA, 3 of these patients died.The
mean simplified acute physiology (SAP) score, at the day of NS was 9.The SAP
score of patients also receiving CPL or OMA was 11.At the day of conversion
of CPL to OMA the SAP score was 16. CONCLUSION: Severe AP is associat-
ed with high mortality rates. Mortality in patients who underwent surgery,
especially OMA, is very high. Surgery should be reserved for critically ill
patients who cannot be treated sufficiently otherwise.
V08.4
Microlithiasis-induced acute biliary pancreatitis: the role of emergency endo-
scopic sphincterotomy
Taher M-Y3, M Osman1, T El-Sefi1, A Shawki1, A Sadek1, I Boghdadi2 and I
MarawanI1
1Department of HPB Surgery, National Liver Institute, University of Menoufiya
2Department of Medicine, Faculty of Medicine, University of Menoufiya
3Department of Medicine, HPB Unit, University of Alexandria, Egypt
BACKGROUND: Biliary pancreatitis is the commonest form of acute pancre-
atitis in Egypt. Early biliopancreatic decompression is of great value to halt the
process of acute pancreatitis.AIM:To assess the value of early endoscopic inter-
ference in the evaluation of the cause and treatment of idiopathic acute pan-
creatitis of suspected biliary origin. PATIENTS AND METHODS:The study was
carried out on 23 patients presented with clinical picture of acute pancreatitis
of suspected biliary origin.Ten patients had previous cholecystectomy one to
18 months before presentation. On admission, all patients were graded as mild
acute pancreatitis, according to Glasgow scoring system. Patients were consec-
utively randomized for either early ERCP/ES within 72 hours from the onset of
acute abdominal pain (n=16) or delayed ERCP/ES within 5 days (n=7). The
patients were then followed-up for one month. RESULTS: In all patients, there
was no ultrasonographic visualization of gallstones or CBD stones. On ERCP
examination, biliary gravel was documented to be impacted at the papilla in 8
patients, in 5 patients the gravel was retrieved after endoscopic sphincteroto-
my (ES) and CBD exploration by Dormia basket, whereas muddy sludge was
seen in another 5 patients. In the remaining 5 patients, neither definite gravel
nor stones could be documented. On follow-up, it has been shown that early
treated group responded promptly to urgent ES and were discharged within
48-72 hours. In the delayed group, all patients developed complications, and
therefore, allocation to delayed ERCP was stopped after the 7th patient. Two
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patients died, one from pulmonary embolism, and the other from severe uncon-
trollable intra-abdominal hemorrhage.Three patients developed pseudopancre-
atic cysts, which have been treated by CT-guided aspiration in two, and surgical
internal drainage in one.The sixth patient developed splenic vein thrombosis
and gastric varices.The last patient suffered from pancreatic abscess, and treat-
ed conservatively. CONCLUSION: Early ERCP and ES within 72 hours are
mandatory as an emergency treatment for acute biliary pancreatitis, even with
no radiologically documented biliary stones.
V08.5
Pancreatic trauma - an Indian experience
S Agrawal, R Bapat, C Kanthari, S Ranka and G Bakhshi 
Kem Hospital, Seth GS Medical College, Mumbai, India, Surgical
Gastroenterology, Mumbai, India
Pancreatic trauma though uncommon is associated with high morbidity and
mortality. Diagnosis is often difficult, and surgery poses a formidable challenge.
This study analyses, a single institutional experience of management of
Pancreatic trauma. STUDY DESIGN: 17 patients of pancreatic trauma, were
identified from our database, in the last 5 years from the year 1996-2000.The y
were analysed with respect to the mode of injury, the diagnostic modalities,
associated injury, the grade of pancreatic trauma, and their management. The
pancreatic trauma was graded as per Modified Lucas classification. RESULTS:
The median age of the 17 patients was 39 years (range19-61years). 12 patients
were following blunt abdominal trauma whereas 5 patients had stab injury.
Bowel injury was associated with all the patients of stab injury and 7 patients
of blunt abdominal trauma. 2 patients had associated vascular injury.As per the
Modified Lucas grading for pancreatic injury, 2 patients had grade 1, 3 patients
had grade 2, 5 patients had grade 3 and 7 patients had grade 4 injuries.
Immediate diagnosis could be reached only in 3 patients, 12 patients were diag-
nosed at the time of surgery for bowel injury, and in 2 patients the diagnosis
was delayed. CT scan was the main diagnostic investigation. 7 patients under-
went distal pancreatectomy with splenectomy, 5 underwent pancreatic head
resection. 3 underwent debridement with external drainage, and 2 patients of
grade 1 injury were treated conservatively. Complications was pancreatic fistu-
la formation - 3 patients (17.05%), pancreatitis - 2 patients (11.7%) and pseudo-
cyst formation - 1 patient (5.4%) , which was treated by percutaneous endo-
scopic cystgastrostomy at a later date. Death occurred in 3 (17.05%)patients, 2
of which had vascular injury involving the Superior mesenteric vessels, and 1
who had undergone pancreatic- duodenectomy. CONCLUSIONS:We conclude
that blunt abdominal trauma is the common mode of sustaining pancreatic
trauma. It is usually associated with bowel or vascular injury. CT scan is the
most sensitive modality of investigation for diagnosis. Appropriate treatment
comprising of accurate assessment of injury, adherence of basic concepts of
vascular management, judicious resection, and adequate drainage is the key to
successful outcome. Morbidity and mortality in pancreatic trauma though sig-
nificant, it is primarily due to associated injuries.
V08.6
Transduodenal sphincteroplasty and transampullary septectomy results in
symptomatic and biochemical recovery, and improves quality of life in patients
with sphincter of Oddi dysfunction
DN Lobo1, MG Dube1, J Field2 and BJ Rowlands1
1University Hospital, Queen’s Medical Centre, Section of Surgery, Nottingham,
United Kingdom
2University Hospital, Queen’s Medical Centre, Clinical Nutrition and
Investigation Unit, Nottingham, United Kingdom
AIMS: To determine whether transduodenal sphincteroplasty and transam-
pullary septectomy (TDS/TAS) improves quality of life in patients with sphinc-
ter of Oddi dysfunction. METHODS: Eight patients with sphincter of Oddi dys-
function and a positive preoperative morphine-prostigmine provocation
(Nardi) test were recruited prospectively before undergoing TDS/TAS.
Preoperative quality of life was assessed using the gastrointestinal quality of life
index (GIQLI).The results of the operation were assessed by recording symp-
toms and repeating the Nardi test and GIQLI 9-12 months postoperatively.All
results are expressed as median (interquartile range) and the Wilcoxon
matched pairs test was used to determine statistical significance. RESULTS:The
age of the seven female and one male patient was 44.5 (27.8-59.2) years.At the
postoperative assessment, one patient had an excellent result, five had good
palliation and two had satisfactory palliation of symptoms. For the preoperative
Nardi test, the baseline and maximum postprovocation concentrations of
serum amylase were 51.0 (31.3-62.5) and 194.5 (77.0-429.0) U/L respectively.
Corresponding postoperative serum amylase concentrations were 58.5 (30.5-
66.3) and 67.0 (37.8-108.3) U/L respectively. Preoperative baseline and maxi-
mum postprovocation concentrations of serum lipase were 83.5 (65.5-98.3 )
and 1485.5 (875.3-4169.5) U/L respectively. Corresponding postoperative con-
centrations for serum lipase were 65.0 (43.3-90.0) and 89.0 (75.8-1211.5) U/L
respectively. Maximum postprovocation concentrations were significantly high-
er for the preoperative Nardi test (P=0.025 for amylase and 0.017 for lipase).
The GIQLI improved from a preoperative score of 72.5 (57.5-88.8) to a post-
operative score of 86.5 (65.0-129.3) (P=0.012). CONCLUSIONS:TDS/TAS pal-
liates symptoms and improves quality of life in sphincter of Oddi dysfunction.
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V09.1
Liver transplantation in children from living related donor
F Vicente1, M Lopez-Santamarã 2, M Gómez2, J Murcia2, Y Quijano1, J Nuão1, P
Lopez-Hervãs1, JC Meneu1,A Honrubia1 and JA Tovar2
1 Hospital Ramon y Cajal, Liver Transplantation Unit, Madrid, Spain
2 Hospital Infantil La Paz, Liver Transplantation Unit, Madrid, Spain
The ever-increasing number of candidates for liver transplantation has led to
longer waiting lists and marked delays in transplant operations, thus provoking
increased waiting list mortality. In the pediatric setting, the situation is even
worse. In an attempt to alleviate demands for whole organ transplantation, over
the last few years there has been a steady increase in the development of alter-
native techniques including reduced-size transplantation, ex-situ and in-situ split
liver transplantation and living related liver transplantation.We report a case of
the latter, in which the patient, of 6 months of age and 7 Kg weight, received a
hepatic left lateral segment from her father.The child had atresia of the biliary
ducts, polysplenia and lacked a retrohepatic vena cava.The donor was subject-
ed to a thorough clinical, analytical and radiological examination to confirm the
absence of medical or psychosocial alterations that might contraindicate dona-
tion.The video shows the main technical aspects of a living related liver trans-
plant performed at our Institution, including the donor and recipient operation.
V09.2
Right hepatectomy including the middle hepatic vein in living related liver trans-
plantation
Belghiti J, GM Ettorre, D Sommacale, F Dondero, A Sauvanet, O Guevara, F
Durand, J Marty1 and O Farges
Beaujon hospital, Digestive Surgery and Transplantation, Clichy, France
Right hepatectomy including Couinaud segments V,VI,VII and VIII is becoming an
acceptance procedure in living related liver transplantation and several sur-
geons offer this option to their patients.The right liver graft ensures an ade-
quate hepatic mass for adult recipients with a graft-to-recipient body weight
ratio of more than 1%. Principally the right hepatic vein drains the right graft.
There are frequently accessory veins from the right that directly drain into the
inferior vena cava.The middle hepatic vein is shared by the medial portion of
the right lobe (segment V and VIII) and segment IV and sometimes we observed
important veins drained segment V and VIII mainly into the middle hepatic vein.
We consider that these segmentary veins could play an important role in the
outflow of the right graft and when necessary we performed right hepatecto-
my including the middle hepatic vein.Among 12 right hepatectomy the middle
hepatic vein remains with the right graft in 4 cases. We present the surgical
technique.
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V10.1
Bengmark’s self-propelling tube for enteral nutrition in liver and pancreatic sur-
gery
G Mangiante, N Nicoli, L Marchiori, S Carluccio, R Asheminia,A Casaril and G
Colucci 
Department Surgery and Gastroenterology, University of Verona, Italy
BACKGROUND: Enteral Nutrition (EN) is increasingly used to minimise the
rate of septic complications related to bacterial translocation, due to its effec-
tiveness and low cost. Bengmark’s Self-propelling auto-positioning feeding tube
(SPT)® Nutricia Italia/Pfrimmer Nutricia Germany, absorbs and uses gut motili-
ty to be quickly transported to the upper small intestine and hereby allow an
uninterrupted EN both in surgical and critically ill patients.We report 72 over
205 SPT experience applied between December 1996 and July 2000, and
analyse safety, compliance, and indications of SPT in liver and pancreatic sur-
gery. MATERIAL AND METHOD: Open study: the feasibility of insertion, time
and rate of placement, compliance and complications related to the tube or to
EN were studied. SPTs was successfully placed in 45 patients before liver resec-
tion, in 24 patients with severe pancreatitis, 3 in pancreatic surgery. RESULTS:
69 /72 pass pylorus: 3/69 remained in the duodenum but 66/6 did reach
jejunum. The tip of the tube reached its final position within, as a mean, 5.2
hours, 8% instantly and all within 24 hours. Enteral nutrition was started imme-
diately after introduction into the stomach to perform the so-called uninter-
rupted enteral nutrition during liver resection and pancreatic tail resection.The
compliance was excellent only 5 /72 patients showed a poor compliance.There
were no aspiration pneumonia or other complications related to SPT.A poly-
meric nutrition was usually supplied at a starting flow rate of 45 ml/hour and
rapidly increasing during the next 48 h., in severe pancreatitis too Four patients
suffered diarrhoea and 6 abdominal distension, leading to a temporary reduc-
tion in EN flow rate. Clogging stopping SPT occurred in 5 patients, but pancre-
atic enzymes and bicarbonate solution could clean them. CONCLUSION: SPT
showed excellent results as a mean to perform enteral nutrition in pancreatic
and liver surgery: on our experience enteral nutrition was safe in severe pan-
creatitis patients too, and allowed a reduction on cytochines response in liver
resections.
V10.2
Influence of enteral nutrition on cytokines response in resective hepatic sur-
gery
G Mangiante, N Nicoli, L Marchiori, S Carluccio, C Martinelli, L Rossi, R
Asheminia ,A Casaril and G Colucci
Department Surgery and Gastroenterology, University of Verona, Italy
INTRODUCTION: Infective complications during post operative are nowadays
the major problem not only in hepatic surgery. Better outcome with related
decrease of treatments and stay costs are a primary objective.This prospective
and randomised study wants to evaluate the cytokine response during and after
portal clamping in patient continuously feed with enteral nutrition faced to
patients with a parenteral nutritional support. PATIENTS AND METHODS: 20
patients (group A) submitted to hepatic resection and fed from the day before
the operation with enteral nutrition (EN) administrated with Bengmark self-
propelling tube were confronted with 20 patients (group B) submitted to
hepatic resection with parenteral nutritional support. Hepatic resection should
interest at least 30% of parenchyma in non-cirrhotic patients or at least seg-
mental resection in cirrhotic ones.To group A from 4 days before surgery and
during the following 4 days, we administrated a mix of probiotics and fibers
with EN (Psyllogel Fermenti, Nathura, RE, STRESSON MULTIFIBERS,
Nutricia).10 ml blood samples were harvested before operation, and 10’, 30’,
60’ after declamping and at 24h. IL-6,a-TNF values were detected on blood
samples.We also evaluated, resumption of bowel movement, and discharge of
patients. RESULTS: Results on blood sample on both groups showed a statisti-
cally significant difference after 24h in IL-6 values (10’group A 121±25.3,group
B 156±31.4, after 24h groupA 31.5±12, group B 105.1±24.1), while a-TNF
dosage did not show any significant difference within the two groups. No sig-
nificant differences between the groups were found also in preoperative fac-
tors. However longer hospital stay (group A10.9 ±3.1 days (range 7-21), group
B13.2 ±2.7(range 8-19) P<0.02) and a quicker resumption of bowel movement
were marked on group A. DISCUSSION AND CONCLUSIONS: Data seem to
show that continuous enteral nutrition produces a modulation of citokine
response following the portal clamping and bacterial translocation. Lower
cytokine activation cascade reduces impacts of cytokine action on hepatic
parenchyma with a exalting of Kupffer cells.All this remarkably reduces hospi-
tal length and consequently costs.
V10.3
The effects of oral l-glutamine, laxative and insuline on bacterial translocation
and intestinal mucosa in obstructive jaundice
N Aydin1, FM Avsar1, M Sahin2, S Hengirmen1, H Vatansev3, M Avunduk4, M
Baykan5, O Saygun6 and H Ozel7
1 Numune State Hospital, General Surgery,Ankara,Turkey
2 Selcuk University, General Surgery, Konya,Turkey
3 State Hospital, Biochemistry, Konya,Turkey
4 Selcuk University, Pathohogy, Konya,Turkey
AIM:We aimed to investigate the effects of oral L-Glutamine, Laxative and insu-
line on Bacretial Translocation (BT) and intestinal mucosa in obstructive jaun-
dice. MATERIAL AND METHODS: 40 spraque-Dawlery male rats were includ-
ed in this study and divided into four groups. The main bile duct ligated and
transsected. Group I: Standard rat pellets and tap water, Group II: Standard rat
pellets and tap water + 15 mg/kg/day L-Glutamine, Group III: Standart rat pel-
lets and tap water + 3 ml/day fleet enema, Group IV: Standard rat pellets and
tap water + 3 U/kg/day NPH insuline. The drugs were given enterally via a
catheter.At 7th day the rats were sacrificed, and blood samples for biochemi-
cal analyses were taken. Blood, liver, mesenteric lymph node, spleen and fecal
cultures were inoculated in culture mediums. 2 cm length terminal ileum seg-
ment was resected for histopathological evaluation. FINDINGS: Biochemical
parameters levels and leucocyte counts were similar in all groups. BT ratios
were 60% in Group I, 20% in Group II, 40% in Group III and 60% in Group IV.
Bacterial count decreased in Group III.Villi length was higher in Group II than
other Groups, and there was villi athrophy. CONCLUSION: L-Glutamine
reduces BT ratio and prevent villi atrophy in obstructive jaundice. Laxative
reduces the bacterial count in cecum in obstructive jaundice.
V10.4
Antiapoptotic effects of insulin-like growth factor-1 and roscovitine on
ischemia-reperfusion injury of the rat liver
S Topaloglu1, O Abbasoglu1,A Ayhan2, C Sokmensuer2, K Kilinc3 and I Sayek1
1Hacettepe University, Department Of Surgery,Ankara,Turkey
2Hacettepe University, Department Of Pathology,Ankara,Turkey
3Hacettepe University, Department Of Biochemistry,Ankara,Turkey
BACKGROUND: Apoptotic hepatocyte death has been observed during the
early phase of reperfusion period after liver ischemia. However, effects of this
process on ischemia-reperfusion (IR) injury are still unclear. This study was
designed to investigate the role of apoptosis on liver IR injury and to determine
the effect of roscovitine and insulin-like growth factor-1 (IGF-1) on this
process. MATERIALS AND METHODS: Rat livers pretreated with IGF-1 (n=9),
roscovitine (n=9) and both of these agents (n=9) received 60 min right lobe
ischemia followed by 4 h reperfusion.Tissue injury was evaluated with serum
alanine aminotransferase (ALT), aspartate aminotransferase (AST), tissue mal-
ondialdehyde (MDA) measurement and histological examination. Dead hepato-
cytes were determined with trypan blue dye test. Apoptosis was evaluated
immunohistochemically in sections stained with M30 monoclonal antibody.
RESULTS:Apoptotic and dead hepatocytes were detected mainly in periportal
areas. Separate administrations of these agents significantly decreased both
apoptotic and dead hepatocyte counts compared to controls (P<0.01) . ALT
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(mean levels; 412 U/L for roscovitine group, 220 U/L for IGF-1 group) and AST
(mean levels; 582 U/L for roscovitine group, 578 U/L for IGF-1 group) levels
were significantly decreased compared to control (mean levels; 915 U/L for ALT
and 1183 U/L for AST) (p<0.005). CONCLUSIONS:This study indicates that
hepatocyte apoptosis may play a role in the development of IR injury of the
liver. Administration of IGF-1 and roscovitine may be beneficial in preventing
this injury.
V10.5
Nitric oxide synthase and ischaemic preconditioning of the liver
R Koti,W Yang,A Seifalian and B Davidson
Royal Free and University College Medical School, Royal Free Hospital,
University Department of Surgery and Liver Transplantation Unit, London,
United Kingdom
BACKGROUND: Ischaemic preconditioning (IPC) of the liver may be mediat-
ed by nitric oxide (NO). METHODS: Sprague Dawley rats were subjected to
45 mins lobar ischaemia followed by 2 hr reperfusion (IR). L-arginine or L-
NAME was administered to stimulate or block NO synthesis. Study groups
(n=6) had, (1) sham laparotomy, (2) IR, (3) IPC with 5 min ischaemia and 10 min
reperfusion before IR, (4) L-arginine before IR, (5) L-NAME + IPC before IR.
Liver enzymes were analysed. NOS distribution was studied using NADPH
diaphorase histochemistry and, eNOS and iNOS identified using immunohisto-
chemistry.Western blotting analysis evaluated expression of eNOS and iNOS
protein after preconditioning . Data was analysed using analysis of variance
(ANOVA) for multiple comparisons and paired Students t test. RESULTS: Both
IPC and L-arginine treatment improved serum liver enzymes (u/L,ALT= 1380‚
±320 and 1257‚ ±970 vs 5173‚ ±215(IR);AST= 1537‚ ±113 and 1501‚ ±731 vs
3103‚ ±190(IR), all p<0.05).These effects were prevented by L-NAME adminis-
tration (ALT= 5962‚ ±317 u/L;AST= 3653‚ ±211 u/L; both p<0.05 vs IPC and
L-arginine). NOS detected with NADPH diaphorase staining was associated
with sinusoidal endothelium and was induced by IPC. Immunohistochemistr y
and Western blotting showed that both iNOS and eNOS were expressed in the
liver after IPC. CONCLUSIONS: IPC increased NOS expression in the liver
and attenuated IR induced liver injury. These data strongly suggest a role for
nitric oxide in IPC.
V10.6
Inflammatory response and endotoxine tolerance after cryosurgery
J Joosten1, G Van Muijen2,T Wobbes1 and T Ruers1
1University Medical Centre Nijmegen, Surgery, Nijmegen,The Netherlands
2University Medical Centre, Pathology, Nijmegen,The Netherlands
INTRODUCTION: Earlier reports showed inhibition of secondary tumour
growth and metastases after cryoablation, probably mediated by an inflamma-
tory response. In this study augmentation of this inflammatory response and its
possible additive anti-tumour effect is evaluated. METHODS:Mice received two
subcutaneous implanted colon tumours. One of these was treated by either
cryoablation or resection. Next to this local treatment, animals received a sin-
gle dose of lipopolysaccharide (LPS), that is, known for its inflammatory and
anti-tumour effect. Growth of secondary tumour was followed and plasma
cytokine levels were measured. RESULTS:Again secondary tumour growth was
inhibited by cryosurgery and plasma levels of IL-1 and TNF were significantly
increased. Additionally administration of LPS did not lead to extra tumour
growth inhibition. However, mortality in mice treated by cryosurgery and LPS
was 80%, compared to 0% in excisional treated animals (p < 0.05). Subsequently
cytokine levels were significantly increased. LPS administration two days after
treatment resulted in gross mortality in animals treated by excision: 72%,
against 10% in cryotreated animals (p< 0.05). Cytokine levels were propor-
tionally elevated. CONCLUSION: These experiments confirm the hypothesis
that cryosurgery leads to a systemic inflammatory response.This reaction can
lead to inhibition of tumour growth.Administration of LPS does not lead to an
extra anti-tumour reaction.At the day of treatment, animals treated by cryoab-
lation are extremely sensitive for LPS, while two days after treatment endo-
toxine tolerance appears. These findings are in accordance with the clinical
observation of cryoshock after cryoablation of liver metastases.
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V11.1
Beger’s procedure for chronic pancreatitis: surgical complications, results and
the learning curve
E Keus1,CJHM van Laarhoven1, EH Eddes2,AAM Masclee3,MEI Schippe4 and HG
Gooszen5
1St Elisabeth Hospital, Surgery,Tilburg,The Netherlands
2Deventer Hospital, Surgery, Deventer,The Netherlands
3University Medical Centre, Gastro-Enterology, Leiden,The Netherlands
4University Medical Centre, Pathology, Utrecht,The Netherlands
5University Medical Centre, Surgery, Utrecht,The Netherlands
The duodenum preserving resection of the head of the pancreas (DPRHP)
according to Beger has been developed as an alternative for Whipple’s proce-
dure for chronic pancreatitis and has shown a high success rate.We have adopt-
ed the procedure if the inflammatory lesion was localised in the head of the
pancreas and performed 36 DPRHP between 1988 and 2000 and now report
on results (median follow-up: 4 4/12 years).We divided the group in the initial
15 (group 1) and the remaining 21 (group 2). Pain was the indication for sur-
gery in all patients. One patient died due to peritonitis by leakage of the
catheter-jejunostomy with intact pancreatico-jejunostomy. For group 1: dura-
tion, 270min, group 2, 195 min; median blood loss: group 1, 2000ml and group
2, 1000ml; median hospital stay: group 1, 21 days and group 2, 17 days.
Complications: group1, 6/16, group 2, 7/21. Initial results are favourable in 77%:
significant improvement or free of pain. Group 1,7/15, and group 2, 6/16 need-
ed exocrine enzyme substitution in the long term. Long-term results were
obtained in 27 out of 30 living patients (90%) and show a success rate of 70%.
DPRHP can be performed with good initial results. There is a learning curve
involved in this physiologically appealing procedure concerning for the opera-
tive technical aspects and not reflected in effectiveness and complication rate.
The challenge in the near future will be to identify the subgroup of 30% of
patients in whom the results are disappointing .
V11.2
Chronic pancreatiti: a choice of therapy
B Kudra,T Popiela, M Sierzega and K Nowak
Jagiellonian University Krakow, 1st Department of General and GI Surgery,
Krakow, Poland
Between 1980 and 2000, 686 patients were treated for chronic pancreatitis at
Ist Department of General and GI Surgery. Median age of the patients was 47
yrs, males to females ratio 2,4.The most frequently occurred symptoms were:
abdominal pain (93.2%), body weight loss (84.4%) and diarrhoea (54.3%). Less
commonly patients presented: palpable abdominal masses (17.4%), diabetes
(17.4%), obstructive jaundice (11.6%) and ascites (2.2%). 541 patients (79,9%)
were treated with conservative therapy only. Of these 541 cases, in 122 percu-
taneous drainage of pancreatic pseudocyst was performed and 75 underwent
endoscopic papillotomy. One hundred thirty-five patients (21,1%) underwent
operative procedures. The indications to surgery were: intractable pain syn-
drome requiring drug therapy, suspected neoplasm and compression on duo-
denum or bile ducts. Forty-seven patients received decompression proce-
dures (cystogastrostomy and cystojejunostomy). Resective procedures were
performed in 98 cases. Thirty-six patients underwent left resection of the
pancreas, 18 subtotal pancreatectomy, and 19 total pancreatectomy.
Pancreatoduodenectomy (Whipple’s resection) was performed in 12 cases and
in 10 patients pylorus-preserving pancreatoduodenectomy (Traverso opera-
tion. 3 patients underwent a segmental resection of the body of pancreas.
Postoperative complications rate was 24%. The most frequent complications
were: pneumonia, wound infection, pancreatic and intestinal fistulas.
Perioperative mortality rate was 0.6% (1 patient). Surgery of chronic pancrea-
titis is the most effective symptomatic therapy in case when advanced pancre-
atic parenchyma damage is present.Alternative non-surgical methods of treat-
ment are less effective than surgery and leads only to temporary amelioration.
V11.3
End to side pancreaticojejunostomy for chronic pancreatitis: a new technique
S Ranka1, R Bapat2, C Kantharia3 and G Bakshi4
1Seth G S Medical College & K E M Hospital, Surgical Gastroenterology,
Mumbai, India
INTRODUCTION:The indication for surgical intervention in chronic pancre-
atitis is pain due to ductal hypertension or perineural inflammation.The popu-
lar surgical procedure for ductal decompression has its own disadvantages.We
propose a new procedure for pancreatic duct decompression. AIM: To assess
the efficacy of this new procedure of pancreatic duct drainage in cases of duc-
tal hypertension in chronic pancreatitis. MATERIAL & METHODS:This is a sin-
gle hospital, single unit prospective analysis of patients with chronic pancreati-
tis over a period of of 13 years from 1987 to 2000, comprising of 64 patients.
All patients underwent the new procedure, which is as described.Abdomen is
opened by a rooftop incision, pancreas isolated by opening the lesser sac.
Pancreatic duct is identified and laid open by serially suturing it on either side
before incising it. The length of the duct laid open is 9-10 cms. A short and
straight roux loop of jejunum is mobilised and fish mouthing of antimesenteric
end is done. End of jejunum is anastomosed to the side of the open pancreat-
ic duct, thus giving a funnel shaped, side to end, lateral pancreatico jejunostomy.
Patients with generalised disease of pancreatic duct, duct size more than 7mm
and pain not responding to analgesics and blocks were included.The mean age
was 38 years (Range 14-70 yrs) with sex distribution being 56:8 (M:F). The
mean follow up was 7 years. Parameters studied were pain relief, weight gain,
morbidity & mortality. RESULTS: Relief of pain was present in 84.36 % (54
patients) and weight gain in 81.25% (52 patients).One patient, who died, had an
anastomotic leak and wound sepsis was seen in 4 patients. CONCLUSION:This
is a good surgical technique that is easy, safe, with only two anastomotic lines
and providing dependent and effective drainage.
V11.4
Percutaneous fine-needle pancreatic pseudocyst puncture guided by three-
dimensional sonography
JR Ladny1, Z Puchalski1, L Zimnoch2, J Palka3 and M Kokoszko1
1Medical Academy, 1st Dept. of General Surgery, Bialystok, Poland
2Medical Academy, Department of Pathological Anatomy, Bialystok, Poland
3Medical Academy, Department of Medicinal Chemistry, Bialystok, Poland
AIM:To evaluate the biochemical, morphological, diagnostic and surgical aspects
of chronic pancreatitis. We attempted also to evaluate the quality of life of
patients after surgery. MATERIAL AND METHODS: Our observation was
based on 222 cases of advanced CP seen and operated upon at our
Department during of the last 21 years. 117 (52,7%) patients underwent pan-
createctomy or pancreato-duodenectomy, the rest anastomotic procedures
and varied procedures for surgery of bile ducts.Quality of life after surgery was
evaluated according to Petrin method.Also, correlations between the presence
and state of mast cells and the activation of pancreatic stellate cells in CP with
varied intensity fibrosis were analysed. Finally whether prolidase activity may
reflect disturbances of collagen metabolism in human pancreatitis was studied.
RESULTS: We obtained satisfactory results after therapy in 86% cases. The
increase in the number of activated pancreatic stellate cells paralleled to the
increase in degranulated mast cells in more pronounced pancreatic fibrosis.
Prolidase activity reflected the extent of disturbances in collagen tissue metab-
olism during pancreatic diseases and the level of its activity may serve as a
marker of pancreatitis and pancreatic cancer. CONCLUSION: it is not possible
from these data to prove that surgical treatment is either more or less likely to
induce favourable state. It would be interesting to study a larger population for
a longer time and to match the results with those obtained from nonsurgically
treated patients.
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V11.5
Long-term follow-up of patients with benign extrahepatic biliary stenosis who
harbour K-ras mutations in their endobiliary brush cytology
NT Van Heek, PDJ Sturm, EAJ Rauws, E Caspers, P Drillenburg, DJ Gouma and
GJA Offerhaus
Departments of Surgery and Pathology,Academic Medical Centre Amsterdam,
The Netherlands
K-ras mutations are an early event in the carcinogenesis of neoplasms in the
pancreatic head region and can be detected in small samples such as cytologic
brushings.The presence of a K-ras mutation in endobiliary brush cytology sup-
ports a clinical suspicion of malignancy in extrahepatic biliary stenosis, even
when conventional cytology is negative or equivocal. However, in a large previ-
ous study K-ras mutations were also detected in brush cytology of patients
with a benign extrahepatic biliary stenosis (11%).The follow-up period of these
patients was recently updated in order to elucidate the meaning of this obser-
vation. From 312 previously described, consecutive patients with extrahepatic
biliary stenosis, endobiliary brush cytology was obtained. Mutations in the K-
ras oncogene were detected by an enriched PCR allele-specific oligonucleotide
(ASO) hybridization assay.The sensitivity and specificity of this assay were 42%
(92/220) and 89% (66/74), respectively. Follow-up was updated of the 8 patients
in whom a K-ras codon 12 mutation was found in a benign extrahepatic biliary
stenosis. General practitioners were consulted for recent information on the
patients, and all medical records were reviewed. Additional K-ras mutational
analysis with the PCR-ASO assay was performed on available patient material
from the biliary tract obtained during the prolonged follow-up.After a median
follow-up of 65 months, 6 of the 8 patients were still alive without malignancy.
One patient had died of cardiac disease without symptoms of biliary disease.
The other, diagnosed with a chronic pancreatitis in the previous study, had died
60 months after the endobiliary brush was performed, possibly due to a ductal
adenocarcinoma in the pancreatic head region. Histology on material obtained
from the papilla did however not show infiltrating carcinoma.The K-ras muta-
tional analysis performed on this tissue revealed the same mutation as previ-
ously found in the brush cytology. CONCLUSION:This study underlines that
results of K-ras analyses on endobiliary brush cytology should be carefully
interpreted.After long-term follow-up all 8 patients without obvious neoplas-
tic disease who harbored K-ras mutations in their brush cytology in previous
study, have to be considered as false-positives. Finding a K-ras codon 12 muta-
tion in a brush specimen should not prompt the surgeon to perform a resec-
tion in patients with an extrahepatic biliary stenosis.
V11.6
Pancreas procurement from marginal donors
U Boggi1, F Vistoli1, M Del Chiaro1,T Vanadia Bartolo1, E Marciano1, C Moretto1,
F Gremmo1,A Pietrabissa1, F Filipponi1 and F Mosca1
1Centro Regionale di Riferimento per la Cura delle Malattie del Pancreas,
Regione Toscana, Pisa, PISA, Italy
BACKGROUND: Pancreas (P) procurement from marginal donors (MD) may
alleviate graft shortage. MATERIALS AND METHODS: between March 1998
and December 2000 29 P transplants were done with graft procured from
either non-marginal donors (NMD) (n=14) or MD (i.e. over 45 years of age,
with history of cardiac arrest and/or marked hemodynamic instability requiring
high dose vasopressors) (n=15).All P were procured with a quick en-bloc tech-
nique and were transplanted either alone (n=1) or simultaneously with a kid-
ney (n=28).Tx outcome was evaluated as incidence of delayed endocrine graft
function (DEGF), actuarial graft survival and complication rate. RESULTS: One-
year, 2-year and 34 months overall insulin independence rate was 92.6%. DEGF
incidence and actuarial graft survival rates were 7% and 92.3% vs 13% and
92.9% for P procured from NMD and MD, respectively (p=NS). procured from
MD aged more than 45 years had an actuarial survival of 100% at 31 months.
Those procured from hemodynamically unstable donors had an actuarial graft
survival rate of 92.3%. Cumulative relaparotomy rate was 17% (21,4% in NMD
and 13,3% in MD). On the whole there was one partial portal thrombosis
(NMD), rescued by total heparinization, and no graft was lost to surgical com-
plication. Infection rate was 35,7% and 20% (cumulative 27,6%) for P procured
from NMD and MD, respectively. CONCLUSIONS: P procured from NMD and
MD have similar Tx outcomes. P procurement from MD can alleviate graft
shortage.
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V12.1
Radical cholecystectomy for carcinoma of the gallbladder
GJ Poston,AM Brown and R Norbury
Department of Surgery, Royal Liverpool University Hospital, Liverpool, United
Kingdom
Gallbladder carcinoma (GB Ca) is increasingly common and afflicting younger
patients.The diagnosis is often thought incurable, but timely surgery does offer
cure, even for patients with stage 3 disease.This 10-minute video demonstrates
the pathophysiology of GB Ca and the principles of radical cholecystectomy for
cure.The video opens with a description of the lymphatic and venous drainage
of the gallbladder with an outline of the current staging for GBCa.This is fol-
lowed by an anatomical description of the regions to be resected (GB+seg-
ments 4B and 5 +extrahepatic biliary tract and lymphadenectomy) .The opera-
tive sequence starts with excision of previous port sites (diagnosis made at
previous attempted laparoscopic cholecystectomy) followed by Intraoperative
ultrasound to assess stage. Surgery continues with a regional lymphadenecto-
my and excision of the extrahepatic biliary tract with gallbladder en-bloc with
segments 4B and 5. Biliary reconstruction is completed using a 70 cm retro-
colic Roux loop to the right and left hepatic ducts.The principles of mucosa-
to-mucosa anastomosis for high hepatico jejunostomy at the porta hepatis are
described in detail.
V12.2
Alternative management of pancreatic stump in pancreaticoduodenectomy
S Alfieri, P Caprino, F Rotondi,A Di Giorgio and GB Doglietto
Digestive Surgical Unit-Clinica Chirurgica, Digestive Surgery, Rome, Italy
The video shows the alternative management of pancreatic stump in pancre-
aticoduodenectomy for tumours. In order to avoid the high risk of pancreatic
fistula we do not perform the pancreatic-enteric-anastomosis.At the end of the
regular demolition time of the operation, about 3-5 cc of synthetic glue are
infused in the pricipal pancreatic duct of the residual stump, in order to obtain
the occlusion of the exocrine secretory tree of the gland. Finally the pancreat-
ic remnant is sutured with a linear stapler or with a continue line suture,
according with the consistence of the pancreatic parenchima. A Traverso-
Longmire reconstruction with hepatic-jejenum and duodeno-jejunum anasto-
mosis completes the surgical procedure. Since 1998 we treated 17 patients
affected by pancreatic or ampullary neoplasms and no perioperative mortality
has been recorded.The patients who presented a pure pancreatic fistula were
easly treated with external drain and medical therapy.The fistula didn’t consid-
erably affect the recovery.We recommend this tecnique particularly to young
and inexperienced surgeons in no referral surgical centres as a valid alternative
management of pancreatic stump reducing to zero the hospital mortality in
high-risk patients.
V12.3
The liver surgeon and the vascular surgery - inferior vena cava resection with
graft replacement
E Vicente1, J Nuão, Y Quijano, P Lãpez-Hervãs, JC Meneu, A Honrubia, A
Dominguez,A Puente, L Foguã and J Die
1Hospital Ramon y Cajal, Liver Transplantation Unit, Madrid, Spain
Resection and graft replacement of the vena cava is a surgical procedure rarely
indicated. Until recently, patients with cancer extensively invading or surround-
ing the vena cava had not been considered candidates for surgery.At the pres-
ent time, with modern surgical and anesthetic methods, resection of the vena
cava can be sefely performed.This video shows the case of a patient with mas-
sive inferior vena cava thrombosis secondary to renal cell carcinoma. The
absence of metastatic disease and local resectability was assessed using CT.
Cavectomy and expanded polytetrafluoroethylene (ePTFE) graft for caval
reconstruction from the suprahepatic veins to iliac bifurcation was perfomed.
An arteriovenous fistula (right saphenous vein to superficial femoral artery)
was created to enhance blood flow through the graft. Three years after the
operation, the patient remains alive and well without evidence of recurrence.
The graft patency was documented by venography in the early and delayed fol-
low-up.
V12.4
Hepatic bisegmentectomy on a cirrhotic liver with intermittent vascular oclus-
sion
MA Secchi, L Quadrelli, L Rossi, D Castellini, and A Ramadan
Surgical and Gastroenterological Division. Italian Hospital, Rosario,Argentina
CLINICAL CASE: A 67-year-old man presented with a hepatic cirrhosis evo-
luting to a chronic hepatitis (C virus) with no portal hypertension.The ultra-
sonography study showed a solid focal alteration on the left lobe suggestive of
a hepatocarcinoma.A CT SCAN confirmed a 96 mm neoplastic lession on the
liver, segment III, and another 30 mm nodule, segment IV; the latter being a sus-
pected regrowth cirrhotic nodule.A hepatic biopsy punction of the segment III
nodule was performed under ultrasound guidance; its report suggested an
anatomopathological differential diagnosis comparing a dysplastic macro nodule
and the presence of a different hepatocarcinoma of difficult definitive interpre-
tation.This fact due to a development over a chronic hepatic disease was sup-
plemented by an immunohystochemical test with positive result for P53 and 67
Ki Index.The patient was admitted on September 14, 2000, for undergoing a
surgical procedure.The Child classification result was “A” and the alfa feto pro-
tein test was 103 mgr/ml.An intraoperative ultrasound and frozen biopsy of a
node from the hepatic pedicle (inflammatory) and of the segment IV node
(regenerative node) were performed, as well as a Hepatic Bisegmentectomy (II
and III) with previous ligation of the left hepatic artery.Three Pringle manoeu-
vres of the hepatic pedicle lasting 15 minutes each were performed and a 5-
minute claping release among each of them.The total surgery duration was 2
1/2 hours. There were no bleedings or any other postsurgical complications,
neither were serological alterations because of intraoperative vascular exclu-
sions. (Video-VHS-PAL).The histopathological diagnosis was a well-differentiat-
ed hepatocarcinoma of the left lobe on an initially cirrhotic parenchyma.
Another six patients with the same pathology underwent a similar procedure
resulting in similar outcomes. CONCLUSION:The segmentary hepatic resec-
tion over a cirrhotic liver from a patient having Child A can be performed with
an intermittent vascular oclussion, which provides a safer and faster surgical
time.
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V13.1
Evaluation of laparoscopic staging for potentially resectable pancreatic and
periampullary tumours
AGW Moses1, DN Redhead2, KK Madhavan1, RW Parks1 and OJ Garden1
1University of Edinburgh, Surgery, Edinburgh, United Kingdom
2Edinburgh Royal Infirmary, Radiology, Edinburgh, United Kingdom
A prospective study in our unit suggested up to 60% of patients referred with
potentially resectable pancreatic malignancies could avoid an ‘inappropriate’
laparotomy following laparoscopy combined with laparoscopic ultrasound stag-
ing. However a recent retrospective study following introduction of preopera-
tive spiral CT scanning has suggested that only 22% of patients benefited from
laparoscopic staging.We have therefore sought to define spiral CT scan crite-
ria that might provide a more selective approach to laparoscopic staging.We
identified all 124 patients between June 1995 and May 2000 who had under-
gone laparoscopic assessment {following prior spiral CT scan) for staging of a
potentially resectable lesion [tumour suspected in: pancreatic head (88), peri-
ampulla (25), lower bile duct (9), duodenum (2)]. Each CT scan was examined
by a specialist pancreatico-biliary radiologist and graded ‘blindly’ according to a
modified existing system for determining local resectability: O (no mass),A (fat
plane between tumour and vessels), B (normal pancreas between tumour and
vessels, C (mass convex to vessel), D (mass concave to vessel), E (vessel encir-
cled, F (vessel occlusion), before these results were compared with the findings
at laparoscopy and laparotomy. In groups O, E and F only 4 out of 59 patients
benefited from laparoscopic assessment (7%), while 27 patients (42%) avoided
an inappropriate laparotomy in groups A to D as a result of improved staging.
Based on these results, only patients graded A-D should undergo laparoscopic
staging. By adopting this more selective policy in future, the number of laparo-
scopic evaluations may be reduced by 48%,while maintaining the efficacy at pre-
venting ‘inappropriate’ laparotomies at 42%.
V13.2
Diagnostic laparoscopy should not be performed in patients with peri-pancre-
atic carcinoma; implemantation of a new diagnostic strategy
EHBM Tilleman, BW Kuiken, ORC Busch, H Obertop and DJ Gouma
Department of Surgery of the Academic Medical Centre, University of
Amsterdam,The Netherlands
Diagnostic laparoscopy with laparoscopic ultrasound (EUS) is frequently used
in addition to radiological examination in the diagnostic work-up of patients
with a peripancreatic tumour. However controversy remains about the effec-
tiveness of diagnostic laparoscopy for these patients. In a previous prospective
randomized study we have demonstrated a limited additional value (13%) of
diagnostic laparoscopy in selecting patients with incurable disease.As no disad-
vantage of surgical palliation compared to endoscopic palliation was found in
terms of hospital-free survival we decided to abolish diagnostic laparoscopy
from the standard work-up of patients with peripancreatic tumours in October
1998.The aim of this study was to analyze the effect of the implementation of
this new strategy in the work-up of patients with peri-pancreatic carcinoma.
Did abolition of diagnostic laparoscopy lead to a higher rate of explorations in
which metastases were found? Between December 1998 and October 2000
127 patients with a potential resectable peripancreatic carcinoma after radio-
logical staging were included in the study. At laparotomy 81 (64%) patients
underwent a resection. In the other 46 patients (36%) a bypass procedure was
performed due to pathologically proven local ingrowth (n=22), lymph node
metastases (n=7) or distant metastases (n=17). Assuming that diagnostic
laparoscopy could only detect distant metastasis, the additional value of diag-
nostic laparoscopy in preventing patients from an unnecessary laparotomy in
this study would be 17/127= 13% (CI 95%: 7-19).As previously shown, not all
distant metastases will be detected during diagnostic laparoscopy due to their
localization or false negative pathology findings.This might result in an actual
additional value of diagnostic laparoscopy that will even be lower. CONCLU-
SION: Implementation of a diagnostic work-up without diagnostic laparoscopy
for patients with a peripancreatic tumour results in the detection of 13% dis-
tant metastases at laparotomy.As not all metastases might be detected or his-
tologically proven during diagnostic laparoscopy the additional value in pre-
venting an unnecessary laparotomy might even be lower, too low to justify its
standard use.
V13.3
The additional value of diagnostic laparoscopy in the work-up of patients with
a proximal bile duct tumour
EHBM Tilleman, SMM de Castro, ORC Busch,TM van Gulik, H Obertop and
DJ Gouma
Department of Surgery of the Academic Medical Centre, University of
Amsterdam,The Netherlands
Tumour staging in patients with a proximal bile duct tumour is focussed on
selecting patients who might benefit from a tumour resection. Diagnostic
laparoscopy has proven its value in GI malignancies. Small superficial liver and
peritoneal metastasis can be visualized and punctured under direct view. Since
1993 diagnostic laparoscopy is used routinely in the diagnostic work-up of
patients with a proximal bile duct tumour. Initial results of a pilot study seemed
to be promising but because of limited data in literature, regarding the addi-
tional value of diagnostic laparoscopy in the staging of proximal bile duct
tumours, we decided to extend our study. Between January 1993 and May 2000
diagnostic laparoscopy was performed in 106 patients (59 male and 47 female
patients, with a mean age of 59 year (range 30-80)) with a resectable proximal
bile duct tumour after radiological staging (US,Doppler, CT, ERCP, PTC). During
laparoscopy 41 of the 106 patients (39%) had incurable disease (36 metastasis
and 5 extensive tumour ingrowth) that could be proven histologically. In these
patients laparotomy was prevented as they were already palliated endoscopi-
cally.The 65 patients staged as having a resectable tumour underwent a laparo-
tomy for tumour resection. Twenty-eight of them (26% of the initial 106
patients) turned out to have an unresectable tumour at laparotomy (8 metas-
tasis, 13 tumour ingrowth in surrounding tissues, 5 encasement of veins/arter-
ies and 2 lymph node metastasis). Sensitivity of diagnostic laparoscopy for
detecting metastases in patients with a proximal bile duct tumour is 84%, the
negative predictive value is 87%. CONCLUSION: Diagnostic laparoscopy could
prevent an unnecessary laparotomy in 39% of the patients with a proximal bile
duct tumour.Therefore this procedure is beneficial in the diagnostic work-up
and should be used routinely. However, improvement could be obtained, as dur-
ing laparotomy in another 8% of the patients metastases were found.
V13.4
Laparoscopic Staging of Colorectal Liver Metastases
C O’Suilleabhain, LR Aseervatham, EJ Currie, RW Parks, KK Madhavan and OJ
Garden
University of Edinburgh, Department of Clinical and Surgical Sciences
(Surgery), Edinburgh, United Kingdom
INTRODUCTION: Early experiences with diagnostic staging laparoscopy (DL)
and laparoscopic ultrasound (LUS) suggested significant benefit in terms of
identifying factors precluding resection prior to laparotomy.Advances in imag-
ing techniques may have reduced the need for further staging modalities.The
aim of this study was to re-evaluate DL and LUS in staging patients with col-
orectal liver metastases. METHODS: 206 patients with resectable colorectal
liver metastases based on preoperative imaging were identified. DL was per-
formed on 152 patients and LUS on 140 patients.The impact of these proce-
dures was studied in terms of additional information obtained and the result-
ing change in management, compared to 54 patients in the same cohort who
did not undergo DL/LUS. RESULTS:The non-therapeutic laparotomy rate was
14.8% in patients not staged with DL/LUS. DL provided extra information in
10.2% of patients while LUS provided additional information in 18.2%.
Important findings were missed by DL and LUS in 3.4% and 11.4% of patients
respectively.Additional findings by DL/LUS in the first 5 years of the study peri-
od (34.4%) was significantly greater than the number in the last 4 years (13.2%),
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but there was no significant difference in the number of missed findings (12.5%
vs 16.2%). Hospital stay was significantly shorter in the DL/LUS group com-
pared to those undergoing non-therapeutic laparotomy (2 vs 8 days). CON-
CLUSION: Refinements in radiological staging of patients with colorectal liver
metastases has reduced the need for laparoscopic staging. Factors have been
identified which may better select patients for laparoscopic assessment.
V13.5
The role of endoscopic ultrasound (EUS) in the assessment of pancreatic
lesions
B Hegab, M Powar, N Pierris,A Maclean1, P Fairclough2 and S Bhattacharya
Departments of Surgery, 1Radiology and 2Gastroenterology,The Royal London
Hospital and St Bartholomew’s Hospital, London, England
AIM:To prospectively evaluate the utility of EUS in the assessment of pancre-
atic lesions, comparing it with abdominal ultrasound (US), spiral CT, and ERCP.
METHODS: 50 patients were assessed over 16 months.All underwent US and
CT; 27 underwent ERCP. EUS was used in 15 selected cases where it was like-
ly to provide additional information.The 50 lesions included 28 pancreatic ade-
nocarcinomas, 7 ampullary tumours, 5 neuroendocrine tumours, 7 inflammato-
ry masses, 2 cysts, 1 pancreatic metastasis. Imaging findings were corroborated
against operative findings or histology in 39 patients (78%) who underwent sur-
gery. RESULTS: In pancreatic adenocarcinomas (n = 4), EUS assessed tumour
size and resectability better than CT or US in 3 of 4 cases. It was not as accu-
rate in assessing lymph nodal disease. EUS evaluated tumour size and duodenal
wall involvement in ampullary carcinomas (n = 2) very accurately. EUS was as
good, if not better than CT in assessing size, location and resectability of neu-
roendocrine tumours (n = 4).Three focal inflammatory masses were assessed
with EUS; 2 were deemed neoplastic on CT, but EUS suggested a benign
process, which was confirmed by histology. EUS provided useful information on
cystic lesions (n = 2), particularly the feasibility of endoscopic internal drainage.
With hindsight, it seemed that EUS, if performed, might have altered manage-
ment in 9 cases from the 35 that did not receive EUS. CONCLUSION: EUS
provides accurate information on the stage and resectability of pancreatic
lesions, particularly when information from conventional imaging is inadequate.
V13.6
Evaluation of multiple organ dysfunction in abdominal surgery
A Levit, M Prudkov and O Korkin
Teaching Hospital Ekaterinburg, Intensive care, Ekaterinburg, Russia
The current scales of multiple organ failure are characterized by the following
shortcoming: the total score does not indicate which system is damaged and
too what degree; the increase of one parameter and simultaneous decrease of
another one by the same number of scores is not reflected on the total amount
of scores.The suggested Scale of the Estimation of Multiple Organ Dysfunction
can evaluate the main body systems in the course of intensive care.The total
estimate of multiple organ dysfunction (MOD) is calculated according to
100X+10Y+1Z formula, where X is the amount decompensated system, Y is
the amount of subcompensated system and Z is the amount of compensated
system.The whole system is arranged in the form of a table and shows which
organs and system are most affected by the pathological process and needs
correction. Repeated surgical interference into the abdominal cavity and adja-
cent cellular tissues was based increasing the amount of scores.The Scale was
tested in 143 patients with urgent abdominal surgery (pancreonecrosis, peri-
tonitis) operated on in 1998 - 2000. In all 18 non-survivals decompensation of
three and more system (the score more than 300) was found, such as decom-
pensation of the intestinal function (83%), endotoxicosis (72%), blood circula-
tion failure (33%) and renal dysfunction (22%). To sum up the Scale of the
Estimation of Multiple Organ Dysfunction may be used to assess both the
severity degree of the organs damage and the dynamics of MOD in surgical
patients.
V13.7
Is there a role for bone scans in the preoperative staging of hepatopancreato-
biliary cancer?
H Sheth1, SS Javed1,A Hilson2, J Buscombe2 and BR Davidson1
1Royal Free Hospital & University College Medical School, Department of
Surgery, London, United Kingdom
2Royal Free Hospital & University College Medical School, Department of
Nuclear Medicine, London, United Kingdom
AIM:To determine whether the routine use of radioisotope bone scans alters
the preoperative staging and surgical management of hepatopancreatobiliary
(HPB) cancers. METHODS: Bone scans performed on all patients with HPB
cancers (n=402) referred to our centre for assessment of operability over the
last 5 years, were reviewed. Patients with positive bone scans had local Xrays
and coned CT scans to characterise these lesions. In cases of diagnostic doubt,
bone biopsy was performed to confirm/exclude bony metastasis. RESULTS: Of
402 patients referred, 25(6%) were reported positive (+ve).Only 9(2%)patients
had true +ve scan.8 of these 9 patients with true +ve scans had locally unre-
sectable disease (n=4) and/or systemic metastasis (n=4) detected by other
imaging modalities. In only one patient with Gall bladder cancer and a true pos-
itive bone scan did the bone scan result influence the resection of HPB cancer.
Sensitvity was 100%, specificity was 96%, negative predictive valuewas 100% and
positive predictive value was 36%. CONCLUSIONS: Routine preoperative
bone scans contribute little additional information to the staging and surgical
management of HPB cancers. Hence routine isotopic bone scans to detect
bony metastasis are not indicated as a part preoperative staging investigation
protocol in HPB cancers.
V13.8
Fluorine -18 FDG imaging in hepatocellular carcinoma using positron coinci-
dence detection
C Verhoef1, R Valkema2, R de Man3, E Krenning2 and JNM IJzermans1
1EMCR Dijkzigt, Surgery, Rotterdam,The Netherlands
2EMCR Dijkzigt, Nuclear Medicine, Rotterdam,The Netherlands
3EMCR Dijkzigt, Gastroenterology, Rotterdam,The Netherlands
AIM:Tumour cells with increased fluorine-18 deoxyglucose (18F-FDG) uptake
may be detected by positron emission tomography, based on their enhanced
glucose metabolism. We prospectively evaluated whether 18F-FDG positron
coincidence detection (PCD) or 18F-FDG single-photon emission tomography
(SPECT) provide additional benefits to our conventional preoperative evalua-
tion of lesion detection in patients suspected for hepatocellular carcinoma
(HCC). METHODS: Thirteen consecutive patients with a suspected HCC
underwent conventional preoperative evaluation with ultrasonography (US),
triple-phase helical computed tomography (CT), superparamagnetic iron oxides
(SPIO) enhanced magnetic resonance imaging (MRI) and serum a-fetoprotein
(AFP) level. All thirteen patients had an 18F-FDG-PCD and SPECT. These
results were evaluated to assess the value of 18F-FDG-PCD and SPECT in addi-
tion to US, SPIO enhanced MRI and triple-phase helical CT. RESULTS:Ten of the
thirteen (77%) patients had atleast one histological confirmed HCC without
extrahepatic abdominal spread.The tumours ranged in size from 1 to 8 cm and
the serum AFP ranged from 3 to 30000 ug/L. Of these ten patients, two patients
had an increased tumour 18F-FDG uptake, (sensitivity of 20%); one patient with
an AFP of 5ug/L and a tumour size of maximum 4.5 cm and one patient with an
AFP of 249 ug/L and a tumour size of maximum 2 cm. In three patients with a
benign liver mass, 18FDG imaging with either PCD or SPECT was negative.
There was no false positive finding. CONCLUSIONS:We found a poor sensi-
tivity of 18FDG-PCD and 18FDG-SPECT for the detection of HCC. There
were no clear relations between AFP or tumour size and FDG uptake.
Therefore, we conclude that FDG imaging with PCD has no value in the pre-
operative work-up for HCC in patients with cirrhosis.
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A proposal of new staging system of hepatocellulur carcinoma
S Yamasaki,T Kosgue, J Yamamoto, K Shimada and M Takigawa
Department of Surgical Oncology, National Cancer Centre Hospital, Tokyo,
Japan
BACKGROUND & AIM: The current TNM Classification of liver cancer has
some faults and is indicated to both hepatocellular (HCC) and cholangiocellu-
lar carcinoma that are different in biological nature. T factor of the current
TNM of liver cancer is composed by complicated combination of the number,
size and distribution of tumour(s) and vascular invasion.One of the faults is that
when two small multicentric HCCs are located in the right and left lobe, it is
classified as stage 4, although the survival is better than that of other types of
stage 4.A staging system that is simple, proper and specific for HCC has been
required. We propose a new and simple staging system just for HCC.
MATERIAL AND METHOD:The subject of this analysis was a total 1196 cases
of HCC that was hepatectomized in our hospital till the end of 1999.A multi-
and uni-variant analyses suggested that tumour size (2 cm or less), tumour
number (solitary or multiple) and vascular invasion were prognostic factors.We
defined T1 as a case meets all 3 factors (2 cm or less, solitary and no vascular
invasion),T2 meets any 2 of 3 factors,T3 meets any 1 of 3,T4 as none of 3.TNM
classification defines positive for regional (hepatoduodenal lig.) node metasta-
sis as N1 and further metastasis as N2. Metastasis in any node other than
regional (N1) is classified as M1. In our series,N positive was only 0.5% (6/1196,
3 N1 and 3 N2) and their survival was as poor as Stage 4.There has been no
evidence that shows difference between the survival of N1 and that of N2 and
N3.We defined when N was positive, the stage is 4 only by N factor. RESULT:
According to our new staging system, the 5-year survival rates + SD were
70.5+4.7, 57.1+2.4, 35.1+2.4 and 28.3+4.3 for stage 1 (n=104), 2 (n=492), 3
(n=462) and 4 (n=138), respectively.The significant differences were observed
between any two stages. CONCLUSION: Our new TNM classification of HCC
is simple and reflects the survival properly.When two HCCs, both are less than
2 cm in diameter without vascular invasion, are located bilobularly, it is classi-
fied as stage 2 by our new system.
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V14.1
Malignant tumours of pancreatic head and periampulary zone - modern con-
cepts of surgical treatment
AA Shalimov,VM Kopchak,AI Dronov, IV Khomyak and IM Todurov
Department of Pancreatic and Bile Duct Surgery, Institute of Surgery and
Transplantology, Kiev, Ukraine
We rely upon the experience of the radical surgical treatment of 857 patients
with the cancer of pancreatic head (PH) and periampular zone in the period of
1976-1999. We used the following radical operations: pancreaticoduodenal
resection (PDR), subtotal PDR, local PDR and extended papillectomy. PDR was
performed in 614 patients in its different modifications.The main point of the
operation was the choice of the optimal way of the pancreatic stump manage-
ment.We used methods of the precision technique of the duct-intestinal suture
on the external pancreatic duct drainage, worked up in our clinic. In patients
(29 cases) when the PH tumour spread in the portal or superior mesenterical
vein without sprouting all the layers of vascular wall and with the absence of
the distant metastasis PDR was performed with the resection of the vein seg-
ment. The venous wall defect was managed by the atraumatic suture or
autovein insertion. In 24 cases of peripapillar pancreatic cancer and Vater papil-
la cancer (T1N0M0) the down local resection of ventral pancreatic segment
with the near part of duodenum and papilla major was performed. In affection
of itrapancreatic part of distal common bile duct segment (T1N0M0) in 10
patients the upper local PDR with the preservation of main pancreatic duct was
performed following by the duodenojejunal and choledohoduodenal anasto-
moses after our methods. In 43 cases of Vater papilla tumours with a size to 1
cm that did not spread on the PH (T1N0M0) the extended papillectomy was
performed.The common mortality after radical surgical treatment was 10,4%.
V14.2
A critical appraisal of pancreatectomy associated with vascular resection
U Boggi, M Del Chiaro, F Vistoli, E Marciano, C Croce, F Gremmo, S Signori and
F Mosca
Centro Regionale di Riferimento per la Cura delle Malattie del Pancreas,
Regione Toscana, Pisa, Pisa, Italy
BACKGROUND:Vascular infiltration (VI) is generally considered a contraindi-
cation to pancreatectomy (P). The aim of this study is a critical appraisal of a
series of P associated to vascular resection (VR). MATERIALS AND METH-
ODS: Seventy-seven P (15.9%) out of 483 performed between November 1987
and December 2000 were associated to VR. RESULTS: Operative morbidity and
mortality rates were 33.7% and 5,2%, respectively. Pancreatic cancer was diag-
nosed in 64 patients (83.1%) and histology confirmed VI in 57% of them.Overall
survival rates at 1, 3 and 5 years were 53%, 17.5% and 5.8%. Cases with vascu-
lar thrombosis, encasement or infiltration of multiple vessels showed the poor-
est outcome and no patient survived the 5-year period. One, 3 and 5-year sur-
vival rates of patients with limited VI (<180Â°) were similar to those with non-
confirmed VI (62.2%, 15.6% and 0% vs. 58.3%, 13.2% and 13.2%; p= ns).Thirteen
patients diagnosed with low-grade malignancies (cystic tumours, silent neu-
roendocrine tumours, or periampullary tumours) had a clearly improved long-
term outcome with 1, 3 and 5-year survival rates of 81.8%, 68.2% and 68.2%,
respectively. CONCLUSIONS: VR do not increase significantly the morbidity
and mortality of P. For pancreatic cancer indication to VR should be restricted
to patients with limited VI without encasement or thrombosis. For low-grade
malignancies VR should be performed more liberally since local disease control
may be associated to long-term survival or cure.
V14.3
Extended lymphatic clearance in curative pancreatic resections: a critical
appraisal
U Boggi, M Del Chiaro, F Vistoli, C Moretto, E Marciano, M Massa and F Mosca
Centro Regionale di Riferimento per la Cura delle Malattie del Pancreas,
Regione Toscana, Pisa, Pisa, Italy
BACKGROUND: Lymph node metastases (LNM) occur frequently in patients
undergoing curative pancreatic resections (CPR). AIMS:To evaluate the thera-
peutic efficacy of extended lymphatic clearance (ELC) in the treatment of local-
ly non-advanced pancreatic cancer (PC).METHODS: Data from 85 consecutive
patients undergoing CPR for locally nonadvanced PC (T1-3 according to last
UICC revision) between November 1987 and December 1998 were prospec-
tively collected. According to Ishikawa’s classification 44 patients received a
standard lymphatic clearance (SLC) and 41 received an ELC. No patient
received antiblastic therapies either before or after surgery. No patient was lost
at follow-up. RESULTS: The 2 groups were comparable regarding to demo-
graphic, clinical and histopathologic characteristics.There was no difference in
mean operative time, proportion of patients needing blood transfusions and
number of units transfused. Mean lenght of post-operative stay (19,6 ± 6,2 days
vs. 20,9 ± 8,9 days),morbidity (31,8 % vs. 46,3 %) and in-hospital mortality rates
(4,5 % vs. 2,4 %) were equivalent in SLC and ELC. Similarly, median survival
times (18 months vs. 22 months) and 3-year survival rates (25,7 % vs. 23,9 %)
did not differ according to lymphadenectomy. Even when the analysis was
restricted to patients with LNM ELC did not prolong survival. CONCLU-
SIONS: ELC seems to add no significant survival benefit to CR for locally non-
advanced PC. The occasional long-term survival of patients with lymph node
metastases seems to be more strictly related to the biology of the individual
tumour rather than the surgeon’s effort to increase local radicality.
V14.4
D2 vs. D1 lymph node dissection: impact on morbidity after Whipple procedure
J Pundzius, G Barauskas and A Gulbinas
Kaunas Medical University, Department of Surgery, Kaunas, Lithuania, Poland
Wide dissection of lymphnodes is proposed to achieve better results in early
forms of pancreatic cancer.AIM:To evaluate impact of extended lymphadenec-
tomy on postoperative morbidity after Whipple procedure. MATERIAL AND
METHODS:We have analysed retrospectively clinical data of 100 patients who
have undergone Whipple procedure or pylorus preseving pancreatoduodenec-
tomy because of malignant or benign tumours during 1995-2000. Patients were
aging from 22 to 78, 41(41%) of them being older than 65. Pylorus preserving
pancreatoduodenectomy was performed in 41%. D1 lymphadenectomy was
performed in 46 and D2-in 54 patients, starting from 1998. Median yeald of lym-
phnodes in D2 dissection is 20, which is more than the standard (? 13).
Influence of extent of lymphadenectomy on postoperative morbidity was eval-
uated using Fishers exact test. RESULTS: Overall morbidity was similar in both
groups (28,26% in D1 vs. 24,07% in D2; p=0.65). Pancreatic fistulas were
encountered in 6(13,04%) patients in D1 and 6(11,11%) in D2 group (p=0,77).
Septic complications occurred with similar frequency also (8,7% in D1 vs.12,5%
in D2; p=0,52). Postoperative mortality was 9% in the series. There were
5(10,87%) deaths in D1 and 4(7,4%) in D2 group (p=0,73). There were
7(15,22%) cases of delayed gastric emptying in D2 as opposed to none in D1
group.We attribute a little higher level of complications and mortality in D1
group to the learning curve, as extended dissection is now applied in every case
of Whipple procedure. CONCLUSION: Our data show that postopreative
morbidity or mortality after Whipple procedure is not influenced by the extent
of lymphnode dissection.
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V14.5
Extended pancreaticoduodenectomy for pancreatic and periampullary carcino-
ma: a single institution experience on 53 consecutive cases
C Iacono, L Bortolasi, E Facci, P Marinello, E Montresor, F Nifosi,GG Delaini and
G Serio
Division Of General Surgery C, Surgery and Gastroenterology, University of
Verona,Verona, Italy
The role of resection of pancreatic and periampullary carcinomas by extended
pancreaticoduodenectomy (EPD) is still contoversial. From 1994 to April 2000,
53 patients underwent consequently EPD. Thirty-six patients were male, 17
were female and the mean age was 60.7 years. Mean operative time was 368
minutes and mean volume of transfused blood was 567 cc (range 0-1500) .
Seventeen patients (32%) did not require any blood transfusion. Pathological
findings showed 38 pancreatic ductal adenocarcinomas (group A), 12 peri-
ampullary carcinomas (group B) and 3 other carcinomas; mean number of
lymph nodes resected were 34 (range 13-61). Lymph nodes metastasis in group
A were absent in 18% of the cases, present in 1st level in 45%, in 1st and 2nd
level in 32%, and in 2nd level in 5%. Lymph nodes metastasis in group B were
present in 33% of the cases only at 1st level nodes. Postoperative mortality and
morbidity rates were 1.8% and 38%, respectively. Mean postoperative hospital
stay was 20 days.Median follow up time was 15 months (range 3-72).Two, 3 and
5-year actuarial survivals in group A were 36%, 24% and 12%, and in group B
were 87%, respectively. Group A patients showed local recurrence and distant
metastases in 19% and 53%, respectively; while in group B only one patient pre-
sented pleural metastasis. EPD is a feasible operation with low mortality and
morbility rate, assures a more radical approach and accurate staging to pan-
creatic and periampullary cancer; any conclusion regarding outcome must be
supported by greater, randomized studies.
V14.6
Does blood transfusion affect results in extended pancreaticoduodenectomy
for pancreatic cancer?
C Iacono, L Bortolasi, E Facci, P Marinello, E Montresor, E Nifosi,GG Delaini and
G Serio
Division of General Surgery C, Surgery and Gastroenterology, University of
Verona,Verona, Italy
Many factors influence survival after pancreaticoduodenectomy for pancreatic
cancer: between them, units of blood transfused intraoperatively have been
considered a negative prognostic factor. From January 1994 through May 2000,
37 patients (25 men, 12 women) underwent extended pancreaticoduodenec-
tomy for pancreatic cancer at the Department of Surgery of the University of
Verona.Ten of these patients did not undergo blood transfusion (group A) and
27 patients (group B) did.The 2 groups were homogeneous for sex, age, per-
formance status, and preoperative laboratory tests (hemoglobin, bilirubin, albu-
min). Mean operative time was significantly longer in group B (402 ± 63 min) vs
group A (327 ± 59 min), p-value<0.01 , instead the groups were similar for type
of operation (hemigastrectomy or pylorus-preserving) and size of the tumour.
Operative mortality was 2.7% (1 patient, group A, died for myocardial infarc-
tion). Major surgical complications (pancreatic or biliary fistula) were present
in 12 pts in group B vs 0 in group A (p-value<0.01) , and therefore length of hos-
pitalization was 21 ± 10 days in group B vs 14 ± 4 days in group A (p-
value=0.03). Survival analysis at 1, 3, and 5-year was 77%, 38%, and 38% in group
A vs 75%, 21%, and 7% in group B (p-value = n.s.), respectively. Eventually intra
and/or postoperative blood transfusion/s are related to a longer operative
time, a higher surgical morbidity and longer hospital stay. Even if it seemed to
be a worse result in terms of survival, there was no statistical difference
between patients who were not transfused.
V14.7
Flutamide suppresses VEGF expression in the Hap-T1 Syrian hamster model of
advanced pancreatic cancer
AT Abraham, SR Shah,Y Sirivatanauksorn and BR Davidson
Royal Free & University College of Medicine, Surgery, London, United Kingdom
AIM:To study the effect of the anti-androgen flutamide on tumour growth and
spread in the HaP-T1 Syrian hamster model of advanced pancreatic cancer, and
determine if its effect is mediated by the suppression of vascular endothelial
growth factor (VEGF). METHODS: Flutamide (30mg/kg/day-sc) was adminis-
tered 5 weeks after implantation of Hap-T1 pancreatic adenocarcinoma cells in
Syrian hamsters (n=12). Controls (n=12) were injected with vehicle.The extent
and pattern of local progression and distant spread was assessed at necropsy
after 14 days.Tumour tissue was harvested for histopathology. Levels of VEGF
mRNA in frozen pancreatic tumour tissues were determined by semi-quantita-
tive RT-PCR. RESULTS: Treatment with flutamide decreased the mean +/- SE
tumour weight (1.3+/-0.4g vs 2.9+/-1.1g, P=0.19) . Number of animals with evi-
dence of metastases was lower in the flutamide group(3 vs 6, P=0.4).Levels of
VEGF mRNA were significantly lower in pancreatic tumours in the flutamide
treated group(0.27+/-0.04 vs 0.46+/-0.06, P=0.03).VEGF MRNA levels were
higher in pancreatic tumours of animals with metastases (0.47+/-0.05 vs 0.26+/-
0.05, P=.01).Tumour weight correlated strongly with VEGF expression in the
control group(r=0.75, P= .03). No such correlation was seen in the flutamide
group(r=0.09, P=0.92). CONCLUSION: Flutamide suppresses pancreatic
tumour VEGF mRNA expression in advanced pancreatic cancer in the HaP-T1
Syrian hamster model.This effect supports a possible role for flutamide as adju-
vant therapy in the palliation of advanced pancreatic cancer in humans.
V14.8
Correlation between physical and psychological symptoms in pancreatic and
other gastrointestinal cancers
KT Sukantarat1 and RCN Williamson
1Hammersmith Hospital, Surgery, London, United Kingdom
The diagnosis of cancer is a potent cause of psychological stress, and the
patient’s’ coping strategy can affect the outcome. A strong fighting spirit is a
good prognostic factor in breast cancer, while depression is particularly com-
mon in pancreatic carcinoma. Correlations between physical and psychological
indices of health were sought among 21 patients with a recent diagnosis of ade-
nocarcinoma of the pancreatic duct (n = 11) or other primary gastrointestinal
cancers (bile duct 3, islet cell 2, stomach, colon, ampulla, duodenum, liver).
Symptom score, performance status and subjective assessment on the EuroQol
scale were used to measure physical health, while the Hospital Anxiety and
Depression (HAD) scale and the Mental Adjustment to Cancer (MAC) scale
were used to measure psychological health. The incidence of anxiety and
depression (19-29 per cent) and the median scores for fighting spirit and help-
lessness were in line with previous reports.There was no significant difference
in any psychological index between patients with pancreatic ductal cancer and
other types of tumour (p = 0.38:Mann Whitney U Test).All measurements were
repeated in 17 patients at a median 8 weeks after treatment, whether surgical
resection or otherwise, when fighting spirit had fallen from median 51 to 48 (p
= 0.001) . Using pooled data, 9 of 12 possible correlations between physical and
psychological parameters achieved statistical significance (Spearman test).
Physical well-being governs the acute psychological response to the diagnosis
and treatment of cancer and seems more important than the particular type of
cancer.
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V14.9
Risk factors of pancreas related morbidity after pancreatoduodenectomy
G Barauskas,A Gulbinas, J Pundzius
Kaunas Medical University, Dept. of Surgery, Kaunas, Lithuania
BACKGROUND:The factors influencing the healing process of pancreaticoje-
junostomy (P-J) following pancreaticoduodenectomy are still not well defined.
AIM: To evaluate risk factors for pancreas related morbidity after pancreato-
duodenectomy. METHODS:We have analysed retrospectively clinical data of 95
patients who have undergone pancreatoduodenectomy at Kaunas Medical
University Hospital during 1995-2000 years. The influence of consistency of
pancreas, diameter of pancreatic duct, exocrine function of pancreas, bilirubi-
naemia, nature of tumour and age of patient to pancreas related morbidity was
evaluated. Satistical analysis was performed using Fisher’s exact test, analysis of
variance - ANOVA and Contingency coefficient C. RESULTS: The protracted
healing of P-J was encountered in 25.26% of cases. Fibrotic remnant of pancreas
was present in 37(38.95%) patients with 8.1% of pancreas related morbidity v.s.
36.2% in patients with soft pancreas. There was statistically significant
(p=0.0031) strong(C=0.85) dependency between consistency of pancreatic
remnant and the rate of protracted healing of P-J. Pancreas related morbidity
among 58(61.05%) patients with dilated pancreatic duct was 17.24%, whereas
in the group with non-dilated duct it was 37.83%. Satistically significant median
dependency is present (p=0.0307,C=0.64) .The median level of stool elastase
test in the group with dehiscence of P-J was 447.5ng/g, whereas 43ng/g in the
group without complications of P-J. The feature is statistically significant
(p=0.0172).There was no statisticaly significant dependency between pancreas-
related morbidity and bilirubinaemia (p=0.808), nature of tumour(p=0.5981)
and age(p=0.6305). CONCLUSIONS: Pancreas related morbidity following
pancreatoduodenectomy is influenced by consistency of pancreatic parenchy-
ma, diameter of main pancreatic duct and exocrine function.
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V15.1
Diagnostic efficacy of (MRCP) magnetic resonance cholangiopancreaticography
and ultrasonography (US) in the patients with obstructive jaundice
M Mähmanlä1, M Basak2, E Altinli1, N Turan2 and U Demir1
1Sisli Etfal Training and Research Hospital, Department of General Surgery,
Istanbul,Turkey
2Sisli Etfal Training and Research Hospital, Department of Radiology, Istanbul,
Turkey
In this prospective study, diagnostic efficacy of ultrasonography (US) and mag-
netic resonance cholangopancreticography (MRCP) were examined in patients
with obstructive jaundice. Fifty-four patients operated for obstructive jaundice
between April 1999-January 2000 were evaluated in this study. US assey were
done for all patients prior to MRCP evaluation. The operative findings were
accepted as the accurate and final diagnosis. The diagnostic efficacy of MRCP
and US for evaluation of intrahepatic ducts was the same for both of the meth-
ods.The results for the measurement of the diameter of the common bile duct
by the US and MRCP were not statistically significant. Obstructive jaundice is
mainly due to common bile duct stones (50%) and periampullary tumour
(27,8). Preoperatively, 87% of the patients were diagnosed correctly with US
and 94% of the patients were diagnosed correctly with MRCP. MRCP was dom-
inantly superior to US in the evaluation of distal common bile duct and diag-
nosis for distal common bile duct stones. Four patients with distal common bile
duct stones who were not evaluated by US were correctly evaluated by MRCP.
MRCP is usually unavailable in small medical centres and also an expensive
method for routine usage in diagnosis of obstructive jaundice but it’s a non-
invazive and easy method with 94% of diagnostic efficacy. MRCP is also a bet-
ter method for diagnosis for lower common bile duct stones. MRCP must be
used as the second method of choice for the patient having obstructive jaun-
dice that could not been diagnosed by US.
V15.2
Diagnostic value of fine needle aspiration cytology with ultrasonography in
focal liver lesions
O Yavuz1, FM Avsar2, D Dede1, S Hengirmen2, H Adiloglu1 and H Lafci2
1Numune State Hospital, Radiology,Ankara,Turkey
2Numune State Hospital, General Surgery,Ankara,Turkey
AIM: We aimed to investigate the efficacy of percutaneous needle biopsy in
focal liver lesions. MATERIAL AND METHODS: 36 patients bearing liver lesion
were included in this study and percutaneous needle biopsy was performed in
the departments General Surgery and Interventional Radiology. RESULTS:
Sensitivity was 91.30%, specificity was 100%, and True diagnosis was 87.8%.
These ranges were similar with other studies.There was no major complica-
tion. Fine needle aspiration cytology is easy, cheep and has low morbidity and
mortality rates and its diagnostic value is higher. CONCLUSION: HBV, HCV
infections and alcoholic lesions are very common in Turkish people. So that fine
needle aspiration cytology should be used routinely for the differential diagno-
sis of liver lesions.
V15.3
Intraoperative and percutaneous radiofrequency thermal ablation in the treat-
ment of liver metastases
L Marchiori, N Nicoli,A Casaril, S Carluccio, G Mangiante,AR Hasheminia and
G Colucci
Department of Surgery and Gastroenterology, Institute of Anesthesiology and
Recovery, University of Verona, Italy 
BACKGROUND AND AIMS: the treatment of choice of liver metastases (espe-
cially from colorectal cancer) is surgical resection; number and sites of metas-
tases often avoid this procedure.Thus, new alternative effective techniques are
needed. The aim of this study is to evaluate feasibility, safety and efficacy of
radio-frequency thermal ablation (RFTA). MATERIALS AND METHODS: from
May 1997 to April 2000 we treated 23 patients (8 male, 15 female, mean age
57,3 years, range 40-79 years) with 55 metastatic nodules (mean diameter 2,7
cm, SD 1,5 cm, range 1-7 cm); 17 patients had metastases from colorectal car-
cinoma (43 nodules), 2 from breast cancer (3 nodules), 1 from renal carcinoma
(1 nodule), 1 from cholangiocarcinoma (1 nodule) and 2 from neuroendocrine
tumours (NET), (7 nodules). Twenty-one nodules were treated by surgical
resection (mean diameter 4,45 cm, SD 2 cm, range 1-7 cm) and thirty-four nod-
ules were treated by RFTA (mean diameter 2,41 cm, SD 1 cm, range 1-4 cm):
11 patients underwent percutaneous RFTA and in 12 patients intraoperatively
(5 with Pringle’s manoeuvre to enlarge necrosis area): 10/12 underwent surgi-
cal resection + RFTA, while 2 patients received only RFTA.We used a modified
needle with four or seven hooks at its end (RITA Medical System, Mountain
View, CA); 1,48 passages were necessary for each nodule (2,27 for each
patient). In none of these patients RFTA was performed before, simultaneous-
ly or after surgery ± locoregional chemotherapy by intraarterial infusion, sys-
temic chemotherapy, ablation by laser. After one-month imaging RFTA was
repeated in 3 cases to improve or complete necrosis area. RESULTS: complete
necrosis was achieved in 82,35% of cases (28/34), and in 91,17% (31/34) after
the second session. No deaths related to RFTA were observed; only 2 major
complications were recordered (mild liver failure and liver abscess). Mean fol-
low-up was 15,2 months (SD 9,8 months, median 15 months, range 3-36
months) in 20 of 23 patients: 4 patients died (5,5,6,20 months). CONCLU-
SIONS: RFTA is a feasible and safe procedure, but resection is the best treat-
ment. RFTA is able to obtain, if complete necrosis is achieved, the same results
than surgery in the treatment of small metastases.Advantages of intraoperative
RFTA are the possibility to perform a better hepatic and abdominal stadiation
and to place a PORT for an intra-arterial infusional loco-regional chemothera-
py.
V15.4
Intraoperative-percutaneous-radiofrequency thermal ablation in liver metas-
tases from colorectal cancer
A Casaril, L Marchiori, G Mangiante,AR Hasheminia and N Nicoli
Department of Surgery and Gastroenterology, University of Verona, Italy
AIM:To evaluate the feasibility, survival rate, complications and hospitalisation
in 47 patients with HCC treated by radio-frequency thermal ablation (RFTA).
Even if the treatment of choice for HCC is surgical resection, the strong asso-
ciation of this disease with cirrhosis often avoids this procedure. RFTA
appeared, in preliminary studies, effective and safe, achieving a predictable area
of tumour tissue coagulative necrosis and saving the surrounding cirrhotic
parenchyma,without significant side effects. Moreover this technique , applicable
by percutaneous way, allows very short hospitalization. SUBJECTS AND METH-
ODS: We report the results of a series of 47 cirrhotic patients with 52 HCC
nodules (mean diameter 2,9 cm, range 1-6 cm) treated in our Institute in a
period of two years by RFTA using an expandable needle with four or seven
hooks at its tip.All patients had hepatic cirrhosis (32 Child A, 13 Child B and
two Child C). We treated patients with both monofocal (mo) HCC (35
patients) and multifocal(mu)HCC(12 patients); 33 patients underwent percuta-
neous (p)RFTA (54 passages) while in 14 patients RFTA was performed during
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laparotomy (22 passages).RESULTS:The mean number of passages to achieve a
complete necrosis was 1,43 for 28 patients with moHCC treated by pRFTA;
1,7 for seven patients with moHCC treated by intraoperative(i)RFTA; 2,8 for
five patients with muHCC treated by pRFTA and 1,43 for seven patients with
muHCC treated by iRFTA. No deaths related to the procedures nor major
complications occurred. Post-treatment dynamic CT was performed in all
patients.All but one patient was followed-up for a mean period of 11,8 months
(1-25 months). Six patients died during the follow-up (three Child A, two Child
B and one Child C).The actuarial survival, computed by Kaplan-Meyer method,
was 83% at 24 months. Mean hospitalization was 3,4 days in patients treated by
pRFTA and 11,2 days in patients treated by iRFTA. CONCLUSIONS: In our
opinion RFTA is an effective and safe technique to achieve good results in con-
servative therapy of small HCC; we believe that curative ablation are possible
for HCC’s nodules up to 3 cm diameter.
V15.5
Prospective trial of portal vein embolisation (PVE) prior to major resection
O Farges1, A Sauvanet1, R Santoro1, H Perrin1, V Vilgrain2, A Denys2 and J
Belghiti1
1Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
Preoperative PVE is increasingly used before hepatectomies.This method has
however never been validated. Between 1997 and 1999, 47 candidates for a
right hepatectomy (segments V,VI,VII,VIII) were entered into this trial.Twenty-
four had a normal liver (Knodell ‘s fibrosis grade 0-1) and 23 extensive fibrosis
or cirrhosis (grade 3-4, all Child A). Randomization was performed separately
in these groups to right PVE 6 - 8 weeks prior to surgery (n = 22) or immedi-
ate surgery (n = 25).Age, BMI, laboratory tests, indication for surgery, baseline
volume of the right and left hemi-livers were similar in patients with or with-
out PVE stratified for liver fibrosis. PVE was uneventful and resulted in a mean
volume increase of the left liver of 36 % (range 5-70%) for normal livers (n: 11)
and 30 % (range 0-114%) for fibrotic livers (n: 11).Among patients with normal
livers mortality was nil. PVE didn’t decrease overall morbidity (18% vs.15%),
temporary liver failure (9% vs. 0%) or in-hospital stay (12 ± 4 vs. 12 ± 4 days).
Among patients with fibrosis mortality was 9% in both groups. Preoperative
PVE resulted in significant reduction of overall morbidity (36% vs. 83%), liver
failure (9% vs. 50%), duration of ICU (6 vs. 15 days), and in-hospital stay (13 ±
4 vs. 30 ± 15 days) even when not excluding 2 patients with no hypertrophy.
Preoperative PVE before right hepatectomy has no or limited benefit in
patients with normal livers but reduces the risk of major resections in patients
with fibrotic livers.
V15.6
The Role of Ultrasound Guided Treatment of Liver Abscesses
T Winternitz1, ZS Nãmeth, P Kupcsulik and L Flautner
1Medical Faculty of Semmelweis University, 1st Surgical Dept., Budapest,
Hungary
BACKGROUND: The aim of this study was to evaluate the clinical value of
ultrasound guided therapy of liver abscesses (LA). METHODS: An analysis of
the cases of LA, treated by US guided intervention from 1989 to 1999 in the
1st Surgical Department of Semmelweis Univ. was performed.A HITACHI EUB
565A ultrasound apparatus was used with 3,5 MHz biopsy transducer type.The
puncture was performed with a 20-22 Gauge disposable Chiba needle.We used
7-16 Frtrocar drains. Controlled suction was applied using a vacuum bottle.
RESULTS: A total of 47 cases of PA (29 males and 18 females, mean age 55,3
ranged 3 to 76 years) were analysed.The LA was single in 30 (64 %) and mul-
tiple in17 (36 %). A positive culture of the abscess was obtained in 38 cases,
being monomicrobial in 26 cases (55.3%).The LA was of biliary origin in 47 %,
contiguous in 12% and unknown in 41 %. Ultrasound guided percutaneous
puncture was performed at 8, drainage at 39 cases. At 41 of 47 patients the
treatment were successful.At six cases the treatment was unsuccessful , and the
patients underwent operation. CONCLUSIONS: The clinical presentation of
pyogenic liver abscess has not varied over time. There has, however, been a
change with respect to its epidemiology and therapeutic management.At pres-
ent, the possibility of rapid diagnosis and image guided percutaneous drainage
offers a better prognosis for this disease.
V15.7
Treatment of surgical jaundice with immunotherapy
R Bapat1, C Kantharia2,A Deshpande3, S Ranka4, S Dahanukar5 And N Rege6
1Seth G S Medical College & Kem Hospital, Surgical Gastroenterology, Mumbai,
India
5Seth G S Medical College & Kem Hospital, Pharmacology Department,
Mumbai, India
6Seth G S Medical College & Kem Hospital, Pharmacology Department,
Mumbai, India
Deranged hepatic function and postoperative sepsis are the causes of poor
outcome of surgery in patients with extra hepatic biliary obstruction. Earlier
study has shown that Tinospora cordifolia (Tc), an immunostimulant agent from
Ayurveda increases the polymorphonuclear function and decreases morbidity
and mortality in patients of surgical jaundice. AIMS: Present study was under-
taken to 1) confirm the immunostimulant effect of Tinospora cordifolia in a
double blind, placebo controlled randomised trial and 2) evolve a treatment
plan for surgical jaundice. MATERIALS & METHODS:The study was conducted
in two phases. In phase I, after taking informed consent, patients of surgical jaun-
dice were randomly located to two treatment groups.Group I received Tc (500
mg thrice daily) and Group II received placebo in equivalent amount for 10
days. Phagocytic activity of polymorphonuclear cells was studied before and
after treatment. In phase II, all patients with surgical jaundice were administered
Tc preoperatively for 10 days (n = 83).They were then subjected to surgery.
Preoperative biliary drainage was not performed. Postoperative morbidity and
mortality at 30 days were noted. RESULTS:The group of patients treated with
Tc with phase I showed a marked increase in phagocytic capacity and intracel-
lular killing capacity [(22.8 + 4.1) Pre-treatment vs. (27.9 + 4.15) Post-treat-
ment] and [(16.4 + 2) Pre-treatment vs. (20.5 + 1.7) Post-treatment] respec-
tively;whereas group treated with placebo showed worsening of both the func-
tions [(21.23 + 5.1 vs. 19.6 + 3.9) Pre-treatment and (16.7 + 1.9 vs. 14.9 + 2.9)
Post-treatment respectively] .Thus treatment with Tc resulted in correction of
non-specific immunosuppression and marked improvement of immune func-
tion. The analysis of phase II patients revealed an uneventful recovery in 68
patients (81.9%) and the mortality was 5% at the end of 30 days. CONCLU-
SIONS:Tc bolsters the immune function and reduces morbidity and mortality
in operated patients of surgical jaundice. Addition of Tc in the preoperative
regime appears to be a rational therapeutic policy for treatment of surgical
jaundice.
V15.8
I-MIBG therapy is safe and cost effective in the control of symptoms in carci-
noid syndrome
GJ Poston, S Vinjamuri, C Byrne and J Vora
Departments of Surgery, Nuclear Medicine and Endocrinology, Royal Liverpool
University Hospital, Liverpool UK
BACKGROUND: Conventional treatment for symptomatic carcinoid syn-
drome (CS) is repeated injection of subcutaneous octreotide.This is expensive
($8000-16000) per year), and may continue for many years. Recent reports
have suggested that 131 I-Metaiodobenzylguanidine (MIBG) may be equally effec-
tive.The aim of this study was to evaluate the efficacy and cost effectiveness of
single dose I-MIBG therapy as an alternative to long-term octreotide. METH-
ODS: 5 patients with symptomatic CS who were either receiving or about to
start octreotide underwent diagnostic MIBG scanning and 13 showed tracer
uptake. One declined further therapy but the other 12 then received one
course of 131I-MIBG (7.4 GBq). Follow up included clinical, biochemical and radi-
ological response, and the need for octreotide. Cost of MIBG and octreotide
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were compared. RESULTS: MIBG treatmnent was well tolerated with transient
side effects. 10 patients showed measurable clinical improvement: 7 required no
octreotide and 3 could reduce their requirement. Mean duration of treatment
was 15.4 months. I-MIBG treatment resulted in a mean saving of $1000 per
patient with effective symptom control compared to octreotide. CONCLU-
SIONS: 131I-MIBG therapy is a safe and cost effective therapeutic option to suc-
cessfully control symptoms in patients suffering from the CS.
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V16.1
CLINICAL PATHWAY FOR HEPATOCELLULAR CARCINOMA, 2001
L Muñoz,T Fishbein, P Sheiner, S Emre, C Miller and M Schwartz
The Mount Sinai Hospital, R/M Transplantation Institute, New York, United
States
INTRODUCTION: Hepatocellular carcinoma (HCC) is an increasing problem
in the U.S.The presence at Mount Sinai of the second-largest liver transplant
program in the world and of one of the busiest hepatobiliary surgical services
in the region has led patients with HCC to gravitate to our centre. METHODS:
Demographics and course of treatment were analyzed for the 254 patients
with known or suspected HCC first seen in our department in 1999. RESULTS:
Of 254 patients with HCC, 192 were male; mean age 57. Underlying liver dis-
ease was present 91%: hepatitis C (54%), hepatitis B (19%), alcohol (9%), cryp-
togenic (5%) other (4%).Vascular invasion or metastasis contraindicating sur-
gery was noted in 64 (25%) at presentation; these patients were referred for
palliative treatment. Resection was performed in 25 (10%).Transplant evalua-
tion was recommended in 165 (65%); 24 were ruled out for medical/social rea-
sons, and 141 (56%) were placed on the waiting list. Treatments to prevent
tumour progression while waiting included chemoembolization in 49 patients,
ethanol injection in 30, and radiofrequency ablation in 1. Due to tumour pro-
gression, 21 (15% of patients listed) were removed from the list; 82 are cur-
rently waiting.Transplant was performed in 38 (15%): cadaveric in 22 with mean
waiting time 414d, and living donor in 16. CONCLUSION: The majority of
patients presenting with HCC would be best treated with liver transplantation;
organ scarcity has limited this option. Living donor transplantation is becoming
an important alternative in patients for whom a living donor can be identified.
V16.2
Liver resection for hepatocellular carcinoma in cirhosis: a multivariate analysis
of risk factors for intrahepatic recurrence
G Ercolani, GL Grazi, M Ravaioli, M Del Gaudio, M Cescon, F Pierangeli, A
Gardini, G Varotti,A Cavallari and A Mazziotti
Surgical Unit, Surgery and Trasplantation, Bologna, Italy
AIM: Intrahepatic recurrence is the major cause of poor prognosis after liver
resection for hepatocellular carcinoma (HCC). Every effort should be done in
order to reduce the incidence of recurrent tumour.We evaluated several prog-
nostic factors that might affect disease-free survival and recurrence rate in
resected cirrhotic patients. METHODS: Two hundreds and sixty-two liver
resections for HCC on cirrhosis were performed since 1984.There were 209
males and 53 females. Mean age was 61.9±8.1 years (range 22-80). Forty-one
pts (15.6%) were HBsAg positive. One hundred and fifty-five (59.1%) were
HCV positive. afetoprotein level was less than 20 ng/ml in 110 (41.9%) pts. and
more than 20 in 116 (44.2%).Tumour diameter was less than 5 cm in 207 (79%)
pts and more than 5 cm in 55 (21%). In 79 (30.%) pts. tumour capsule was com-
plete, while it was absent in 164 (62.5%). A single nodule was present in 232
(88.5%) pts, while multiple nodules were in the remaining 30 (14.5%).Vascula r
thrombosis was revealed in 138 (52.6%) pts. Furthermore, alanine aminotrans-
ferase levels (ALT) were less than 80 U/L (2N) in 150 pts (57.2%) and more
than 2N in 112 (42.8%).Aspartate aminotransferase levels (AST) were less than
2N in 178 pts (67.9%) and more than 2N in 84 (32.1). RESULTS:A wedge resec-
tion was performed in 82 pts (31.3%), segmentectomy in 159 (60.7%), and
major hepatectomy in 21 (8.0%). Overall 3 and 5 year disease-free survival was
49.3% and 27.9%.At the univariate analysis, 5-year disease-free survival was sig-
nificantly better in patients with single nodule (49.2% vs 0%), complete tumour
capsule (50.1% vs 41.1%), absence of microvascular thrombosis (52.5% vs
36.8%), and preoperative AST level less than 80 U/L (56.7% vs 26.4%). Pts. with
ALT less than 2N showed a slightly better survival (50.8% vs 43.4%, p=0.06).
However, at the multivariate analysis, only AST levels < 2N were independent-
ly related to lower incidence of tumour recurrence (p<0.0003) . The global
recurrence rate at 3 and 5 year was 44.3% and 59.8%, respectively. Patients with
ALT < 2N showed a lower incidence of tumour recurrence 5 year after resec-
tion (54.6% vs 58.6%; p=0.04); similarly, 5-year recurrence rate was lower
among patients with AST < 2N (50.1% vs 73.2, p=0.005). CONCLUSIONS:
Satisfactory long-term results after liver resection for HCC can be obtained in
patients with single nodule, complete tumour capsule and without vascular
thrombosis. Intrahepatic recurrence is strictly linked to the status of underly-
ing cirrhosis, and 80 U/L in AST seemed to be a sensitive cut off to stratify
patients with different risk. Cirrhotic patients with preoperative aminotrans-
ferase levels more than 2N showed the highest risk of intrahepatic recurrence
and may benefit of adjuvant anti-inflammatory treatments, or alternative treat-
ments such as liver transplantation.
V16.3
Impact of intraoperative ultrasonography on surgical management of hepato-
cellular carcinoma
V Vergara,A Ferrero, R Polastri,A Muratore, H Bouzari and L Capussotti
Ospedale Mauriziano, Surgery,Torino, Italy
Accurate staging of hepatocellular carcinoma (HCC) is mandatory to define
prognosis and to guide surgical or non-surgical procedures. The aim of this
prospective study was to evaluate the impact of intraoperative ultrasonography
(IOUS) on surgical decision-making during liver resection for HCC. Between
January 1992 and December 1999, 123 patients with HCC underwent opera-
tion for curative hepatectomy.All patients were evaluated preoperatively with
ultrasonography and Computed Tomography (CT): the total number of lesions
was 135.The first step of the operation has always been an IOUS and a thru-
cut biopsy has been performed when necessary. During the operation, 54 new
nodules were detected by IOUS in 32 patients (26%), and new information
were found in 56 patients (45.5%).The surgical procedures were altered in 46
patients (37.4%): the resection was extended in 32 patients (26%), reduced in
2 (1.6%); ten patients (8.1%) were found to be non-resectable (three were
treated with ethanol injection), two were resected with palliative intent. The
sensitivity of IOUS was higher than that of preoperative CT (99% vs 74%,
p=0.05). In conclusion, IOUS is more accurate in diagnosing HCC than preop-
erative conventional diagnostic work-up, correctly changes the stage of the dis-
ease and consequently the surgical management.
V16.4
Advanced hepatocellular carcinoma (HCC): surgical treatment and outcome
S Gautier, O Tsiroulnikova,A Filine, J Kamalov and D Semenov
National Research Centre of Surgery, Organ Transplantation, Moscow, Russia
Though the results of surgical treatment of advanced HCC depends on many
circumstances, the opportunity to perform a curative liver resection remains
the main point in prognosis on survival. During last decade the experience of
36 major liver resections for advanced or gigantic HCC was obtained. The
patients were 16 male and 20 female of 8 to 64 (mean 35.7+/-5.8) years old.All
patients were free of any diffuse liver disease.Alpha-fetoprotein level was sig-
nificantly high in 14 (38.9%) cases. The number of C.Couinaud’s segments
involved was 3 to 6. Monofocal gigantic tumour was found in 28 (77.8%) cases.
Six patients (16.7%) had 2 or 3 HCC nodes, 2 patients (5.5%) had multifocal
tumour. The surgical procedures were hemihepatectomy (7 right and 5 left),
extended hepatectomy (12 right and 9 left) and 3.
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V16.5
Treatment of hepato-cellular carcinoma: results of surgically resected cases
G Illomei, C Murru, O Nardello, M Mocci and M Cagetti
Clinica Chirurgica, Scienze Mat.Infant e Diagnostica per Immagini, Cagliari, Italy
Techniques of hepatic surgery quickly improved in the last two decades. In pres-
ence of higher perioperative risk, alternative therapies have been recently vali-
dated. From 1980 to December 2000 we observed 91 patients with HCC. In
presence of cirrhosis (52 patients, 57.1 %) hepatic function was evaluated by
the use of Child Pugh Classification. In 45 % of the cases (n = 49 patients, M 34;
F 15, mean age: 62,7 ) surgical treatment was indicated. Cirrhosis was present
in patients (40). Lesions were multiple in 48 cases and single in 53 cases. Mean
size of the lesions was 3.1 cm (1-8 cm).All patients were radically resected. 19
right and 2 left side hepatectomies, 18 segmentectomies, and 10 wedge resec-
tions were perfomed. Intra operative mortality was absent. Perioperative mor-
tality was absent. Major postoperative morbility was present in 12 patients
(25%). We encountered 7 cases of transient hepatic failure, one case of dis-
seminated intravascular disease (DIC), 4 cases of biliary fistula. According the
literature we believe that the use of minimal resections in Child Pugh A patients
affected by single or monolateral tumours, is a safe, effective and potentially
radical treatment with accettable mortality rate. Alternative therapies can be
conveniently considered in case of multicentric Child Pugh B-C patients or in
presence of tumour recurrence after surgery.
V16.6
Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellu-
lar carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias
P Zondervan1, J Wink1, JC Alers1, JNM IJzermans2, SW Schalm3, RA de Man3
and H van Dekken1
1AZR Rotterdam, Pathology, Rotterdam,The Netherlands
2AZR Rotterdam, Surgery, Rotterdam,The Netherlands
3AZR Rotterdam, Gastroenterology and Liver Diseases, Rotterdam, The
Netherlands
We have used comparative genomic hybridization (CGH) to analyse 26 HCC’s
(11 non-viral, 9 HBV, 6 HCV) and 12 concurrent dysplasias (5 non-viral, 5 HBV,
2 HCV). Frequent gain was detected, in decreasing order of frequency, on 8q,
1q, 17q, 12q, 20q, 5p, 6q and Xq. Frequent loss was found, in decreasing order
of frequency, on 8p, 16q, 4q, 13q, 1p, 4p, 16p, 18q, 14q, 17p, 9p and 9q.
Aberrations appeared more frequent in HBV-related HCC’s, than in HCV-asso-
ciated tumours (p=0.008). This was most prominent with respect to losses
(p=0.004), specifically loss on 4p, 16q, 17p and 18q. In addition, loss on 17p was
significantly lower in non-viral cancers, than in HBV-related HCC (p<0.001) .
Further, loss on 13q was more prevalent in HCC’s in non-cirrhotic livers
(p=0.02), thus suggesting a different, potentially more agressive pathway in neo-
plastic progression.A subset of the HCC-associated genetic changes was dis-
closed in the preneoplastic stage, i.e. liver cell dysplasia.This group of dysplasias
showed frequent gain on 17q, frequent loss was distinguished on 16q, 4q, and
17p. The majority of the dysplasias with alterations revealed genetic changes
also present in the primary tumour.
V16.7
Surgical treatment of small hepatocellular carcinoma
KH Lee1, DG Kim2,YK You3, IY Park4, S Lee5, EK Kim6 and SN Kim5
1Our Lady of Mercy Hospital, Catholic University of Korea, Surgery, In-Chon,
Korea
2Kangnam St Mary’s Hospital, Surgery, Seoul, Korea
3Daejeon St Mary’s Hospital, Surgery, Daejeon, Korea
4Holy Family Hospital, Surgery, PuCheon, Korea
5St Paul’s Hospital, Surgery, Seoul, Korea
6St Mary’s Hospital, Surgery, Seoul, Korea
In recent years, non-surgical methods have come to be widely used in the treat-
ment of small hepatocellular carcinomas. In a retrospective analysis, the authors
evaluated the surgical role in treating small hepatocellular carcinomas, regard-
ing the survival rate and the pathological report. Eighty-seven patients with a
small hepatocellular carcinoma, defined as less than 5 cm in diameter, under-
went a hepatectomy at our department during the 9 years between January
1990 and December 1998.We analyzed the pathologic findings, the operation
method, and the survival rate as functions of the tumour size. Multiple nodules
were presented in 18(20.7%) of the 87 patients, and the incidence of multiple
nodules was significantly higher for large-sized tumours.The incidences of cap-
sule invasion, extranodular growth, and portal and intrahepatic metastasis were
closely related to tumour size. For tumours less than 2 cm, no multiple nod-
ules, portal invasion or intrahepatic invasion was observed; however, very small
incidence of capsule invasion, extranodular growth (27.3% and 11.1% respec-
tively) and a high incidence (45.5%) of well differentiated tumours were noted.
The operative mortality was 3.45%(3/87 hepatectomies): two died of hepatic
failure, and one died of gastrointestinal bleeding.The 1-, 3- and 5- year survival
rates were 86.9%, 72.0%, and 61.1%, respectively, and the tumour size and num-
ber were significantly related to survival rate.The amount of resections how-
ever, was not significantly related to the survival rate.Tumours less than 2 cm
in size have a good prognosis and are quite different pathologically compared
to tumours, over 2 cm in size.
V16.8
Cooled tip radiofrequency treatment of liver metastases of endocrine tumours
P Hellman1, A Elvin2, B Skogseid3 and G Ãkerstrãm1
1Department of Surgical Sciences, Department of Surgery, Uppsala, Sweden
2Department of Radiology, Department of Radiology, Stockholm, Sweden
3Department of Medical Sciences, Department of Medicine, Uppsala, Sweden
Liver metastases of endocrine tumours are treated with biotherapy (alpha
interferon, somatostatin analogues), embolization or surgical resections.
Surgery may be used in cases with solitary metastases, or tumours confined to
only one lobe.Tumour reduction has been coupled to reduced morbidity and
increased survival in these patients. We have now added cooled tip radiofre-
quency (RF) in 19 patients with 2-7 metastases of midgut carcinoid, endocrine
pancreatic tumours or adrenal carcinoma. In 7 cases local ablations were per-
formed intraoperatively. In selected cases RF has enabled us to offer surgical
resections of other liver metastases. The remaining patients were treated in
local anesthesia during ultrasound guidance.Treatment with approximately 70
W lasted for 12 minutes, and end-temperature averaged +69 C. Effect of treat-
ment was monitored during and after the procedure by doppler enhanced
ultrasound or contrast enhanced computed tomography. If signs of complete
ablation was not seen, the procedure was prolonged or performed a second
time. In total, 31 lesions were treated.No major side effects occurred.Transient
elevation of liver enzymes occurred, but returned to normal within 5 days. No
local recurrence has (yet) been noted, during a mean follow-up of 1.5 years.
CONCLUSION: Cooled tip RF ablation is safe and efficient for liver metastases
of endocrine tumours.RF may increase the number liver resections. If increased
survival and/or reduced morbidity is achieved may be answered in a random-
ized trial.
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V16.9
Interstitial laser coagulation (ILC), with inflow occlusion, in patients with hepa-
tocellular carcinoma ensures local control at long-term
J Heisterkamp1, JW Kuiper2, R van Hillegersberg1, RA de Man3, HW Tilanus1,
PMT Pattynama2 and JNM IJzermans1
1University Hospital Rotterdam, Surgery, Rotterdam,The Netherlands
2University Hospital Rotterdam, Radiology, Rotterdam,The Netherlands
3University Hospital Rotterdam, Hepatogastroenterology, Rotterdam, The
Netherlands
ILC is a thermal technique aiming at coagulation of solid tumours by local light
delivery using thin flexible fibre(s). Recently, new strategies which combine
internally water-cooled fibre catheter systems with selective hepatic inflow-
occlusion resulted in volumes of coagulation of 5,5 cm in diameter. Whether
this increased rate of direct effectivity also results in local control at long-term
was investigated in the present prospective, observational, study. Patients with
unresectable hepatocellular carcinoma (HCC) were eligible provided that
triphasic spiral computed tomography (CT) and ultrasonography (US) showed
no more than 4 tumours with a maximum diameter of 4,5 cm and excluded
extrahepatic spread. ILC was performed percutaneously under general anaes-
thesia in the angiography suite. During ILC the inflow of the hepatic artery was
occluded with a balloon catheter, introduced through the femoral artery. In 15
patients 27 tumours were treated in 21 ILC sessions. Complete coagulation
was accomplished in 23/27 tumours (85%) and 12/15 patients (80%), of which
only two required a repeated treatment session. In none of the completely
coagulated tumours local recurrence has been found with a median follow up
time of 12 months (range: 6-39 months). In two of the 12 patients, locally con-
trolled with ILC, extrahepatic spread was diagnosed resulting in systemic con-
trol in 10/15 patients (67%). Initial successfully ILC, with selective inflow occlu-
sion, results in local control.These results combined with the high rate of ini-
tial success in the first treatment session, legitimates the use of this approach
in patients with unresectable HCC.
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V17.1
Hepatic resection for colorectal liver metastases: analysis of prognostic factors
A Muratore, R Polastri, H Bouzari,A Ferrero and L Capussotti
Instituto Per La Ricerca E La Cura Del Cancro, Surgical Department, Candiolo
(TO), Italy
The liver is the most common site of metastases from colorectal cancer.
Surgery is the only effective therapy with 5-year survival rates ranging from
20% to 40%. Aim of this prospective study is to determine factors that affect
long-term outcome after curative liver resection. Patients operated on for col-
orectal liver metastases in our surgical department between January 1990 and
December 1998 were identified from a prospective hepato-biliary database.
One hundred seventeen patients were submitted to resection for metastatic
colorectal cancer : 94 (80.3%) had a curative resection. Mean follow up was 35
months. In-hospital mortality was 1.7% with a 22.2% morbidity rate. Radical
resection was the most important predictive factor of long-term survival a 5-
year survival rate of 36.3%(p=0.00009) . When we analyzed this subset of
patients by univariate analysis, three factors were found to be significant pre-
dictors of poor long-term outcome: disease-free interval from primary to
metastases < 12 months (p=0.03) and preoperative (pre-hepatic resection)
CEA serum levels >30 ng/ml (p=0.002), number of liver metastases > 3
(p=0.04). By multivariate analysis, preoperative CEA serum levels and number
of metastases (o > 3) were indipendent factors related to long-term survival.
Liver resection for colorectal metastases is the only potentially curative thera-
py for metastastic colorectal cancer. Most of the patients undergone curative
resection will have a recurrence; CEA serum levels and number of metastases
are available factors in the preoperative evaluation and may be useful in order
to select patients with higher risk of recurrence and that can benefit from a
neoadjuvant therapy.
V17.2
A 10-year experience of hepatic resection: risk factors and outcome in 137
patients
B Fioole, MSL Liem,AH Hennipman, IHM Borel Rinkes
University Medical Centre, Utrecht, Surgery, Utrecht,The Netherlands
In order to analyze the influence of pre- and perioperative risk factors on the
development of postoperative complications and to assess the survival for
resections of colorectal liver metastases,we have reviewed all consecutive elec-
tive resections done between January 1991 and November 2000 at the
University Medical Centre, Utrecht. Pre- and perioperative parameters, com-
plications and mortality were recorded.The postoperative course was consid-
ered complicated, when reintervention was indicated or when discharge was
delayed. Major resections were considered resections of three segments or
more. Stepwise logistic regression analysis was applied after significant univari-
ate risk factors were found.A total of 133 patients underwent 137 resections
for benign (n=29) and malignant (n=108) disease. Sixty-nine patients were
operated on for colorectal metastases. Seventy-four procedures were consid-
ered major hepatic resections and blood transfusion was required in 97 cases.
Forty-three postoperative complications were observed in 32 patients (23%).
Eight patients died as a result of postoperative complications (overall postop-
erative mortality 5,8%).The only independent risk factor associated with the
development of postoperative complications appeared to be the number of
perioperative blood transfusions (OR 1,28).The 5-year survival rate after liver
resection for colorectal metastases was 38% with a 5-year disease-free survival
rate of 25% and the postoperative mortality in this group was 2,9%. CON-
CLUSIONS: Hepatic resection is a relativily safe and effective therapy in a wide
variety of hepatobiliary pathologies, but remains associated with a substantial
morbidity.A significant risk factor on the development of postoperative com-
plications is the number of perioperative blood transfusions.
V17.3
Is there a place for simultaneous hepatectomy for colorectal liver metastases?
I Iesalnieks,A Fuerst, M Anthuber and KW Jauch
University Clinic of Regensburg, Dept. of Surgery, Regensburg, Germany
INTRODUCTION: No clear evidence exists for the survival benefit and safe-
ty of one-stage hepatectomy and colon resection in patients with synchronous
colorectal liver metastases.The aim of this study was to compare the morbid-
ity and long-term survival after simultaneous versus delayed hepatectomy.
PATIENTS AND METHODS: Forty-six patients with synchronous liver metas-
tases from colorectal carcinoma underwent hepatectomy in our institution. In
21 of these patients, simultaneous hepatectomy and colon resection was done
(simultaneous-group); in 25 patients liver metastases were operated separately
after median interval of 2.75 months (interval-group). Fourteen patients in the
interval-group were treated adjuvantly after colon resection (systemic
chemotherapy in 10, and radiochemotherapy in 4). The survival rates and the
postoperative morbidity were evaluated and compared in both groups.
RESULTS: The complication rate was 38% in the simultaneous-group, but only
20% in the interval-group. Infectious complications were observed only in the
simultaneous-group, although there were no anastomotic leaks.The median dis-
ease-free survival was 11.1 months in the simultaneous-group and 10,0 months
in the interval-group. The median overall survival was 39.8 and 33.9 months,
respectively (no statistically significant difference, p>0.05). CONCLUSIONS:
Increased morbidity, but no survival benefit , could be observed for simultane-
ous resection of synchronous liver metastases of colorectal cancer in this
patient population.The ‘one-stage’ approach should be avoided in patients with
an increased risk for postoperative complications and tumour relapse (e.g.
numerous metastases, involvement of mesenterial lymph nodes).The benefit of
neoadjuvant chemotherapy previous to hepatectomy in the latter group is sug-
gested, although not evident yet.
V17.4
Synchronous colorectal liver metastases: simultaneous resection or two-stage
procedure
D Jaeck, Ph Bachellier, JC Weber, H Nakano, E Oussoultzoglou and Ph Wolf
Hautepierre Hospital,Digestive Surgery and Transplantation, Strasbourg Cedex,
France
BACKGROUND: Simultaneous resection of primary colorectal tumour and
synchronous liver metastases (LM) in a one-stage procedure is still controver-
sial. The aim of the present study was to investigate which patients could be
selected for a safe simultaneous resection. PATIENTS AND METHODS:
Between 1985 and 1999, 258 patients underwent a first hepatectomy for col-
orectal LM in our institution.Among them,97 presented with synchronous liver
metastases of which 35 underwent a simultaneous LM resection (Group SR)
and 62 a two-stage procedure with delayed LM resection (Group DR).
Postoperative morbidity and mortality and long-term outcome were compared
between the two groups. RESULTS: Major liver resection was significantly more
frequent in Group DR (p<0.05) . Mean duration of hepatic pedicular clamping,
mean operative time, number of patients undergoing perioperative blood trans-
fusion, and mean hospital stay did not differ between the two groups even in
case of a major hepatectomy. Postoperative morbidity did not differ between
the two groups (25% in Group SR and 35% in Group DR). Postoperative death
occurred in one patient of Group SR (pulmonary embolism at day 18, mortal-
ity = 2%) and did not occur in the Group DR. Survival rate was also identical
between the two groups (5-year survival: 26% in Group SR and 23% in Group
DR) CONCLUSION: This study demonstrated that one-stage procedure
should be considered as a good option when particularly the three following
criteria are completed: 1) elective surgery 2) primary tumour located in the
right, transverse or upper left colon 3) minor hepatic resection.
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V17.5
Two-stage hepatectomy procedure combined with portal vein embolization for
initially unresectable multiple bilobar liver metastases from colorectal carcino-
ma
P Bachellier1, H Nakano1, JC Weber1, E Oussoultzoglou1, P Wolf1, M Greget2and
D Jaeck1
1Hautepierre Hospital, Digestive Surgery and Transplantation, Strasbourg,
France
2Hautepierre Hospital, Radiology I, Strasbourg, France
AIM:To assess surgical outcomes of patients with multiple bilobar colorectal
liver metastases (MBLM) undergoing a two-stage hepatectomy procedure com-
bined with portal vein embolization (PVE). BACKGROUND: In patients with
MBLM, postoperative mortality reported after hepatectomy is still high (9%)a.
Liver failure due to insufficient functionnal volume of the remnant liver is the
main cause of postoperative mortality. Preoperative PVE has been proposed to
induce compensatory hypertrophy of the future remnant liverb. Some success-
ful cases undergoing right hepatectomy and simultaneous left lobe wedge
resections after PVE have been reported in patients with MBLMc. However,
growth rate of metastatic nodules in the future remnant liver after PVE can be
more rapid than that of the non-tumoural remnant hepatic parenchymad.
Therefore, metastases located in the future remnant liver should be ideally
resected before PVE, and a major hepatic resection can be then performed,
after PVE, in a second stage.The present study reports our results of this two-
stage hepatectomy procedure associated with PVE in patients with initially
unresectable MBLM. PATIENTS AND METHODS: 92 patients with MBLM
underwent hepatic resection in our institution (1993-1999) . Among them, 7
patients presented with initially unresectable MBLM due to insufficient volume
of the future remnant liver (left liver or left lobe of the liver).A two-stage hepa-
tectomy procedure combined with PVE was attempted in these 7 patients.
RESULTS: Non-anatomical resections for left liver metastases were performed
as a first hepatectomy without any complications in these 7 patients. All 7
patients underwent a right liver PVE. Sufficient hypertrophy of the remnant liver
was obtained in 5 patients.A right hepatectomy or an extended right hepatec-
tomy as a second stage hepatectomy was therefore performed in these 5
patients (feasibility = 71%). Mortality was nil. Morbidity occured in one case
(20%) with transitory liver failure.Three of the five patients are still alive with-
out reccurence more than 3 years after the second hepatectomy (60%).These
results can favorably be compared with the survival of patients undergoing a
right or an extended right hepatectomy for colorectal liver metastases in our
institution (3-year survival = 47%). CONCLUSION:The present results suggest
that a two-stage hepatectomy strategy combined with PVE is feasible in
patients with initially unresectable MBLM without increasing incidence of
recurrence in the remnant liver. References: JS Bolton et al Ann Surg 2000; 231:
743-751; D Azoulay et al Ann Surg 2000; 231: 480-486 ; S Kawasaki et al, Surgery
1994; 115: 674-677; D Elias D et al Br J Surg 1999; 86: 784-788.
V17.6
Edge cryotherapy after liver resection for colorectal metastases reduces recur-
rence risk for involved or inadequate margins
T Gruenberger, JL Jourdan, J Zhao, J King and DL Morris
St. George Hospital, Surgery, Sydney,Australia
HYPOTHESIS: Limited knowledge exists regarding the usefulness of additional
edge cryotherapy after liver resection for liver metastases from colorectal can-
cer to improve in involved or inadequate (less than 1cm) margin.This article
assesses the ability of edge cryotherapy to prevent locoregional recurrence
after liver resection. DESIGN: Retrospective analysis of prospectively collected
data. SETTING: Department of Surgery at a University Hospital. PATIENTS:
Eighty-six consecutive patients with hepatic metastases from colorectal cancer
in whom we applied additional edge cryotherapy to involved or inadequate
margins between 5/1992 and 2/2000. INTERVENTION: Potentially curative
treatment was achieved by adding edge cryotherapy to insufficient resection
sites in patients not amenable for further resection. MAIN OUTCOME MEA-
SURES: Edge recurrence rate in the study group; validation of an additional
treatment to improve curative resectability. RESULTS:At a median follow-up of
39 months 47 patients are alive and 39 have died. Local recurrence at the resec-
tion site was diagnosed in 9 patients (10.5 percent), of whom 7 occurred in
patients with involved margins and 2 in patients with resection margin below
one centimeter. 36 patients (41.8%) experienced recurrence in the remnant
liver. Extrahepatic recurrence occurred in 38 patients (44.2%), the lungs being
the commonest side (22 patients, 25.6%). CONCLUSION: Edge cryotherapy is
a potent additional surgical treatment option in patients with liver metastases
from colorectal cancer. The percentage of curative treatable patients can be
increased especially if complex liver surgery is demanded.
V17.7
Is curative Resection of Colorectal Liver Metastasis combined with Radio-
Immunotherapy (CI131 IF023C5) effective?
R Canelo1,T Behr2, F Braun1, B Sattler3 and B Ringe1
1Georg-August-Universität Göttingen, Klinik f?r Transplantationschirurgie,
Göttingen, Germany
2Georg-August- Universität Göttingen, Nuklearmedizin, Göttingen, Germany
3Georg-August- Universität Göttingen, Zentrum Pathologie, Göttingen,
Germany
INTRODUCTION:The most effective therapy of colorectal metastasis is a cur-
ative resection (R0). Nevertheless, a high tumour recurrence is today report-
ed. Is the use of new therapeutical approaches such as radio-immunotherapy
helpfully to improve this situation? METHODS: We analysed 27 patients (18
men and 9 women) who underwent curative liver resections. Mean age was 46
years (range 58.2-78) . Sole liver resections were peformed in 16 patients, in 11
patients were combined with radio-immunotherapy (CI131IF023C5) . In 7/11
cases was as adjuvant and in 4/11 as a rescue. RESULTS: Overall survival rates
were after 12 months (21.9 resection vs. 21.7 resection + radio-immunothera-
py). Survival rates were after 12 months 80.0% (24 patients), 24 months 46.3%
(11 patients) and 36 months 23.3% (6 patients). In the resection group (n:16)
four patients died after 8.5 (range 1-22) months, three of them showed a
tumour progression. 7/11 patients of the resection group + radio-immunother-
apy (adjuvant) are alive after 14.5 (range 9-19) months, while 4/11 patients of
the same gruop (rescue) died after 12.2 (range 9-19) months. CONCLUSION:
The use of radio-immunotherapy did not improve the survival rate. However,
the fact that patients who underwent resection combined with CI131IF023C 5
as adjuvant therapy are alive, may be considered as a beneficial effect.
V17.8
Results of surgical resection of liver metastases from carcinoid tumours
N Nicoli, S Carlucci1, A Casaril, L Marchiori, G Mangiante, AR Hasheminia, G
Colucci
Department of Surgery and Gastroenterology, 1Anesthesiology and Recovery,
University of Verona, Italy
We reviewed our experience concerning resection of liver metastases from
carcinoid tumours in 21 pts (13 female, 8 male; mean age 56 years, range 38-71
years) in the period between June 1976 and December 1999. Six pts showed
typical clinical picture of carcinoid syndrome; 5 of them showed pathological
values of serological serotonin level. In 12 pts liver resection was synchronous
with surgical procedure for primary malignancies, in 4 pts metachronous and in
5 pts primary tumour was not found. In metachronous lesions, mean time
between primary tumour resection and surgical treatment of metastatic liver
disease was 57 mo (range 7-106 mo). In 12 pts carcinoid tumour was localized
at terminal ileus, in 1 pts at stomach, in 1 pts at duodenum, in 1 pts at jejunum
and in 1 pts at lung. In one case preoperative transcatheter arterial chemioem-
bolization (TACE) with Lipiodol and Dacarbazine was performed. Eleven major
hepatic liver resections and 10 wedge resection or single or multiple metasta-
sectomies were performed without operative mortality. Extrahepatic disease
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was present and resected in 9 pts (8 nodes, 3 peritonaeum, 2 appendix, 1
adnexa). Histological pattern was confirmed by immunohistochemical studies.
Major postoperative morbility consisted in 4 cases of pleural effusion, 1 case of
hepatic abscess and biliary fistula and 1 case of hepatic failure. Mean follow up
was 54 mo (range 4 – 286).Three pts with multinodular disease were submit-
ted to TACE after hepatic resection. Five pts were treated with systemic
chemiotherapic agents. Four pts evidenced hepatic recurrence and were there-
fore submitted to repeat hepatic resection (3 major hepatectomy and 1 wedge
resection) respectively at 30, 43, 56 and 112 mo. Cumulative survival was 85%
at 36 mo and 76% at 60 mo and 63% at 120 mo. Liver resection can be con-
sidered the treatment of choice in pts with hepatic metastases from carcinoid
tumours.Aggressive management is integrated with multidisciplinary approach
consisting in systemic chemotherapy, hormone therapy and pre – and postop-
erative TACE.
V17.9
Liver resection for noncolorectal nonneuroendocrine hepatic metastasis
C Kantharia, S Chakravarti, D Mirza and J Buckles
Queen Elizabeth Hospital,The Liver Unit, Birmingham, United Kingdom
ABSTRACT: Hepatic resection, being considered as a safe procedure, the indi-
cation for resection of hepatic resection for noncolorectal, nonneurondocrine
(NCNE) hepatic metastasis is increasing. This study analyzes a single institu-
tional experience of hepatic resection for NCNE hepatic metastasis from 1990-
2000.Survival after liver resection in this group of patients is reported and fac-
tors predictive of survival are analyzed. 34 patients were identified.Their mean
age was 60 years with a median follow up of 13 months.The primary tumour
sites were grouped into gastrointestinal and nongastrointestinal, gastrointesti-
nal being 8 pts  (gastric n=4, small bowel n=2and pancreas n=2) and nongas-
trointestinal being 26 patients (sarcoma n=7 pts, adrenal n=4pts, uterus n=3
pts, ovary n=3 pts, testis n=2 pts , kidney n=3 pts, breast n=1 pt, thyroid n=I pt
lung n=1 pt, and melanoma n=1 pt.) All patients underwent surgery with an
intent of cure.There was no surgical mortality.The overall five year survival was
45.6%, with increased survival rate in patients with non- GI NCNE metastasis.
The extent of liver resection included Rt hemihepatectomy in 11 pts, Lt hemi-
hepatectomy in 4 pts, extended Rt hemihepatectomy in 6 pts, extended Lt in 3
pts. Lt lateral segmntectomy in 3 pts, segmental resection in 6 pts and nonseg-
mental resection in 1 patient.There was no difference in survival according to
type of liver resection, bilateral and resection of extrahepatic disease. CON-
CLUSION: We conclude that patients with NCNE hepatic metastasis benefit
from liver resection, with increased survival in patients with non -GI tumours.
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V18.1
Surgical treatment of the congenital choledocal cyst
J Grondona1, R Bracco2 and M Dualde1
1Centro Medico Martinez y Omar,HPB Unit,Department of Surgery, San Isidro,
Argentina
2Clinica Privada Pueyrredon, HPB Unit, Department of Surgery, Mar del Plata,
Argentina
AIM: Congenital choledocal cyst is an infrequent pathology in Occidental coun-
tries, but it is considered a high-risk lesion for malignant transformation.This
disorder is usually related to the presence of an abnormal Pancreato-
Choledoco-Duct Junction (PCDJ). In this video, a 28 year old female patient
with a congenital choledocal type I cyst, according to Todani’s classification, is
presented. STATEMENT OF FINDINGS: The patient was symptomatic three
months before admission. Ultrasonography and magnetic resonance cholan-
giopancreatography showed a large dilatation of the Extrahepatic Bile Duct
(EBD). Intra-Operative Cholangiogram (IOC) revealed the cyst dilatation of the
whole EBD, and was very useful to discover the right lateral bile duct collector
draining, segments 6 and 7 into the proximal part of the cyst. Further, an
abnormal PCDJ (pancreato-biliary type) was observed. Resection of the whole
EBD, including the intra-pancreatic bile duct was carried out. In a Roux-en-Y
reconstruction, both a Bihepaticojejunostomy ( right and left hepatic ducts) and
a Cholangiojejunostomy ( right lateral bile duct) in the same loop, were per-
formed with magnification. The postoperative period was uneventful and the
patient was discharged on the 7th day. KEY CONCLUSIONS: 1) The widely
accepted surgical treatment for Todaniâ ™s type I congenital choledocal cyst
is the total excision of the EBD, with a Roux-en-Y hepaticojejunostomy. 2) IOC
is very important to evaluate the choledocal cyst and the PCDJ, and plays a
great role in identifying a bile duct collector, draining into the cyst. 3) To dimin-
ish postoperative strictures and cholangitis, the anastomosis must be per-
formed with magnification.
V18.2
Videolaparoscopic pancreatectomy
E Crema,A Silva, R Lenza,V Bridi and A Martins
Faculdade de Medicina do Triangulo Mineiro, Digestive System Surgery,
Uberaba, Brazil
This video shows a 47-year-old male patient presenting with dorsal pain for a
year. A month prior the admission, the pain increased and he underwent CT
scans of the abdomen, which revealed hypodense lesion in the pancreas body.
The patient was the referred to treatment at the Department of Digestive
System Surgery of Faculdade de Medicina do Triangulo Mineiro. He underwent
pancreatectomy with cystic lesion and pancreas body resection through video-
surgery. Five openings were used (19/1/2000). Pancreatic head and tail were
preserved.Anatomopathologic study of the specimen evidenced serous oligo-
cystic cystoadenoma.The patient developed pseudocyst of pancreas and Y-Roux
inner deviation was performed one month after the first procedure. Control
US and CT scans after 9 months showed no evidence of cystic lesion in the
pancreas.The patient remains assymptomatic.
V18.3
Transduodenal sphincteroplasty and transampullary septectomy: an operation
in search of a disease
DN Lobo and BJ Rowlands
University Hospital, Queen’s Medical Centre, Section of Surgery, Nottingham,
United Kingdom
Sphincter of Oddi dysfunction is a complex and poorly understood syndrome
that usually manifests as pain of apparent biliary or pancreatic origin in the
absence of an organic cause after conventional investigations. Transduodenal
sphincteroplasty in combination with transampullary septectomy is one of the
therapeutic options for the condition. However, there is much scepticism about
the existence of the condition and the procedure has been termed ‘an opera-
tion in search of a disease’.This presentation consists of an intraoperative video
film demonstrating the technique of transduodenal sphincteroplasty and
transampullary septectomy in a patient with sphincter of Oddi dysfunction.
Criteria for patient selection, which include a morphine-prostigmine stimula-
tion test and results of the operation are discussed.
V18.4
Hand assisted laparoscopic splenectomy (HALS) in cases of splenomegaly
EM Targarona, G Cerdán, E Gracia, M Rodriguez and M Trias
Service of Surgery, Hospital S Pau. UAB, Barcelona, Spain 
Laparoscopic splenectomy (LS) is a well-accepted technique for cases with nor-
mal or slightly enlarged spleen. However, the difficulty of LS increases when the
spleen is enlarged because of the manipulation of a big organ into the abdomen.
Recently, some devices have designed to assist laparoscopic procedures with
the hand inserted in the abdomen, while the pneumoperitoneum is maintained.
This device permits to recover the tactile feeling and facilitate the mobilization
and dissection of the organ. Finally, the organ is recovered through the minila-
parotomy.AIM:The aim of this video is to show the main steps when HALS is
used including : 1) lateral mobilization of the spleen, traction of the gastric big
curvature and section of short vessels, 2) identification and clipping of the
splenic artery, 3) section of the splenodiaphragmatic ligament, 4) individualiza -
tion and section of the splenic hilum, and 5) organ extraction. MATERIALS,
METHODS AND RESULTS: Between feb-93 and January 2001, 151 LS were
attempted. The last 8 consecutive cases with clinical and radiological signs of
splenomegaly were approached by HALS. Mean age was 57 y. (44-72) and mean
operative time 111 min (85-165) .Any case was converted and there were no
postoperative complications.Mean stay was 3.6 d. (2-4) and spleen weight 1324
g. (720-3100) . CONCLUSION: Hand assisted laparoscopic surgery facilitates
significantly the surgical manoeuvres during LS, while keeping the advantages of
a purely laparoscopic approach.
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V19.1
A refined approach to the repair of bile duct structures
Y Yuzer,Y Tokat, O Yaprak and M Zeytunlu
EGE University Medical School, HPB Surgical Unit, Izmir,Turkey
Bile duct structures are still a common surgical problem especially with
enlargement of the laparoscopic cholecystectomy area.The aim of study is to
assess the results of a refined approach to repair of bile duct structures.The
medical records of 31 patients surgically treated for biliary structures between
January 1995 and June 2000 were reviewed and immediate and long-term
results retrospectively analyzed. Patients consisted of 15 females and 16 males.
The avarage age was 53.The etiology of biliary lesion was surgical operation of
bile duct in 24 patients, sclerozing cholangitis in 3 patients, liver transplantion
in 4 patients. 28 patients were submitted to Roux-en Y hepaticojejunostomy,
central hepatectomy with double cholangiojejunostomy was applied for two
patients, one patient was performed triple cholangiojejunostomy.
Nopostoperative was seen. 6 patients presented 8 postoperative complica-
tions; biliary fistula (1),wound infection (4),pneumonia(2) , intrahepatic cholesta-
sis(1).The average hospital stay was ten days.The follow up study was possible
in 31 patients and ranged from six months to five years.Two patients developed
structures reccurence cholangitis epizode and for this reason baloon dilation
and percutan transhepatic stent were replaced. High or low Roux-en Y hepati-
cojejunostomy in the clear margins without any dissection limit with mucosa
opposition without transanastomotic stent is a safe and efficient surgical repair
with longtime good results for biliary structures.
V19.2
Biliary, vascular and infectious complications induced by laparoscopic cholecys-
tectomy
O Mathisen1,A Bergan2 and O Soreide3
1Gastroenterological Surgery, Surgery, Oslo, Norway
From 1992-2000 , 33 patients with complications after laparoscopic cholecys-
tectomy were referred to our unit. Over the years there was no significant
reduction in the number of patients referred. A consultant surgeon had per-
formed the operation in 91%.At the local hospital 76% underwent various pro-
cedures in attempts to treat the damage. Complete transection of the bile
ducts were observed in 73%, while 27% had bile leakage injuries. On median
patients were referred after 3 months (day 0-34 months).Vascular injuries were
present in 24%, whereas 70% had infectious complications. Operative manage-
ment (hepaticojejunostomy Roux-Y) was employed in 73%. Non-operative
strategies were chosen in 27%.Three patients died, one of vascular complica-
tion, two of infection.Three patients have complaints with cholangitis.The other
27 patients are in good condition with normal/almost normal liver function
tests. Still a decade after introduction of laparoscopic cholecystectomy, bile
duct injuries continue to occur.These injuries are of considerable concern.They
are associated with mortality and serious morbidity. Vascular injuries are also
often present.There is a time lag in the referral of such injuries to a competent
unit.About 75% of the patients had serious infection.The surgical community
must continuously work to decrease the rate of these potential dangerous
complications.
V19.3
Management of laparoscopic bile duct injuries at a tertiary referral centre
A Agarwal, M Manesegran,A Chaudhary and AK Sachdev
GB Pant Hospital & MAM College, GI Surgery, Delhi, India
Iatrogenic injury to the bile tree is an uncommon but serious complication of
Cholecystectomy. The advent of laparoscopic cholecystectomy led to an
increase in the incidence of bile duct injury during cholecystectomy. Over the
last 6 years (August 1993 to November 1999) 47 patients were referred to our
centre for the management of biliary injury inflicted during laparoscopic chole-
cystectomy.There were 10 males and 37 females. In 10 patients the injury was
detected during laparoscopic cholecystectomy by the primary surgeon, while
remaining 37 was detected in the early postoperative period. At the time of
referral to our centre, 17 patients presented with external biliary fistula, while
the presentation was with biloma and Jaundice in 15 patients each. Of the 15
patients presenting with a biloma, percutaneous drainage was performed in 11
patients and 4 patients underwent surgical drainage.The resultant biliary fistu-
la closed over a variable period of weeks to months.The type of injury was type
C in 1, E1 in 2, E2 in 15, E3 in 27 & E4 in 2 patients. Roux-en-Y Hepatico-
jejunostomy was carried out in all these patients.All patients underwent PTC
or MRCP prior to the repair of the stricture.A stented hepatico-jejunostomy
was done in 9 of these patients.There was no postoperative mortality and the
patients are doing well over a median follow up of 17.2 months (range 1 year
1month to 6 years).
V19.4
Multidisciplinary treatment and follow-up of iatrogenic biliary lesions (IBL) per-
formed during cholecystectomy
G Nuzzo, I Giovannini, F Giuliante, G Boldrini, F Greco and C Chiarla
Catholic University, General Surgery, Hepato-Biliary Unit, Roma, Italy
Treatment of IBL performed during cholecystectomy represents a challenging
problem. Recent experience in a referral centre was reviewed, with regard to
factors affecting pre- and post-referral decision-making , severity of illness, out-
come.Twenty-four patients were treated, 14 with acute lesions (Group A), 10
with late unsuccess of previous repairs, mostly stenoses of hepatico-jejunos-
tomies (H-J) at pedicle (Group B).Group A: 9 patients with transected main bile
duct (MBD) had H-J at hilum (Hepp-Couinaud) , delayed after full recovery in
cases with sepsis, choleperitoneum, fistulae; one had H-J on duct for VI-VII, the
remainder (Bismuth I-II-V, or a fistula after H-J at pedicle) had endoscopy and
stenting or healed spontaneously. Group B: 5 patients (Bismuth III-IV) had H-J
at hilum or on left and right bile duct, 5 (with cirrhosis or complex stenoses)
had percutaneous dilation and/or endoscopic stenting. Postoperatively, one
patient developed intra-abdominal abscess; at mean 32 mo. follow-up, 2 patients
needed percutaneous dilation of left bile duct anastomosis.Treatment of lesions
and secondary complications required strict co-operation of surgeon, endo-
scopist and radiologist. Immediate repairs performed before referral (10 cases,
all without intra-operative cholangiography) increased complexity of lesions, or
resulted in late unsuccess. Delays in referral increased severity of illness.After
referral, strategy of delayed surgical repair in MBD transections with complica-
tions caused unsmooth clinical courses with prolonged hospitalization. Optimal
treatment of IBL often needs early referral to a specialized multidisciplinary
centre.Advantage of delayed vs early biliary reconstruction, in cases with sec-
ondary complications, remains an unsolved issue.
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V19.5
Can the fatal consequences of cholecystectomy be minimised?
A Briezat,A Al Domour, J Al Khalidi
Al Bashir Hospital, Ministry of Health, Jordan, Surgery,Amman, Japan
In the period between 1992 and 2000, 31 patients with different types of post-
cholecystectomy biliary complications were treated (Female: 21/31=68%, Male:
10/31=32%), age (23-57 years), 18 patients following open surgical cholecys-
tectomy (58%) and 13 patients following laparascopic cholecystectomy.There
were two groups of patients; the first was referred from other hospitals for fur-
ther management (15/31)while the second group included the patients whom
I was consulted upon at different stages during their management by other col-
leagues (16/31).There were different types of biliary injuries. Prior to referral
or consultation, different interventions were tried. Presentations varied from
internal and external biliary fistulas to bile duct stenosis with or without jaun-
dice. Patients were fully investigated. Procedures: different procedures were
done to treat the complications ranging from simple external drainage to con-
stuction of bi-hepatico-jejunostomy (Roux-en-y) with stenting and angiograph-
ic embolization. RESULTS: there were no mortalities in the referred group and
in patients upon whom consultaion was done at early stages. However there
were (4/16 =25%) deaths in patients who underwent consultation at late
stages. One patient needed further management in each group. CONCLU-
SION: In order to minimize the fatal consequences of biliary complications of
cholecystectomy, there should be an early comunication between primary
operating surgeon and experts in this field.
V19.6
The effect of bilirubin level on postoperative mortality rates in obstructive
jaundice
T Muftuoglu1, M Odabasi1 ,U Topaloglu3,A Saglam4 and E Bakircioglu5
1Haydarpasa Numune Teaching & Research Hospital, 4General Surgical
Department, Istanbul,Turkey
OBJECTIVE: To determine whether preoperative biliary level are associated
increased morbidity after biliary tract surgery. STATEMENT OF FINDINGS:
From January 1995 to December 2000, One hundred sixty seven patients with
obstructive jaundice operated in our hospital were retrospectively analyzed. By
chart review, the following variables were retrospectively collected: age, sex,
diagnosis, preopeartive biliary decompression, preoperative bilirubin level, pre-
operative investigations, type of operation, hospital stay, associated illness and
postoperative mortality rates. Different operations were performed to treat or
relieve to obstructive jaundice for pancreatic cancer (n=83), cholecystochole-
docholithiasis (n= 45), acute cholecystitis (n=14), stomach cancer (n=7), chron-
ic pancreatitis (n=1) and gallbladder cancer (n=1). Postoperative mortality rates
after biliary tract surgery were 6 %, 4 %, 3%, 12.5%, 16%, and 18% respectively
for total bilirubin levels (mg/dl) with, 0.5-5, 5-10, 10-15, 15-20, 20-30, >30.
Preoperative bilirubin levels were determined to be statistically significant vari-
able associated with postoperative death (p=0.0130) . CONCLUSIONS:
Patients with high bilirubin levels continue to be accompanied by mortality rate
despite advances in perioperative management and surgical techniques.
Because, biliary decompression have been well documented in the literature to
be associated with increased incidence of postoperative morbidity and mortal-
ity, so there is no trend toward a decreasing level of preoperative bilirubin
except in selected patients.
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C Iacono, N Nicoli, GC Mansueto, M Zicari, P Marinello, E Facci, L Bortolas, A Casaril,
P Capelli and G Serio
V20.1
Indication and outcome of surgery for benign hepatic tumours
T Terkivatan1, JHW De Wilt, RA De Man, HW Tilanus and JNM IJzermans
1Erasmus University Medical Centre Rotterdam, Surgery, Rotterdam, The
Netherlands
2Erasmus University Medical Centre Rotterdam, Hepatogastroenterology,
Rotterdam,The Netherlands
In contrast with Haemangioma (HMG), focal nodular hyperplasia (FNH) and
hepatocellular adenoma (HCA) are uncommon benign hepatic tumours that
continue to pose therapeutic dilemmas.A retrospective study was performed
to evaluate indications for surgery and outcome of long-term follow-up.A total
of 201 patients with benign liver tumours were managed in our institution
between January 1979 and December 1999. Sixty-nine patients were treated
surgically; 26 focal nodular hyperplasias, 16 hepatocellular adenomas, 24 hae-
mangiomas and 3 other benign tumours were resected. In the surgically treat-
ed group most patients presented with abdominal pain or other complaints, but
in 18 patients (26%) the tumour was an incidental finding. Major hepatic resec-
tions were performed in 17 patients (25%). Median operative blood loss was
1750 cc, which necessitated blood transfusion in 58% of patients. During post-
operative hospital stay, overall morbidity was 28% and operation related mor-
tality was 3%.After a mean follow-up of 39 months (1-182), 13 patients (19%)
had abdominal pain or other complaints related to surgery (2 incisional her-
nias). Altogether, 132 patients (FNH 42, HCA 14, HMG 24) were managed by
observation. During a mean follow-up of 45 months (24-74), 6 patients with
FNH had mild abdominal pain considered to be unrelated to the tumour, and
among patients with haemangioma 1 showed growth of the tumour without
any complaints. Six patients with HCA showed regression of the tumour after
cessation of oral contraceptives and two of these tumours were not detectable
during last follow-up.There was no evidence of malignancy, bleeding or other
complications. In conclusion, a careful patient selection is warranted since liver
surgery for benign tumours may well be accompanied by morbidity and mor-
tality.We advise surgery for solid liver tumours when there is doubt about the
diagnosis. In addition, resection should be performed in case of FNH and HMG
with severe complaints and in case of large HCA’s (>5 cm), regarding the
potential risk for rupture and malignant degeneration.
V20.2
Hepatobiliary cystadenoma: clinicopathological features and treatment, a twen-
ty-year experience
E Vicente-Lopez, JC Meneu-Diaz, J Nuão,Y Quijano, P Lopez-Hervãs and J Die-
Trill
University Hospital Ramon y Cajal, Hepatobiliary and Transplantation Unit,
Madrid, Spain
Hepatobiliary cystadenoma is a rare entity and represents less than 5% of intra-
hepatic cysts arising from the epithelium. Due to its neoplastic nature, it
becomes mandatory to distinguish from simple non-malignant lesions.
MATERIAL/METHODS:A retrospective analysis of all patients with a patholog-
ical diagnosis and treated surgically at our institution (February 1980 to June
2000). Variables were included among others: surgical findings, type of treat-
ment, pathological features of the resected specimen, operative mortality,
recurrence rate and malignant degeneration after treatment. RESULTS:There
were 10 patients. M/F was 3:7. Median age was 64 (range, 35-84). Abdominal
pain, mass and fullness were present in up to 80% . Laboratory data were nor-
mal in 80%. On pathological examination, the presence of mesenquimal stroma
was demonstrated in one case (10%).A partial cystectomy was performed in a
patient with a big lesion in the right lateral sector (segments 6 and 7) closely
adhered to the retrohepatic vena cava. Enucleation was carried out in two cases
(20%), segmentectomy and enucleation in one case and a major liver resection
was performed in 70% of the cases (6 left lateral sectorectomy and one right
hemihepatectomy).There was no operative mortality.After a median follow-up
of 8 years (range, 3-15) there was recurrence or malignant progression were
discovered. CONCLUSIONS: resectional therapy with clear margins seems to
be the optimal approach for cystadenoma. Exceptionally, partial resection can
be done in the absence of malignant degeneration or atypia.There are no clin-
ical or physical findings useful in determing the nature of hepatic cyst.
V20.3
Apoptin-induced apoptosis in hepatoma cells: opportunities for in vivo gene
therapy of HCC in a syngenic rat model
IH Straatsburg1,AG van Ginkel1, SA Rutjes2, M Cooreman2,AM Pietersen3, MN
Noteborn3 and TM van Gulik1
1Academic Medical Center, Surgical Laboratory, Dept. Surgery,Amsterdam,The
Netherlands
2Academic Medical Center, Experimental Hepatology, Amsterdam, The
Netherlands
3Leadd BV, Leiden,The Netherlands
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common pri-
mary malignant liver tumour. Apoptin, a small protein derived from Chicken
Anemia virus, induces apoptosis in transformed cells only, which makes it a
promising tool for cancer gene therapy. In nude mice, the size of a subcutaneous
tumour of human hepatoma cells (HepG2) was reduced after intratumoural
injection of adenoviral Apoptin.To study gene therapy for HCC in the liver of
an immunocompetent animal, the syngenic model of rat hepatoma cells (H4IIE)
in ACI rats is used.To investigate the sensitivity for Apoptin, H4IIE cells were
transfected with Apoptin-DNA. Transfection efficiency was compared with
transfection in human hepatoma cell lines HuH7 and HepG2. METHODS:
Hepatoma cells were incubated 4-6 hrs with Apoptin-, LacZ- or Desmin-DNA
in liposomes. 2-5 Days after transfection cells were fixed for immunocyto-
chemistry using FITC-labellinged antibodies against Apoptin, beta galactosidase
or desmin. DNA was visualized using DAPI. RESULTS:Apoptin was localized in
the nucleus and (weaker) in the cytoplasm of transfected cells. Nuclear local-
ization is supposedly essential for induction of apoptosis. All cell lines were
equally sensitive for Apoptin, reaching 75% apoptosis after 5 days.Transfection
with LacZ or desmin DNA resulted in 15-20% apoptosis. Background apopto-
sis without DNA never exceeded 5%. CONCLUSION: Our in vitro results
show high sensitivity of the rat hepatoma cell line H4IIE for Apoptin. Further
studies should be directed towards efficient transduction of Apoptin using re-
targeted viral vectors for in vivo gene therapy of rat HCC in a syngenic model.
V20.4
Pre-operative right portal vein embolization (PRPVE) for liver tumours
A Polikarpov1,A Granov2, P Tarazov1, D Granov2 and V Sergeev2
1Research Institute Of Roentgenology, Angio/Interventional, St Petersburg,
Russia
2Research Institute Of Roentgenology, Surgery, St Petersburg, Russia
AIM. To evaluate effectiveness of PRPVE for inducing contralateral hepatic
hypertrophy and decrease risk of postoperative liver failure in patients with
hepatic tumours. METHODS. Between 1997-2000, we performed 14 ultra-
sound guided PRPVE in pts with colorectal liver metastases (n=8), hepato-
cholangiocellular carcinoma (n=3), and hepatocellular carcinoma (n=3). For
PRPVE, a mixture of lipiodol, gelatine sponge and ethanol was used. Computer
tomographic liver volumetric studies were performed before and 4 weeks after
PRPVE. Right lobectomy was made in 10 pts in 28-50 (mean, 31) days.The four
remaining pts were not operated because of revealing intra- or extrahepatic
metastases. RESULTS. No complications were observed after PRPVE.The mean
volume of the non-embolized left liver lobe showed a 39,2% increase after
PRPVE. The mean intraoperative blood loss was 1.5 L. There was no hepatic
insufficiency and postoperative mortality. CONCLUSION. PRPVE is a safe and
well-tolerated procedure that decreases both the intraoperative blood loss and
risk of postoperative liver failure.
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V20.5
Photodynamic therapy for experimental liver cancer
T Dyuzheva1, N Kazachkina2, R Goloshapov1, N Raichlin2, V Sokolov2, G
Vorozhtsov2, E Lukjanets2 and E Galperin1
1Moscow Medical Sechenov Academy, Department of Liver Surgery, Moscow,
Russia
2State Scientific Centre, Moscow, Russia
OBJECTIVE: Photodynamic therapy (PhDT) of liver tumour (LT) has not been
elaborated yet.The purpose of this study is to elaborate methods of PhDT for
experimental LT and determine its effectiveness. METHODS: 58 mongrel male
rats 120 g in weight have been used into which alveolar mucous cancer was
grafted into the central hepatic lobe. PhDT was carried out on the 12th day.
Photosense (PhS, Russia) was administered regionally into an afferent vessel of
the central lobe (n = 23) or by punction (n=10). Irradiation was carried out (l=
675 nm, 100–200 mW, 100J) 15 min after regional injection and 2 hr after
administration of PhS by puncture. PhDT was assessed on the 21st day by the
tumour growth inhibition (TGI) and the morphological study.The control group
was made up of rats with LT that did not undergo treatment (n=25). RESULTS:
Regional administration of PhS led to a rapid (within 15 min) and considerable
accumulation of PhS in the tumour: 88 ± 9 c u, compared to 63 ± 7 c u with
intravenous administration, p < 0.05. The TGI index was 81.3 percent for
regional and 60.8 for punction injection.Total necrosis of the tumour has been
found in 90 percent of the animals. CONCLUSION: LT PhDT in regional and
administration by puncture of PhS is an effective method that allows tumour
irradiation to be carried out during surgery which considerably facilitates treat-
ment.
V20.6
Surgical and multimodality treatment of liver metastases from neuroendocrine
pancreatic and peripancreatic neoplasms: results on 23 patients
C Iacono1, N Nicoli1, GC Mansueto2, M Zicari2, P Marinello1, E Facci1, L
Bortolasi1,A Casaril1, P Capelli3 and G Serio1
1Division of General Surgery C, Surgery and Gastroenterology, University of
Verona,Verona, Italy
2Division of General Surgery C, Radiology, University of Verona,Verona, Italy
3Division of General Surgery C, Pathology, University of Verona,Verona, Italy
Hepatic metastases represent the more frequent event in functioning or non-
functioning neuroendocrine pancreatic neoplasms. We observed 82 pts with
neuroendocrine tumours of the pancreas or peripancreatic area.Twenty-three
patients had hepatic metastases: 20 synchronous and 3 metachronous. Non-
functioning neoplasm (NFN) was present in 14 patients, and functioning neo-
plasm (FN) in the other 9. Seven patients (5 NFN, 2 FN), at the beginning of
our series, underwent laparotomy only for diagnostic or palliative purpose
(Group A); instead 16 patients were submitted to resection of the primary (3
pancreaticoduodenectomies , 10 left splenopancreatectomies, 2 enucleations, 1
total gastrectomy) and treatment of hepatic lesions (Group B).This treatment
consisted in: 5 (2 NFN, 3 FN) hepatectomies or metastasectomies and 11 mul-
timodal approaches (hepatic resections, also repeated, with or without hepatic
chemoembolization, alcohol injection, thermoablation, medical therapy).There
was no postoperative mortality. A splenic abscess was a complication of
chemoembolization. Five and 10 years overall actuarial survival was 59% and
45%, respectively; 5 and 10-yrs survival in group B vs group A were 76% and
55% vs 20% (p=0.08) , respectively. In group B, there were no statistical differ-
ences between patients that underwent only surgery vs multimodal treatment
(80% and 60% vs. 77% and 57%, p=0.6).We believe that an aggressive surgical
approach, that is resection of primitive tumours and hepatic lesions, must be
pursued when technically feasible. In the other cases resection of primary must
be followed by individualized multimodal management of hepatic secondaries
according to the type of neoplasms and patient status.
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V22.1
Elevated endothelin-immunoreactivity in human and possum gallbladder epithe-
lium in vitro
BO Al-Jiffry,ACB Meedeniya, J Toouli and TP Saccone
Flinders University of South Australia, General and Digestive Surgery,Adelaide,
Australia
BACKGROUND: Exogenous endothelin (ET) induces a strong contraction in-
vitro in guinea pig, possum and human gallbladder (GB).Whilst ET immunore-
activity (IR) is present in cultured human GB epithelial cells, the presence and
distribution of ET in other layers of the GB and in pathological human GB have
not been reported.Aims:To determine, by immunohistochemistry, the presence
and distribution of ET in: 1) the different cell types in the GB from normal fast-
ing and fed possum; 2) cholecystic human GB. Methods: GBs were collected
from 8 fasted, 4 fed possums and 7 patients undergoing laparoscopic cholecys-
tectomy for chronic gallstone disease. Half of each GB specimen was fixed
immediately in fixative and the other, placed in organotypic culture for 24 hours
prior to fixation.An antiserum against ET followed by a fluorescent secondary
antibody was applied.RESULTS: In the human GB, ET-IR was observed in epithe-
lial cells, both before and after culture. In contrast, no ET-IR was seen in the
epithelium of freshly-fixed GB from fed or fasted possums, although ET-IR was
seen in blood vessels. Notably, following culture, ET-IR was seen in GB epithe-
lial cells from both fed and fasted possums.No ET-IR was observed in other cell
types in either human or possum GB, before or after culture. Conclusion:We
propose a role for ET in GB pathogenesis rather than in physiological function,
where ET synthesis/expression is an early event in gallbladder pathophysiology,
contributing to GB dysmotility.
V22.2
Endothelin-3 increases gallbladder motility in-vivo
BO Al-Jiffry,J Toouli and GTP Saccone
Flinders University of South Australia, General and Digestive Surgery,Adelaide,
Australia
BACKGROUND: Endothelin-3 evokes contraction in-vitro, but the endothelin-
3 effects on the gallbladder motility in-vivo are unknown. AIMS:To determine
the effect of endothelin-3 on the blood pressure (BP) and gallbladder motility.
METHODS: 18 anesthetized Australian possums, BP and gallbladder motility
was measured. Endothelin-3 (5-200 pmol/kg) was administered by close intra-
arterial injection. Tezosentan was infused at 10 and 100 nmol/kg/min (close
intra-arterial). To determine if nerves modulated the endothelin-3 effect, TTX
(9 µg/kg, close intra-arterial) was injected prior to endothelin-3 (50, 100 and
200 pmol/kg). Maximal changes in BP (mmHg) and gallbladder tone (as % of the
contraction induced by carbachol, 100 nmol/kg) were determined. Repeated
measures ANOVA and Kruskal-Wallis analysis were used for statistical analysis
as appropriate. RESULTS: Endothelin-3 induced a dose-dependant increase in
BP and gallbladder tone (P<0.05), which were TTX-insensitive. The maximal
increase in BP and gallbladder tone, at 200 pmol/kg, was 18.1±4.0 mmHg, and
37.5±4.7 % of the carbachol-induced response respectively. Pre-treatment with
Tezosentan at 10 or 100 nmol/kg/min decreased the endothelin-3 induced gall-
bladder response (P<0.02).The endothelin-3 induced BP change was unaffect-
ed by tezosentan at 10 nmol/kg/min, however it was significantly reduced with
the 100 nmol/kg/min infusion (P<0.05). CONCLUSION:This is the first demon-
stration that endothelin-3 strongly enhances possum gallbladder motility, acting
directly on the smooth muscle.The low and high dose Tezosentan antagonized
the endothelin-3 induced gallbladder contraction, but only the high dose antag-
onized the endothelin-3 induced BP, indicating that the reduced BP response
was associated with no additional change in the gallbladder response.
V22.3
Morbidity and justification of the complete excision of choledochal cysts in
adults
A Kianmanesh, JM Regimbeau,A Sauvanet, O Farges and J Belghiti
Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
Cancer arising on choledochal cysts (CC) is in part related to the presence of
anomalous bilio-pancreatic junction (ABPJ).The preventive excision of the com-
mon bile duct including the CC is the recommended treatment. However it
extent is not well standardized.The principle aim of this study was to evaluate
the morbidity of complete excision (CE) especially after extensive intrapancre-
atic dissection of choledochus.Among 28 consecutive adult patients (21 type I
or IV), 24 (85%) had CE, 11 (39%) with extensive intrapancreatic dissection of
choledochal (all with ABPJ). First 4 cases, had the dissection passing by extra or
intramural plan of choledochus (classic technique), while last 7 patients by vas-
cular plan of epicholedochal plexus.Three patients (10%) had cholangiocarci-
noma (2 ABPJ) while in 2 cases preoperative investigations were considered as
normal.Two died 14 and 34 months later.The overall morbidity of CE was 38%.
The proper morbidity of extensive intrapancreatic dissection was 43%.Among
4 reoperated patients, 3 (75%) had extensive intrapancreatic dissection accord-
ing to classic technique . No major morbidity was observed for the last 7
patients following extensive intrapancreatic dissection of choledochus passing
by the plan of epicholedochal vessels (p<0.01). Amylase concentration in the
bile was higher in patients with individualized AJBP vs. those without ABPJ
(p<0.001). Our results suggest that (i) CE with extensive intrapancreatic dis-
section of the choledochus in presence of ABPJ can be safely performed pass-
ing by the plan of epicholedochal plexus; (ii) in all cases routine frozen sections
should be performed to do not misdiagnose an early stage of cancer ; (iii) amy-
lase in the bile can help to affirm the presence of ABPJ.
V22.4
Choledochal cyst: late presentation in adults
T El-Sefi1 , M Osman1 , A Sadek1 , A Shawki1 , I Boghdadi2 , I Marwan1 , F
Sedeky3and M-Y Rashed3
1Department of HPB Surgery, National Liver Institute, University of Menoufiya,
Egypt
2Department of Medicine, Faculty of Medicine, University of Menoufiya, Egypt
3Department of Hepatology, Faculty of Medicine, University of Alexandria,
Egypt
BACKGROUND: Choledochal cyst is usually a disease of infancy and child-
hood. However, the diagnosis of choledochal cyst should not be excluded
because the patient is an adult. AIM:To describe the clinical presentation and
management of adult patients with choledochal cysts. PATIENTS AND
METHODS: The medical records of 16 adult patients with choledochal cysts
were retrospectively analyzed in the period from 1992 to 1999 at our institu-
tions.The age range was 17-56 years, with a mean of 33±6.4 and male to female
ratio 2:1. Cysts were classified using the Todani modification of the Alonso-Lej
classification. RESULTS: All patients presented clinically with recurrent right
upper quadrant pain, and with symptoms and signs of cholangitis. Six patients
were diagnosed after being submitted for cholecystectomy, 3-20 months before
presentation.Type-I Todani classification was the commonest (9 patients), type-
II (one patient), type-III (3 patients), type-IVA (two patients), and type-V Caroli’s
disease in one. Cystectomy, total or partial, and hepatico-jejunostomy (HJ) have
been done for 12 patients. Type-III patients were submitted to endoscopic
sphincterotomy (ES).The only patient with Caroli’s disease died whilst on med-
ical treatment, 20 months after diagnosis. Two patients had late complications
(38-43 months) after cyst excision, in the form of recurrent attacks of cholan-
gitis. CONCLUSION: Proper preoperative evaluation of the biliary tree with
cholangiography is mandatory in patients with disturbed liver profile and recur-
rent attacks of cholangitis before embarking on cholecystectomy. Choledochal
cysts, in adults, is not uncommon finding in the era of recent imaging, and there-
fore, clinicians should be aware of such diagnosis in the adult patient.
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V22.5
Choledochal cysts - results of treatment
B Kudra,A Zajuc, M Sierzega and T Popiela
Jagiellonian University Krakow, 1st Department of General and GI Surgery,
Krakow, Poland
Choledochal cysts are rare anomalies of biliary tract, usually diagnosed in child-
hood. Only about 20% of cysts can be diagnosed in adults. Between 1980-2000 ,
14 patients (9 F, 5 M) were treated in our department for choledochal cysts.
Mean age was 29,2 ranging from 15 to 63yrs.The classical complex of symp-
toms (abdominal pain, palpable tumour and jaundice) occurred in 2 patients, the
rest presented mostly one or two of symptoms: jaundice in 10, and epigastric
pain in 9. Diagnosis was made using ERCP (9 patients), USG (6) and CT (3)
scan.The type of cysts was described according to Todani’s classification. Most
common types were IVA (6 patients, and I (5 patients). Patients were qualified
for surgical or conservative treatment (58,3% and 41,6%, respectively). In first
group 5 patients underwent resection of the cyst, in one case the Roux -Y anas-
tomosis of the cyst was performed and one was subjected to external drainage
only. In the group qualified to conservative treatment endoscopic papillotomy
with endoprothesis was performed.There were no complications observed in
group after surgery, except one patient after anastomosis between cyst and
intestine. In this case, after 6 years, stenosis was observed. Half of patients in
second group developed recurrent cholangitis. All of these patients required
replacement of the prothesis. Our obsevations in both groups of patients con-
firm opinion, that radical resection of the choledochal cyst remains therapy of
choice. Such a procedure relieves complaints and is practically free of compli-
cations.
V22.6
The spectrum of symptoms and late complications of biliary cysts from infancy
to adulthood
J de Vries1, S de Vries2, DC Aronson2, 6, D Bosman4, EAJ Rauws3, A Bosma5, HA
Heij2, 6, DJ Gouma1 and TM van Gulik1
1Academic Medical Centre, Surgery,Amsterdam,The Netherlands
2Academic Medical Centre, Pediatric Surgery,Amsterdam,The Netherlands
3Academic Medical Centre, Gastroenterology,Amsterdam,The Netherlands
4Academic Medical Centre, Pediatric Gastroenterology, Amsterdam, The
Netherlands
5Academic Medical Centre, Pathology,Amsterdam,The Netherlands
6Vrije Universiteit, Pediatric Surgery,Amsterdam,The Netherlands
Biliary cysts occur as extrahepatic, intrahepatic (Caroli’s disease) or as both
intra- and extrahepatic lesions.AIM:To assess presentation, complications, diag-
nosis and treatment in pediatric and adult patients. PATIENTS: 42 patients were
analyzed (age range 0-72 years), subdivided in three age groups:A: 0-1 yr, B: 2-
16 yr, C: >16 yr. RESULTS: Jaundice was seen in 57% patients: 100% in group A,
73% in group B, 29% in group C. 76% patients presented with abdoninal pain:
30% in group A, 82% in group B and 95% in group C. 33 cysts were classified as
extrahepatic, 5 as intrahepatic and 4 as intra- and extrahepatic. Delay in treat-
ment had occurred in 14/42 patients of whom 4 cysts contained cholangiocar-
cinoma. Excision of the extrahepatic cyst was performed in 30/37 patients. In 1
patient with carcinoma, a Whipple procedure was performed. Four patients
with extrahepatic-cysts were initially treated by internal drainage, of whom 1
was recently reoperated for excision. In 2 patients (1 intahepatic, 1 intra- and
extrahepatic) partial liver resection was performed. 5 patients were beyond
curative treatment at the time of diagnosis (4 of whom had unresectable can-
cer). 6 patients had died at the closure of this study, 5 of carcinoma.
CONCLUSIONS: Presenting symptoms are age dependent with jaundice pre-
vailing in children and abdominal pain in adults. In view of the high risk of
cholangiocarcinoma, early resection and not internal drainage is the appropri-
ate treatment of extrahepatic biliary cysts.
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V23.1 New objectives of caval flow preservation during liver transplantation : lessons from an 8-year
experience
J Belghiti, GM Ettorre, F Durand, D Sommacale, A Sauvanet and O Farges
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V23.5 The role of Doppler-Sonography in early detection of vascular complications after living
related liver transplantation
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V23.6 Complete venous drainage improves early function of living right liver graft
J Belghiti, D Goere, AR Kianmanesh, D Sommacale, A Sauvanet, O Farges and F
Durand
V23.1
New objectives of caval flow preservation during liver transplantation: lessons
from an 8-year experience
J Belghiti, GM Ettorre, F Durand, D Sommacale,A Sauvanet and O Farges
Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
As promoter of orthotopic liver transplantation (OLT) with preservation of
caval flow we have reviewed our 8-year experience to assess the feasibility of
this technique .Between 1991 and 1998, 275 OLT using a whole graft were per-
formed in 259 patients with a policy consisting in a systematic attempt to pre-
serve inferior vena cava (IVC) and caval flow. Preservation of the IVC was pos-
sible in all cases and none was converted to the conventional technique . Caval
flow was maintained throughout the procedure in 246 (90%) cases.Temporary
IVC cross-clamping was required in 29 (10%) cases including 24 during outflow
obstruction. IVC cross-clamping required during hepatectomy was more fre-
quently required in cases in large liver with a mean duration of 11+/-4 min. but
without any significant influence on early postoperative risk including one graft
failure (4%) and one postoperative death (4%).The mean duration of IVC cross-
clamping required after reperfusion was 23+/-5 min. and was associated with 4
graft’s failure (80%) and 4 deaths (80%).The IVC preservation, which was feasi-
ble in all candidates, allows us to consider, whatever the underlying disease, the
use of split liver either from cadaveric or living donors. Transient IVC cross-
clamping which was required in 10% of cases does not seem to affect early
postoperative graft function when resuired during hepatectomy whereas IVC
cross-clamping required after graft reperfusion had a high risk of early postop-
erative graft failure. Although, the preservation of caval flow is possible in the
large majority of cases, we recommend, if necessary, a transient IVC cross-
clamping in order to perform a large cavo-caval anastomosis.
V23.2
Special technique of caval venous reconstruction for living donor’s right hepat-
ic lobe implantation
S Gautier,A Filine, O Tsiroulnikova and B Konstantinov
National Research Centre of Surgery, Organ Transplantation, Moscow, Russia
Living related liver transplantation (LRLT) with right lobe becomes still more
popular. Being very convenient for teenagers and adults the procedure has
some special features, which are important to obtain the success. Since
November 1997 among other liver transplant procedures we performed 20
LRLT using the right hepatic lobe.The patients were 10 male and 10 female in
the age of 9 to 54 (mean 18.6 +/- 3.08) years old.Their body mass was 20 to
78 (mean 57.2 +/- 2.6) kg. All recipients had chronic liver diseases with B-C
Child-Pugh stage of cirrhosis. The donors were healthy relatives of 24 to 49
years old.The donors’ operation was right hepatectomy. During mobilization in
donor all retrohepatic veins from the right lobe even large ones were being
clipped or ligated and transected.The most important point of graft implanta-
tion we considered the hepatico-caval venous reconstruction.To avoid kinking,
stenosis or other troubles for hepatic blood outflow we never used end-to-end
or end-to-side technique.The anastomosis was being performed almost side-
to-side between the artificial wide opening in the right caval wall partially using
the recipient’s right hepatic vein orifice and widely proximally dilated graft’s
hepatic vein opening.Normal caval outflow from all parts of the graft in all cases
was observed. All recipients are alive within follow-up of 1 month to 3 years
with good quality of life. The technique seems to be effective and avoids the
necessity of other anastomosis with significant retrohepatic veins if any.
V23.3
Surgical morbidity of living related liver harvesting is not influenced by the
extent of the resection
J Belghiti1, D Sommacale1, F Dondero1, AR Kianmanesh1, A Sauvanet1, O
Farges1and D Valla2
1Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
2Beaujon Hospital, Hepatology, Clichy, France
The procedure for harvesting grafts in living donors may range from left later-
al segmentectomy (LLS) to right hepatectomy (RH). The recent and rapid
expansion of adult-to-adult right liver donation raises concern about the safe-
ty of RH in healthy donors.The aim of this study was to determine if RH in liv-
ing donors is associated with a higher morbidity compared to left resections.
From 1994 to 2000, the perioperative course of 72 living donors (aged from 18
to 72) has been analyzed. Hepatic grafts were for 20 adults and 52 child recip-
ients. The surgical procedure was divided into 3 groups: a LLS (n=35), a left
hepatectomy (LH) including the middle hepatic vein (n=19) and a RH (n=18)
including middle hepatic vein in 6 cases. Operative blood loss was significantly
(p<0.02) more important after LH (650+/-350mL) compared to others groups
respectively (620+/-280 and 510+/-230mL) in RH and LLS. None of the donors
had intraoperative transfusion. Six donors (8.3%) presented surgical morbidity
including postoperative hemorrhage reoperated (n=1), chylous ascitis treated
by laparoscopy (n=1) and biliary leak (n=4) all treated conservatively. Surgical
morbidity was present in 4 (11.4%) after LLS and 2 (10.5%) after RH (NS).Non-
surgical morbidity, including pulmonary atelectasia (n=6), sterile intra-abdomi-
nal collection (n=5), depressive syndrome (n=2), iatrogenous pneumothorax
(n=1) and one massive pulmonary embolism with secondary upper tract diges-
tive bleeding.This morbidity was present respectively in 8 (23%), 4 (21%) and 4
(22%) after LLS, LH and RH (NS). In this study, the overall morbidity of the
donors was not correlated to the extent of the liver resection.
V23.4
Single centre experience in adult-to-adult living related liver transplantation
from turkey
Y Tokat1,Y Yuzer1, Z Karasu2, M Alper3, R Killi4and S Aydogdu5
1EGE University Medical School, Hepatobiliary Pancreatic Surgery, Izmir,Turkey
2EGE University Medical School, Hepatology, Izmir,Turkey
3EGE University Medical School, Plastic and Reconstructive Surgery, Izmir,
Turkey
4EGE University Medical School, Radiology, Izmir,Turkey
5EGE University Medical School, Pediatric Hepatology, Izmir,Turkey
Adult-to-adult living related liver transplantation using right lobe was popular-
ized in the last two years.Although the initial results were encouraging, modi-
fications in recipient and donor selection and refinements in surgical technique
continued to date.We herein report our results of 11 adult-to-adult living relat-
ed liver transplantation.All cases were Child-Pugh class II patients and four of
them were United Network for Organ Sharing (UNOS) status IIA. Donor eval-
uation followed a rigid protocol. The graft-to-recipient body weight ratio was
between 0.85 % and 1.8 %.There were one to four hepatic veins to be anasto-
mosed. Biliary anatomy was changing between one to three holes that were
anastomosed in all but two patients which were stented internally with modi-
fied Turcotte catheters.All arteries but two were anastomosed with 10X mag-
nification using an intra-operative microscope and microsurgical technique.
Immunosupression consisted of Tacrolimus and Prednisolone taper. Target
Tacrolimus levels were aimed between 5 to 8 ng/mL after the first two cases.
There was minimal donor morbidity, however,we experienced mortality in four
of the recipients.Tree of the four recipients who were died following the living
related liver transplantation were UNOS status IIA patients. Septic complica-
tions were minimized with less aggressive immunosuppression, better recipient
selection and excluding UNOS status IIA patients.
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V23.5
The Role of Doppler-Sonography in Early Detection of Vascular Complications
after Living Related Liver Transplantation
M Dämland, H Lang, F Saner, G Testa, M Malagã and CE Broelsch
University Hospital Essen, Department of General Surgery and Transplantation,
Essen, Germany
AIM: Living related liver transplantation (LRLTX) of the right liver lobe liver has
become an attractive alternative to full organ transplantation.Due to short ves-
sels the vascular anastomoses are technically demanding and repeated postop-
erative controls with doppler sonography are mandatory. METHODS: In this
prospective study we performed dopplersonographic studies in 10 adult recip-
ients of right liver lobes.We examined the blood flow velocity, the flow pattern
and the flow volume of the liver artery, the right portal trunk and the right liver
vein in triple measurements. In case of pathologic arterial flow we investigated
the influence of Epoprostenol (FlolanÂ®) on the flow characterisitics.
RESULTS: Overall, six pathologic arterial and portal venous flow patterns could
be found.The sonographic diagnoses were intraoperatively confirmed as arte-
rial thromboses in two cases and as one arterial flow obstruction secondary to
compression.The pathologic portal venous flow patterns comprised of portal
vein thrombosis in two cases and flow reversal secondary to severe parenchy-
mal damage in one patient. The application of Epoprostenol resulted in an
increase of the arterial flow velocity up to 46% und decrease of the pulsatility
index under 1.5. Dampening of the flow pattern of the right liver vein from a
physiological triphasic to a biphasic flow pattern clinically coincided with the
development of pleural effusion and ascites. CONCLUSION:
Dopplersonographic flow measurements give a reliable estimation of graft per-
fusion after LRLTX. The indication for early surgical revisions is justified by
dopplersonographic findings alone without the necessity of additional angio-
graphic confirmation.
V23.6
Complete venous drainage improves early function of living right liver graft
J Belghiti, D Goere,AR Kianmanesh, D Sommacale,A Sauvanet, O Farges and F
Durand
Beaujon Hospital, Digestivev Surgery and Transplantation, Clichy, France
Harvesting and reconstruction of the middle hepatic vein (MHV) is controver-
sial in living transplantation using the right lobe.The aim of the study was to
compare the early postoperative course in two groups of donors and recipi-
ents of right lobes with and without harvesting MHV.Among 18 cases of right
liver grafts, excluding two cases (1 vascular thrombosis, 1 emergency), 16 have
been divided into 2 groups: 9 donors without MHV and 7 with systematic har-
vesting of the MHV. In the donors, duration of transection was slightly longer
in the group with MHV (137±43 vs 171±52 mn) with a higher blood loss
(517±210 vs 838±286 mL). Postoperative ALT level was higher at day 1, in the
group without MHV (242±125 vs 310±160 iu/mL) but similar at day 3.
However, the increase in liver volume was similar in the 2 groups at day 5 (45%
vs 48%). In the recipients,ALT levels were lower in the group with MHV at day
1 (238±65 vs 701±260) and day 3 (198±102 vs 541±233). Although the ratio
between graft and recipient weight was lower in MHV group (1.01±0.2 vs
1.38±0.4), coagulation factors were higher (PT, 60±21 vs 52±17 % of normal);
the proportion of patients with PT>50% was higher (5/7 vs 4/9) and bilirubin
level was lower at day 3 in MHV group (32±23 vs 69±50 micromol/l). Results
of this study confirm that complete venous drainage of the right graft including
the MHV improves early liver function without deleterious effect on the
donors.
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V24.1
Nonparasitic cysts of the liver- diagnostic and therapeutic problems
V Tasev, R Gaydarski,V Popov and D Boulanov
Medical University of Sofia, Bulgaria, Department of General Surgery, Sofia,
Bulgaria
INTRODUCTION: Nonparasitic liver cysts are usually asymptomatic. When
the cysts reach a size that causes epigastic discomfort, abdominal pain and
treatment is indicated.The aim of this study is to assess our experience in diag-
nosis and treatment of nonparasitic cysts of the liver. PATIENTS and METH-
ODS: During a 15-years period/1985-1999/in our Department, a total of 58
patients were operated for nonparasitic cysts of the liver- 15/25,9%/male and
43/74,1%/female. Of them 39/67,2%/were diagnosed with solitary cysts and
19/32,8%/- policystic liver disease. Diagnostic procedures used were scintigra-
phy, angiography, US,CT, immunilogical tests.On the 17 patients, cysts were rad-
icaly removed. On the rest of 41- were applied various more conservative pro-
cedures. RESULTS: Also discussed is the diagnostic procedures and various
resources of the treatment of these patology.The complication rate was low-
5,2%. Postoperative stay was - mean 12,8 days. There were no perisurgical
deaths. CONCLUSION: Ultrasonography, computed tomography and immuno-
logical tests are enough for preoperative diagnosis. Intraoperative histology
examination is necessary to prove the malignant or benignant nature of the
cysts. Our experience demonstrates that the treatment of nonparasitic cysts
varies according to the nature and appearance of the disease.
V24.2
Surgical treatment of hepatic hydatid disease
M Mocci, C Murru, G Illomei and M Cagetti
Clinica Chirurgica, Dipartimento Di Scienze Materno Infantili E Diagnostica Per
Immagini, Cagliari, Italy
Human echinococcus is still endemic in some areas of the world, including
mediterranean countries, like Sardinia. Because there is no effective medical
therapy, surgery remains the principal mode of treatment.The videos shows the
author’s experience in the treatment of hydatidosis. We report three cases:
Case 1: complete pericystectomy; Case 2: subtotal pericystectomy and Case 3:
multiple localization.The surgical treatment depend on the biliary three involve-
ment and how deep is located the cyst. Better results in management of hydatid
liver disease can be obtained by using a surgical method appropriate to each
one of the different anatomo-clinical situation. In conclusion, after 30 years
experience , surgery remains to be the gold standard in the treatment of hepat-
ic hydatid disease, offering the only chance for cure. But there is still no stan-
dard surgical modality for every cyst! Surgical approach should be tailored to
the individual patient.
V24.3
Lobar hydatid cyst - videolaparoscopic assisted treatment
MA Secchi, G Rodriguez de Sanctis, A Vismara, L Quadrelli, J Bandeo and D
Castellini
Servicio de Clínica Quirúrgica “B” Hospital Italiano De Rosario,Argentina
CLINICAL CASE (VIDEO PRESENTATION): A 29-year-old man presented
with a giant symptomatic cyst in the right hepatic lobe.An ultrasound showed
a 20 cm cyst of serous or biliary appearance, and a CT scan a doble wall sug-
gesting a hydatid diagnosis. Elisa and specific serological tests were negative.
Surgery was indicated for treating a giant serous or hydatid cyst.A US guided
punction showed a clear fluid content without scolex. A video laparoscopic
procedure was started for hepatic mobilization and cyst treatment. The cyst
was opened in the upper segment VII area and all the content was aspirated.
The internal proliferous membrane was found to be in close contact with a
hepatic vein, thus a laparoscopic removal was unsafe to perform. (Their analy-
sis confirmed the parasitic presence).A small subcostal incision was done and
the internal membrane was safely and completely removed.The residual cavity
was washed with an isotonic solution under laparoscopic image.The omento-
plasty and a drainage were placed in the cyst residual cavity with videolaparo-
scopic control. The patient stayed in the hospital for only 48 hs. and the
drainage was removed on the 5 th day after surgery, without any biliary loss.
Adjuvant chemotherapy with albendazole was started. Two months after the
surgical procedure the patient remained asymptomatic without any sign of
recurrence. CONCLUSION: The laparoscopic approach for hydatic cysts is a
safe procedure if applied following the basic rules for the traditional treatment
(conservative or radical).This case shows the technical advantages of the sur-
gery with the video laparoscopic support.
V24.4
Radical surgery for recurrent hydatic cyst
R Bracco1, J Grondona2,A Michetti3 and L Trinchero4
1Clinica Privada Pueyrredon, HPB Unit, Department of Surgery, Mar del Plata,
Argentina
2Centro Medico Martinez y Omar,HPB Unit,Department of Surgery, San Isidro,
Bs As,Argentina
3Hospital Saintout, Department of Surgery, Benito Juarez, Bs As,Argentina
AIM:The Hydatic Cyst (HC) disease is frequent in our country and, the liver is
the primarily involved organ. In this video, a 22 y.o female patient with a recur-
rent HC and whose pericystum was removed almost completely, is presented.
STATEMENTS OF FINDINGS:The patient was operated on one year before
admission for a large central hepatic HC, and treated by marsupialization of the
cyst.The patient did not have a good evolution and had early suffered pain in
the right upper quadrant.A huge cyst image with calcified areas was observed
by abdominal imaging studies. Through a bilateral subcostal incision the liver
was approached by division of multiple adhesions. The close relationship
between the posterior aspect of the pericystum, the right hepatic vein and the
vena cava, were clearly observed by intra-operative cholangiography.The ultra-
sound dissector was extremely useful to separate the normal liver parenchyma
from the pericystum.The dissection was interrupted in the area where the ves-
sels were in contact with the capsule, leaving a small patch of it in the deepest
part of the cavity.The postoperative period was uneventful and the patient was
discharged on the 7th day. One year after surgery no evidence of recurrence
has been observed. KEY CONCLUSIONS: 1) The conservative surgery for
hepatic HC has a high incidence of complications and recurrences. 2) The rad-
ical approach should be carefully evaluated, bearing in mind that the HC is a
benign disease and the patient must not be exposed to a high operative risk.
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V25.1
FDG-SPECT and CT in diagnosis of focal pancreatic lesions
MG Romijn1, 3, R Valkema2, EJ Krenning2, JS Lameris3 and CHJ van Eijck1
1Erasmus Medical Centre, General Surgery, Rotterdam,The Netherlands
2Erasmus Medical Centre, Nuclear Medicine, Rotterdam,The Netherlands
3Academic Medical Centre, Radiology,Amsterdam,The Netherlands
AIM:To compare the predictive value of diagnosis of focal pancreatic lesions of
CT and FDG-SPECT with histopathology as gold standard. PATIENTS AND
METHODS: 66 patients were included. All were evaluated for suspected ade-
nocarcinoma of the pancreatic head.A 2-head positron coincidence detection
(PCD) camera (Picker 200 XP) was used after 185 MBq 18-FDG.Visual grad-
ing: grade 0: no increased uptake, grade 1: equivocal, grade 2: moderate, grade
3: intense, suggestive for malignancy. Contrast enhanced triphasic helical CT
was performed (Siemens Somatom Plus 4).The level of confidence of diagnosis
on CT:(1): very confident,(2):moderately confident,(3):not very confident for
adenocarcinoma. RESULTS: Histopathology revealed 52/66 adenocarcinoma, 9
focal pancreatitis and 5 benign lesions. 14/52 patients with adenocarcinoma
underwent resection, 38/52 received palliation. 36/52 adenocarcinoma had
grade 3 uptake, 16/52 had grade 1-2. 2/14 benign lesions had grade 3 uptake,
12/14 had grade 1-2, so sensitivity was 69%, specificity 86%. On CT 39/52 ade-
nocarcimoma had level of confidence 1, 13/52 had 2-3. 4/14 benign lesions had
1, 10/14 had level 2-3 for being malignancy, so sensitivity was 75%, specificity
71%. CONCLUSION: FDG-SPECT certainly has an additive value in diagnosing
focal pancreatic lesions. Sensitivity for correctly diagnosing malignancy was
comparable with results of state-of-the-art CT, but specificity was considerably
higher. In other words, FDG was superior to CT in excluding malignancy and at
least equal to CT in confirming malignancy.
V25.2
Intensity of FDG-SPECT predicts survival in patients with pancreatic carcino-
ma
MG Romijn1, 3, R Valkema2, EJ Krenning2, JS Lameris3 and CHJ van Eijck1
1Erasmus Medical Centre, General Surgery, Rotterdam,The Netherlands
2Erasmus Medical Centre, Nuclear Medicine, Rotterdam,The Netherlands
3Academic Medical Centre, Radiology,Amsterdam,The Netherlands
AIM: To evaluate the predictive value of FDG-SPECT by comparing with sur-
vival using histopathology as gold standard. PATIENTS AND METHODS: 75
patients were included. All were evaluated for suspected adenocarcinoma of
the pancreatic head. A 2-head positron coincidence detection (PCD) camera
(Picker 2000 XP) was used after 185 MBq 18-FDG.Visual grading: grade 0: no
increased uptake, grade 1: equivocal, grade 2: moderate, grade 3: intense.
Survival analysis was performed using current standards. RESULTS:
Histopathology revealed 56/75 adenocarcinoma, 11 focal pancreatitis, 5 benign
lesions and 1 neuroendocrine carcinoma. In 2 no final diagnosis was possible.
15 of the 56 patients with adenocarcinoma underwent resection, 41 received
palliation. 7/15 resected patients had grade 1 or 2 uptake: 6 alive after 406 days,
one died after 365 days. 8 patients had grade 3 uptake: 3 alive after 270 days, 5
died after 350 days. 10/41 non resected patients had a grade 1 or 2 uptake: 4
alive after 303 days, 6 died after 135 days. 31 had a grade 3 uptake: 12 alive after
284 days, 19 died after 145 days (p=0.0308 for the 15 resected patients,
p=0.8896 for the 41 not resected patients). CONCLUSION: FDG-SPECT may
have a predictive value for survival of pancreatic cancer.Grade 3 uptake of FDG
survived significantly worse after treatment by resection than lower grades.
Survival of unresected adenocarcinoma appeared to be worse for grade 3
uptake compared with grade 1-2 uptake, although this difference was not sig-
nificant.
V25.3
Comparison of the ARMS and ASO text for K-ras mutations with cytology on
endobiliary brushes from 312 patients with extrahepatic biliary stenosis
NT Van Heek, SJ Clayton, M Tascilar, PDJ Sturm, EAJ Rauws, J Walker,DJ Gouma,
GJA Offerhaus and JC Fox JC
Departments of Surgery and Pathology,Academic Medical Centre Amsterdam,
The Netherlands
Benign and malignant diseases can cause extrahepatic biliary stenosis (EBS).The
sensitivity of biliary cytology for a malignant cause is relatively low. K-ras muta-
tional analysis on brush cytology is a valuable adjunct, but the specificity
remains a concern. A quantitative test for K-ras mutations (ARMS) has been
developed. The additional diagnostic value and the test characteristics to
increase specificity were assessed. Brush samples obtained during ERCP were
prospectively collected from 312 patients with EBS.A new quantitative test for
K-ras analysis was used, in which ARMS allele specific amplification was coupled
with real time fluorescent detection of PCR products.The results were com-
pared to both K-ras analysis using PCR-ASO hybridization and conventional
cytology, and evaluated in view of the final diagnosis. Characteristics of the
three tests are summarized in Table 1. ASO and ARMS were largely in agree-
ment.The specificity of the quantitative ARMS test could be increased to 100%
by setting limits for the false positives. This reduced the sensitivity of ARMS
from 49% to 43%. CONCLUSION: ARMS can be considered comparable to
ASO, and supplementary to conventional cytology in diagnosing patients with
malignant EBS. A specificity of 100% can be acquired with ARMS, and is then
accompanied by a sensitivity of 43%.
Table 1. Summary of the diagnostic specificity and sensitivity of cytology,ASO
& ARMS in relation to malignancy
Test result Sensitivity Specificity PPV NPV
(%) 
Cytology 36 91 94 39  
ASO 42 89 92 34  
Cytology 
& ASO 62 89 94 34  
ARMS 49 93 96 38  
ARMS 
(adj)1 43 100 100 37  
Cytology
& ARMS 58 92 96 44  
PPV = positive predictive value
NPV  = negative predictive value
1 adj. = adjusted ARMS results based on quantities of K-ras mutant sequence in
non-malignant samples
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V25.4
K-ras, p53, and DPC4 alterations in fine-needle aspirations of the pancreas: a
genetic panel correlates with and supplements cytologic diagnosis
NT Van Heek,A Rader, GJA Offerhaus, DM McCarthy, M Goggins, RH Hruban
and RE Wilentz
Department of Pathology, Academic Medical Centre Amsterdam, The
Netherlands; Department of Pathology, Oregon Health Sciences University,
Portland, Oregon, and Departments of Pathology, Medicine, and Oncology,The
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of
America
Although fine-needle aspiration is a useful technique in the diagnosis of pan-
creatic cancer, a significant number of cytological specimens cannot definitively
diagnose or completely rule out adenocarcinoma. Because most pancreatic
adenocarcinomas show alterations in the K-ras, p53, and DPC4 genes, we
hypothesized that a genetic panel of these three genes may supplement tradi-
tional cytological analysis. Between January 1997 and February 2000, 101 fine-
needle aspirations of the pancreas were prospectively collected. After a cyto-
logic diagnosis was made, possible genetic alterations were determined using a
genetic panel consisting of the K-ras, p53, and DPC4 genes. Of the included 94
fine-needle aspirations of the pancreas, 48 (51.1%) were diagnostic of adeno-
carcinoma, 19 (20.2%) were atypical (“suspicious for, but not diagnostic of, ade-
nocarcinoma”), 25 (26.6%) were negative for adenocarcinoma, and 2 (2.1%)
were diagnostic of a neoplasm other than adenocarcinoma. On clinical follow-
up, 12 (63.2%) of the 19 patients with atypical cytologies were shown to have
adenocarcinoma. Forty-two (70.0%) of the 60 patients with the final diagnosis
of adenocarcinoma had an alteration in at least one gene on the panel. In con-
trast, only 2 (5.9%) of the 34 patients without adenocarcinoma had an alter-
ation in one gene on the panel. Overall, the genetic panel resulted in a defini-
tive diagnosis of adenocarcinoma in 6 (32%) aspirations originally diagnosed
only as atypical by cytology alone. Conclusion:Therefore, a genetic panel that
includes the K-ras, p53, and DPC4 genes correlates with and supplements tra-
ditional cytologic diagnosis of fine-needle aspirations of the pancreas.
V25.5
Is cystic fluid analysis helpful in the diagnosis of cystic tumours of the pancreas?
JM Badia1, L Oms Bernad2, LA Hidalgo Grau, R Muns, J Sala Pedros2 and JM
Gubern
Departments of Surgery and Pathology,Hospital de Matar, 2Hospital de Terrassa
and 1Hospital de Granollers, Barcelona; Spain.
Preoperative diagnosis of cystic lesions of the pancreas can be difficult. Clinical
data and radiological examinations are often inadequate to discriminate among
pseudocysts and true tumours.AIM:To investigate the value of cystic fluid analy-
sis for tumour markers, amylase content and cytology in the diagnosis of cystic
tumours of the pancreas. METHODS: Fifteen cases of cystic tumours were ana-
lyzed. Clinical data, plasma tumour markers, and radiological and pathological
diagnosis are evaluated. Amylase contents, tumour markers, and cytology are
studied in cystic fluid. RESULTS: Two serous cystadenoma, 3 mucinous cystic
neoplasm, 1 mucinous cystadenocarcinoma, 1 ductal carcinoma and 8 pseudo-
cysts were analyzed. Radiological tests achieved a high index of correct diagno-
sis. Cystic amylase was useful to diagnose pseudocysts, but followed an erratic
pattern in neoplastic tumours. Cystic CEA levels were normal in serous cyst-
adenoma and most pseudocysts, but elevated in benign or malignant mucinous
neoplasm and in ductal carcinoma, with mean value of 2774 ± 759 ng/mL
(p=0.7). CA 19.9 followed a variable pattern, being elevated in 3 mucinous neo-
plasm and in ductal carcinoma, but negative in mucinous cystadenocarcinoma
and pseudocysts. CA 125 was only positive in malignant or borderline tumours
(1661 ± 223 U/mL). CONCLUSIONS: Preoperative analysis of cystic fluid,
obtained by FNA, can provide useful data in certain cases of pancreatic cystic
tumours, but add few information to clinical and radiological diagnosis. Cystic
CEA and CA 125 can be useful to differentiate mucous and malignant tumours
from pseudocysts and serous tumours.
V25.6
Frozen section of pancreas at surgery for cancer : caught at the neck.
H Kocher1, R Al-Ghnaniem1, M Sohail2 and AG Patel1
1GKT School of Medicine, King’s College London, Academic Department of
Surgery, London, United Kingdom
2King’s College Hospital, Department of Pathology, London, United Kingdom
BACKGROUND: Loco-regional recurrence is a major problem after pancre-
aticoduodenectomy (PD) for malignancy, and affects survival adversely. We
sought to improve the local resectional clearance at the time of surgery.
METHOD: In 12 consecutive patients who underwent resection for suspected
malignancy in the head of pancreas from Oct 1999-2000 , frozen section (FS)
was sent from both the pancreatic lesion and resection margin (RM). Further
resection was performed if the RM was +ve. Comparison was made with an
historical group of 6 consecutive patients from the 6 months preceding this
study period, when this protocol was not followed. RESULTS: Of the 12
patients, 2 had +ve RM on initial FS and underwent total pancreatectomy (TP).
The other 10 had -ve RM on FS and on definitive histology.The extent of pan-
creatic cancer into the distal pancreas was confirmed on definitive histology
with 100% accuracy in the protocol group. Of the 6 patients in the control
group, 4 had +ve RM on final histology, none of which was recognised intra-
operatively (negative predictive value 0.33 (historical group), compared to 1.00
(protocol group); z = 2.86, p < 0.05). 3 of the 4 patients with RM +ve in the his-
torical group have already shown local recurrence within a year of surgery
despite adjuvant therapy. CONCLUSION:Our protocol for FS of both the pan-
creatic lesion and RM improves the local clearance at the time of PD.This pro-
tocol deserves to be analysed in other centres. Long-term survival results are
awaited.
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V26.1 Epidemiology of biliary tract tumours from South-East England: any lessons?
HM Hocher, K Linklater, AG Patel and IS Benjamin
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V26.1
Epidemiology of biliary tract tumours from South-East England: any lessons?
HM Hocher1, K Linklater2,AG Patel1 and IS Benjamin1
1GKT School of Medicine, King’s College London, Academic Department of
Surgery, London, United Kingdom
2 GKT School of Medicine, King’s College London, Thames Cancer Registry,
London, United Kingdom
AIM:Biliary tract tumours are rare cancers with very little epidemiological data.
We studied the time trend for biliary tract tumours over 37 years in the South
East of England. METHODS: The Thames Cancer Registry database was sys-
tematically searched for cholangiocarcioma according to ICD 10 classification
for the years 1960-96 and time trends were studied separately for both sexes,
according to the Age Standardised Incidence Rates (world) [ASR(W)].
RESULTS: 1073 cholangiocarcinomas were identified over this period. There
was an overall increase in the incidence of biliary tract tumours for both sexes
(chi-square (c2) trend in men = 383.9 and in women =16.94; p< 0.001). For the
intra-hepatic tumours there was an increase for both sexes though more
prominent for men (c2 trend: men = 537.3; women =179.7; p< 0.001).There
was a decrease in the incidence of the cancers of the gall bladder for both sexes
(c2 trend: men = 67.8; women =143.4; p< 0.001). Extra-hepatic bile duct
tumours are not separately classified in the ICD 10 classification, but the
unspecified parts of biliary tract, demonstrated an increase in incidence of
tumours (c2 trend: men = 101.6; women = 34.5; p< 0.001). CONCLUSIONS:
The numbers of cancers studied each year are very small.Therefore the inter-
pretation should be cautious. One can safely state that the improved biliary
imaging could account for the overall increase in the incidence of biliary tract
cancers and a shift of diagnosis from gall bladder to bile duct cancer.
V26.2
Study on hepatolithiasis and secondary intrahepatic cholangiocarcinoma
Y Feng Zhi1 and C Bi Fen2
1Fujian Medical University, Union Hospital, Institute of Hepatobiliary Surgery,
Fuzhou, China
2Fujian Medical University, Pathology, Fuzhou, China
OBJECTIVE: To prove the relationship beetween the hepatolithiasis and the
intrahepatic cholangiocarcinoma by clinical and pathologic study. METHOD: A
retrospective clinical analysis was made in 38 cases of hepatolithiasis compli-
cated by intrahepatic cholangiocarcinoma.All patients had suffered form hepa-
tolithiasis for 5 to 50 years, and had been subjected to operations with biliary
diseases for 1 to 3 times. Paraffin blocks in 38 patients were studied by
immunohistochemistry methods with mucus, Tn antigen,CEA,Ki67 and cyclin
D1 antibodies,and the DNA contents were evaluated by image analysis.
RESULTS: The incidence of cholangiocarcinoma in hepatolithiasis was 4.56%
(38/833),Thirty percent of these patients were correctly diagnosed preopera-
tively. Only 10(26.3%) cases were radically resected, and their average survival
period was 24.0 months, 15(39.5%) cases were subjected to palliative opera-
tion and the average survival period was 6.0 months.The pathologic study in 38
cases was found that the adenocarcinoma in 21, and the papillary adenocar-
cioma in 17.The epithelial of bile ducts beside tumours associated with dyspla-
sia, and transitional change to carcinoma.The quality of mucus and expression
of antigens in the cells by immunohistochemistry were idential with the mor-
phology changes. CONCLUSION: Long-term chronic inflammatory stimulation
due to primary hepatolithiasis and epithelial dysplasia lesion are the causes
inducing intrahepatic cholangiocarcinoma and early diagosis and resection on
time might improve the therapeutic effectively.
V26.3
Detection of hepatitis c virus RNA sequences in hepatic portal cholangiocarci-
noma tissue by reverse transcription polymerase chain reaction
Y Feng Zhi1 and C Bi Fen2
1Fujian Medical University, Union Hospital, Institute of Hepatobiliary Surgery,
Fuzhou, China
2Fujian Medical University, Pathology, Fuzhou, China
OBJECTIVE: The role of HCV in the cholangiocarcinomas is not know. We
detected HCV RNA sequences in the hepatic portal cholangiocarcinoma tis-
sues and explored their relationship. METHODS: Formalin-fixed paraffin-
embedded specimens of 18 patients with cholangiocarcinoma in hepatic portal
bile duct were obtained from the Department of Pathology, Union
Hospital.The tumours were located in the left hepatic bile duct in 12 patients
and the right hepatic duct in 6.The resected specimens diagnosed histological-
ly were found to have glandular adenocarcinoma with various sclerosis in 11
and papillary adenocarcinoma with mucous in 7. RNA was extracted from
paraffin-embedded cholangiocarcinoma tissue of 18 patients by guanidinium
method, subjected to reverse transcription and then amplified by double PCR
technique using nested primers from the highly conserved 5’noncoding region
of HCV genome. RESULTS: HCV RNA of 5’NT sequences was found in hepat-
ic portal cholangiocarcinoma tissue of 15 out of 18 (83%) patients.Among them
the left hepatic bile duct carcinoma tissues in 10 patients and the right in 5.
CONCLUSION: HCV RNA sequences present with high infectious in cholan-
giocarcinoma,and reverse transcription polymerase chain reaction (RT-PCR)
assay using primers derived from 5’NT region of HCV sequence is most useful
in detecting HCV infection.The development of cholangiocarcinoma waits fur-
ther studies.
V26.4
Surgical management of hilar cholangiocarcinoma
M Pierie1, K Feenstra1, J Kuiper2, J Lameris2, HJ Tilanus1 and JNM IJzermans1
1EMCR Dijkzigt, Surgery, Rotterdam,The Netherlands
2EMCR Dijkzigt, Radiology, Rotterdam,The Netherlands
OBJECTIVE: To evaluate the outcome of surgical management of hilar cholan-
giocarcinoma on patient survival and pattern of recurrence after resection.
Setting: tertiary referral hospital. Study design: retrospective study. PATIENTS
AND METHODS: An analysis was performed of 61 patient with hilar chola-
giorcarcinoma between January 1991 and July 2000 at the EMCR(1). (33 men,
28 women, mean age 63). Patients were diagnosed by ultrasonograhy, percuta-
neous transhepatic cholangiography, ERCP and CT. Treatment consisted of
either palliation by introduction of endoprothesis (n=32) or resection of the
bile duct bifurcation alone (n=10) or in combination with hepatic resection
(n=12).A number of patients were treated by radiotherapy (n=11). Histological
examination of the resected specimens was performed. RESULTS:The overall
patient survival rate was 55.7% at 1 and 11.4% at 3 years. The survival of
patients treated by intentionally curative resection was 72.7% at 1 and 21.7%
at 3 years. Histological examination demonstrated a curative resection in 7 out
of 22 cases.The mean survival of the radical resected group was 40.9 months
(SD± 31.6); recurrence rate of 42.8% at 30 months (incomplete resection 18.5
months (SD± 14.6); recurrence rate of 66.7% at 30 months). Underestimation
of tumour extension contributed to inadequate surgical approach.
CONCLUSION: Underestimation of tumours extension hampers complete
resection of hilar cholangiocarcinoma; A more aggressive surgical approach
seems justified to improve these results.
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V26.5
Surgical treatment of hilar cholangiocarcinoma
P Lukovich and P Kupcsulik
Semmelweis University, 1st Dept. of Surgery, Budapest, Hungary
Adenocarcinomas of the bifurcation of the hepatic ducts are rare cause of
obstructive jaundice . Prognosis is still poor, and long-term survival can be
expected only after surgery, which is the treatment of choice. Between 1991
and 2001 35 patients underwent surgical resection in our hospital. According
to the Bismuth-Clark classification there were 12 type I, 6 type two, 5 type IIIA
and 6 type IIIB and 19 type IV lesions. 5 patients underwent also an associated
regional vascular resection, 30 patients underwent tumour resection with
CUSA alone, the other patients had combined tumour and liver resection. One
in-hospital death was recorded. Complete tumour-free surgical specimen mar-
gins were found only 18 of 35 patients. Patients were regularly followed up to
date or death. Survival rates for 1, 3 and 5 years after hepatic resection were
78%, 37% and 9%. US was the most valuable tool for preoperative imaging and
staging of hilar cholangiocarcinoma, but the sensitivity of the CT was low.The
average size of the tumours was less than 3 cm. Even small tumours can be diag-
nosed with conventional abdominal ultrasound.Antibiotic prophilaxis or treat-
ment of cholangitis is mandatory before surgery, because the bile was infected
in more than 40% of the cases (E.coli, Pseudomonas, Klebsiella). Recent
progress in surgical techniques for and the perioperative management of
Klatskin tumour has led to improved outcomes for aggressive resections. In the
absence of evident contraindications surgical resection is worthwhile also at
the type IV tumour of Bismuth-Clark.
V26.6
Role of hepatectomy in surgical treatment of hilar cholangiocarcinoma
A Ferrero, R Polastri, A Muratore, P Massucco, H Bouzari, V Vergara and L
Capussotti
Ospedale Mauriziano, Surgery,Torino, Italy
Curative resection of hilar cholangiocarcinoma is still today difficult , due to
tumour site, relation with hilar vascular structures and tendency of intra- and
extra-luminal spreading. Aim of this study is to evaluate the role of hepatic
resection in the radical treatment of hilar cholangiocarcinoma and to analyse
the clinical and pathological prognostic factors related to long-term survival.
Between January 1988 and December 1998, 23 patients underwent surgical
attempt of radical resection (resectability rate: 64%). According to Bismuth-
Corlette classification, there were 2 patients with type I, 5 patients with type II
and 16 patients with type III (69%). Standard surgical procedures included in all
patients resection of the common bile duct and the upper biliary convergence ,
associated to extended lymphadenectomy and hepatectomy on the site of the
biliary tumour extension in 19 patients (83%).The caudate lobe was removed
in 16 patients (69%).A radical R0 resection was achieved in 21 patients (91%).
There was no operative and hospital mortality and the complication rate was
57%. Overall survival rate at 1, 3 and 5 years were 59.4%, 37.1% and 22.3%,
respectively. Univariate statistical analysis demonstrated that T and N stages
were significant prognostic factors; the single prognostic factor significantly
related to prognosis in the multivariate analysis was tumour spread (T). In con-
clusion, major hepatic resection can be accomplished for hilar cholangiocarci-
noma with low mortality and morbidity rates.
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V27.1
Laparoscopic formal left hepatectomy
D Cherqui and E Husson
Hopital Henri Mondor, Surgery, Cr?teil, France
In this video, we present the case of a 44 year-old man with fever and elevated
liver tests (cytolysis and anicteric cholestasis). Ultrasound and CT showed
dilatation of the left hepatic duct with intrahepatic microstones in the dilated
ducts. MR cholangiography showed stenosis of the left hepatic duct at the level
of the round ligament with proximal dilatation. A diagnosis of symptomatic
stenosis of the intrahepatic left bile duct with a possible tumour was made and
left lobectomy was decided upon.Under general anesthesia, the patient was
placed in the suppine position with lower lilbs apart. CO2 pneumoperitoneum
was created and 5 trocars were inserted permtting visualization of the liver and
laparoscopic intraoperative ultrasound.There was no evidence of tumour.The
procedure included: transcystic cholangiography confirming preoperative imag-
ing, mobilization of the left lobe and control of the left hepatic vein, dissection
and clamping of the left portal pedicle , placement of a tourniquet around the
porta hepatis, liver transection with an ultrasonic dissector, transparenchymal
section of the left portal pedicle by stappling, stappling of the left hepatic vein
to complete transection and the specimen was placed in a plastic bag and
externalized through a suprapubic incision.The operation lasted 3 hours and
blood loss was < 100 mL. Postoperative course was uneventful and the patient
was discharged at day 8. Pathology disclosed benign, possibly congenital, stric-
ture of the left hepatic duct with proximal cholangitis.
V27.2
Laparoscopic formal right hepatectomy
D Cherqui and E Husson
Hopital Henri Mondor, Surgery, Cr?teil, France
In this video we present the case of a 50 year-old woman with a 10 year-his-
tory of breast cancer. Liver metastases confined to the right lobe were diag-
nosed one year before and a 50% response was obtained after chemotherapy.
There was no evidence of extrahepatic disease and the patient was in good
general condition. Under general anesthesia, the patient was placed in the sup-
pine position with lower limbs apart.CO2 pneumoperitoneum was created and
3 trocars were inserted permtting visualization of the liver and laparoscopic
intraoperative ultrasound. Disease confined to the right lobe was confirmed (4
lesions 2-4cm in size) and resection was undertaken. Two additional trocars
were placed.The procedure included: ligation and division of cystic duct, divi-
sion of the right branches of the hepatic artery and portal vein, hepatic tran-
section without prior right lobe mobilization, hepatic transection was per-
formed with a harmonic scalpel and an ultrasonic dissector, a 20 minute Pringle
maneuver was used to terminate the procedure, the right hepatic vein was
approached anteriorly at the end of resection and stappled, the resected right
lobe was then mobilized from the diaphragm and placed in a plastic bag and the
specimen was externalized through a suprapubic incision. Operative time was
4 hours and blood loss 300 ml (no transfusions). Postoperative course was
uneventful and the patient was discharged at day 7.
V27.3
Laparoscopic enucleation of giant liver hemangioma
T Karahasanoglu1, E Altinli1, S Erguney1, M Ertem1 and F Numan2
1Cerrahpasa Medical School, University of Istanbul, Surgery, Istanbul,Turkey
2Cerrahpasa Medical School, University of Istanbul, Radiology, Istanbul,Turkey
Cavernous hemangiomas are the most common benign tumour of the liver.
Most of them are asymptomatic. They usually become symptomatic as they
reach a certain size.There are certain modalities in the treatment of cavernous
hemangiomas of the liver. A 49-year-old man having symptomatic giant liver
hemangioma had embolization prior to surgery and had laparoscopic enucle-
ation of this giant liver hemangioma. The operative time was 75 minutes.The
post-operative course of the patient was uneventful and he was discharged on
the second post-operative day.The follow-up of the patient is 5 months and the
patient does not have any complaints at the time being. Enucleation is the best
surgical technique for symptomatic giant hemangiomas and could be performed
with no morbidity or mortality with preservation of all normal liver parenchy-
ma. Enucleation was also associated with significantly fewer intra-abdominal
complications compared with anatomic resection. The laparoscopic approach
for enucleation requires patience  and careful dissection to prevent bleeding. In
conclusion, laparoscopic enucleation of giant liver hemagiomas is safe and easy
to perform in selective cases.We present here a video-presentation of a giant
liver hemangioma that has been treated by laparoscopic enucleation.
V27.4
Hepatojejunal anastomosis in excluded loop through laparoscopy in the treat-
ment of iatrogenic ligature
E Crema,A Silva, R Lenza,A Martins, C Oliveira and V Bridi V 1
Faculdade de Medicina doTriángulo Mineiro, Digestive System Surgery,
Uberaba, Brazil
Although bile duct surgery is a commonly performed procedure, complications
are observed.According to most authors, the proper choice to correct upper
iatrogenic bile duct lesions would be excluded loop hepatojejunal anastomo-
sis.This video shows the experience of the authors using laparoscopic treat-
ment for iatrogenic ligature of hepatic duct.A case of a patient undergoing open
cholecystectomy are reported, she presented with jaundice at early postoper-
ative period. During investigation total ligature of commom hepatic duct was
observed.Anastomosis of hepatic duct with transmesocolic jejunum excluded
loop was performed through laparoscopic. Laparoscopy was performed
through 5 openings (two 10-mm long and three 5-mm long). Common hepatic
duct ligature by chrome catgut was identified. Following this, the 10-mm open-
ing was extended to 40 mm and jejunal loop was exteriorized at 20cm from
Trietz angle, and cut with a 75-cm linear stapler.The loop was reinserted in the
abodminal cavity and moved to upper mesocolic level through an opening in the
transverse mesocolon. Common hepatic duct was opened longitudinally in its
anterior side without removing the ligature. Then, side-to-side hepatojejuno
anastomosis was performed using separate stitches Prolene 3-0. Follow up
after twenty-four months revealed assymptomatic patient.We considered that
performance of hepatojejunal anastomosis were favoured by laparoscopy.We
conclude that the procedure is feasible and safe, however the mastering of the
technique requires apropriate training in advanced laparoscopic surgery for the
entire surgical team.
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V28.1
Hypocholesterolemia following liver resection: a cumulative index of severity of
illness
I Giovannini1, C Chiarla1, F Giuliante1, M Vellone1, F Greco1 and G Nuzzo1
Catholic University, Surgery, Hepato-biliary Unit, Roma, Italy
Data from 92 patients undergoing liver resection were collected prospectively
to characterize the determinants of postoperative hypocholesterolemia. Plasma
cholesterol, together with other variables, was measured preoperatively (PRE-
CHOL, mg/dl) and postoperatively (POSTCHOL, mg/dl), at day 1, 3 and 7, and
in patients with complications until recovery or death, for a total of more than
400 measurements. Cholesterol decreased at postoperative day 1 and 3, and
remained low in the presence of complications. It increased with recovery, or
fell persistently until death in nonsurvivors. Regression analysis showed that
main correlates of POSTCHOL, at any time during the postoperative period,
were PRECHOL, number of resected liver segments (NSEG), simultaneous
bowel operations (SBO, 1=yes, 0=no), presence of liver cirrhosis (CIR, 1=yes,
0=no), presence of sepsis (1=yes, 0=no), hematocrit value (HCT, %), plasma
albumin (ALB, g/dl) and alkaline phosphatase levels (ALP, UI/L, n.v. 98-279):
POSTCHOL=0.3(PRECHOL)-11 (NSEG)-20(SBO)-23(CIR)-19(SEP)
+0.7(HCT)+21(ALB)+0.05(ALP)-13   r2=0.73, p<0.001. Our data show that
hypocholesterolemia after liver resection may be considered as a cumulative
index of severity of illness. These results quantify the impact of preoperative
cholesterolemia and of “adverse factors” (number of resected liver segments,
simultaneous bowel operations, presence of cirrhosis and/or sepsis, hypoalbu-
minemia, hemodilution from blood loss) in decreasing POSTCHOL. Among
adverse factors, cholestasis is unique , causing an increase in POSTCHOL (like-
ly due to release of lipoprotein-X from the liver) which moderates the
decrease related to the other factors.
V28.2
Surgical treatment of hepatocellular carcinoma in noncirrhotic liver
C Verhoef1, P Zondervan2, R de Man3, M Leelie1, HW Tilanus1 and JNM
IJzermans1
1 EMCR Dijkzigt, Surgery, Rotterdam,The Netherlands
2 EMCR Dijkzigt, Pathology, Rotterdam,The Netherlands
3 EMCR Dijkzigt, Gastroenterology, Rotterdam,The Netherlands
AIM: Much has been written about surgery of a hepatocellular carcinoma
(HCC). However, the results of surgical treatment of HCC in non-cirrhotic liv-
ers are less well described.The present study was initiated to evaluate the man-
agement of patients with HCC in non-cirrhotic livers and to define criteria for
resection with the help of an electronic medline search. METHODS: In the
Erasmus Medical Centre Rotterdam, the medical records of 180 patients with
HCC were reviewed in retrospection. A non-cirrhotic liver was found in 44
patients (24%) with HCC and a detailed analysis of these patients was con-
ducted.The diagnosis HCC was made by ultrasound imaging and percutaneous
ultrasound guided biopsy.A biopsy of the remaining liver and peroperative find-
ings documented the absence of cirrhosis. RESULTS: The mean tumour-diame-
ter was 9 cm (range 1,5-16). Twenty-two patients were selected for surgical
treatment, 21 partial hepatectomies and one patient received a liver transplan-
tation. There was no operative mortality. Survival rates for operated patients
after one and five years were 92% and 74% respectively.The survival rates for
inoperable patients after one and five years were 15% and 8% respectively.
Tumour recurrence was seen in two patients after 7 and 11 months who were
treated by curative resection. The patient with a liver transplantation had a
recurrence after 11 months. CONCLUSION: In the absence of cirrhosis, large
HCC can be treated successfully by surgical resection, even if the diameter
exceeds 5 cm. In this group of HCC in a non-cirrhotic liver, there seems to be
a lower recurrence rate compared to the HCC group in a cirrhotic- liver.
V28.3
The technique of resection influences outcome in patients with small hepato-
cellular carcinoma
J Regimbeau, O Farges,AR Kianmanesh, F Dondero,A Sauvanet and J Belghiti
Beaujon hospital, Digestive Surgery and Transplantation, Clichy, France
Long-term outcome following resection of hepatocellular carcinoma (HCC) is
influenced by parameters related to the tumour and to the presence of an
underlying liver disease.The influence of the surgical margin and technique of
resection (anatomical or limited) is controversial. The aim of this study is to
address this issue in a selected group of cirrhotic patients with small HCC.
Sixty-four cirrhotic patients with HCC of less than 4 cm underwent curative
liver resection between 1990 and 1996 and were divided into two groups
according to the technique of liver resection. Thirty patients underwent
anatomical resection (complete removal of the portal area containing the
tumour) and 34 patients limited resection with a 1-cm margin for peripheral
tumours (n=24) and tumours located at the border of several segments
(between segments V.VI.VII.VIII , or between segments IV.V.VIII, or between seg-
ments III.IV, n=10) because they would require a large liver resection.The two
groups were comparable.The end point measured were: a/ in-hospital mortal-
ity and morbidity rates; b/ overall and disease-free survival rates; c/ topography
of recurrence.The 30-day mortality (7% vs. 6%) and morbidity (62% vs. 60%)
following limited and anatomical liver resection were comparable.The 5 and 8-
year overall survival rates following anatomical and limited resection were 58
vs. 33% and 39 vs. 0% (p<0.05) and the 5 and 8-year disease-free survival rates
were 57 vs. 25% and 45 vs. 0 (p<0.05) . Similar results were obtained after strat-
ifying patients for age, sex and preoperative serum transaminases level.
Intrahepatic recurrence adjacent to the first resection margins was observed
more frequently after limited resection than after anatomical resection (74% vs.
30%, p<0.05).Anatomical resection, including the tumour and the adjacent por-
tal territory is associated with an improved patient and disease-free survival.
This carcinologic concept of the resection must become the surgical treatment
of reference of small HCC in cirrhotic patients. On the other hand, in patients
in whom anatomical resection is not possible because of the location of the
tumour and/or the liver function, liver transplantation and percutaneous treat-
ment should be discussed first.
V28.4
Enhanced inflammatory cytokine production at ischemia /reperfusion(I/R) in
human liver resection
YI Kim,YJ Hwang,YK Yun and KW Lee
Department of Surgery, Biomolecular Engineering Centre, Kyungpook National
University, School of Medicine,Taegu, South Korea
OBJECTIVE:To investigate clinical implications of inflammatory cytokines in the
pathogenesis of I/R liver injury in humans. METHODS: In serial samples of por-
tal and systemic venous blood, acute inflammatory cytokine activities were
examined during resection and at day 1 after continuous hepatic inflow occlu-
sion (HIO) in patients undergoing elective hepatectomy (15 major and 10
minor). Responses of TNF-a , IL-1, IL-6 and IL-8(ELISA method) were compared
with the duration of HIO, portal venous pressure during the occlusion(PVP),
postoperative hepatocyte injury markers(serum transaminases and bilirubin),
and also related complications. Results- TNF-a and IL-1 levels were very low.
Portal IL-6 levels were significantly elevated during HIO, as compared with the
systemic events (P<0.02), but there were no differences in the IL-8 levels
between the portal and systemic circulation.The increase in portal IL-6 levels
during liver resection significantly correlated with the duration of HIO
(48±9min, mean±sd), PVP (500±127mmH2O) and postoperative day 1 levels of
S-ALT (705±1023U/L) and S-AST (892±1255U/L), and maximum biliru-
bin(2.6mg/dl). IL-8 levels in the portal circulation showed no such correlation,
but the levels in systemic blood showed significant positive relationships with
intra- and postoperative parameters. CONCLUSIONS: These observations
suggest that overproduction of acute reactant cytokines (IL-6 and IL-8) in
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hepatic I/R relates positively with postoperative hepatocyte injury in humans.
Treatment strategies against “hypercytokinemia” are recommended for safer
liver surgery.
V28.5
Laparascopic liver resection for hepatocellular carcinoma (HCC) in cirrhotic
patients: a case-control study
A Laurent, E Husson, B Malassagne, PL Fagniez and D Cherqui
Hopital Henri Mondor, Surgery, Créteil, France
Resection for HCC in cirrhotic patients has been associated with significant
rates of mortality and morbidity, particularly postoperative decompensation of
cirrhosis. Recently, techniques of laparoscopic liver resection were developed.
To assess the potential benefit in cirrhotic patients, a case-control study was
designed comparing laparoscopic and open liver resections. METHODS: 11
consecutive patients underwent laparoscopic liver resection for HCC located
in segments 2-6 (laparoscopy group (LG)).A group of 14 patients undergoing
open liver resections for HCC matched for the tumour, liver resection and
severity of cirrhosis (Child Pugh score, portal hypertension) was extracted
from our database for comparison (open group (OG)). One segment was
resected in 17 patients and two in eight patients. RESULTS: Operative duration
was longer in the LG (278±99 vs 182±57 min, p<0.01). Cumulative portal triad
clamping times (intermittent in LG) were 67±24 min in LG and 25±20 in the
OG (p <0,001) . Mortality rates were 0% and 14% in the LG and OG respec-
tively (NS). Postoperative ascites occurred in 9% (1/11) in the LG and 36%
(5/14) in the OG (NS). Postoperative liver tests were similar except for a high-
er transminase peak in LG. CONCLUSION: Laparoscopic liver resection for
HCC in cirrhosis is a safe procedure in selected cases (peripheral lesion requir-
ing limited resection). It was associated with longer operative and clamping
times without consequences on outcome. On the contrary, mortality and
decompensation of cirrhosis were lower after laparoscopy. Other advantages
may include easier reoperation such as liver transplantation.
V28.6
Extended hepatectomies after preoperative portal branch ligation
Z Biejat1, M Tacikowska2 and J Polanski1
1Medical University of Warsaw, 3rd Dept of Surgery,Warszawa, Poland
2Institute and Centre of Oncology, Department of Radiology,Warszawa, Poland
AIM: Extended hepatectomies are connected with high morbidity and mortali-
ty due to postoperative liver failure. Ligation of the portal vein branch on the
affected side of the liver promotes the hypertophy of the opposite lobe and
increases the remnant liver volume. Second stage hepatectomy performed after
sufficient hypertophy may become safer. MATERIAL AND METHOD: Five
patients with huge, poorly localised or multiple tumours were qualified to two
stage extended right hemihepatectomy.All of them have had small volume seg-
ments 2+3 or 1+2+3.Three cases with colon cancer metastases, one with renal
cell carcinoma and one with Klatskin tumour were treated. RESULTS: There
were no complications after portal vein ligation. Increase of remnant liver vol-
ume 6 to 10 weeks after right portal vein ligation in four cases vary from 38 to
88%. Four cases were finally hepatectomised. One patient died on the opera-
tive day due to surgical complications. Two patients were discharded. In one
case we have noticed the dissemination of the colon cancer metastases to both
liver lobes and to the lungs in 6th week of follow up.The last case is now in 7th
postoperative day after right extendet hepatectomy. CONCLUSIONS: Two-
stage hepatectomy may be the last chance procedure for the radical oncologi-
cal treatment in patients demanding very extended hepatectomy or/and in
cases with altered liver function.
V28.7
Ex situ liver surgery resection
F Vicente1, J Nuão, Y Quijano, P Lopez-Hervãs, JC Meneu, A Honrubia, A
Candela, G Monge,A Moreno and G Zarzosa
1Hospital Ramon y Cajal, Liver Transplantation Unit, Madrid, Spain
The majority of major liver resections can be performed with conventional
techniques of vascular control and normothermic ischemia. In very selected
cases as tumoural invasion of hepato caval confluence, resection is not possi-
ble.The period of vascular clamping and resulting ischemia can be too short to
allow for major and complex liver resections and vascular reconstruction. In an
attempt to offer new options to increase the resectability rate for these
extreme cases, has been developed different procedures in which hypothermic
protection of the remnant liver was added to hepatic vascular exclusion.The
video details the presentation of a patient with cholangiocellular carcinoma
occupying the right lobe and segmet IV of the liver.The right and middle hepat-
ic veins and the inferior vena cava were markedly compressed and invaded by
the tumour. No evidence of distant spread was observed. Preoperative percu-
taneous transhepatic right trisegment portal vein embolization was performed
to initiate compensatory hypertrophy in the remnant segments II and III.
Extracorporeal extended right hepatic lobectomy (ex vivo procedure) com-
bined with resection of inferior vena cava was performed. An ePTFE graft, 20
mm in diameter was interposed in the defect of the inferior vena cava, avoid-
ing the use of venous extracorporeal bypass.The left hepatic vein, was reim-
planted into graft replacement. A groin arteriovenous fistula was created
between superficial femoral artery and saphenous vein.
V28.8
Comparison of the efficacy of the ultrasonic dissector in cirrhotic and normal
liver
J Belghiti, O Guevara, F Pierangeli, D Sommacale, O Farges and A Sauvanet
1Beaujon Hospital, Digestive Surgery and Transplantation, Clichy, France
It is assumed that the ultrasonic dissector (UD) is less effective in cirrhotic
patients for reducing bleeding during hepatectomies.We have taken the oppor-
tunity of a pre-release trial of an UD (Satelec, France) to test this hypothesis.
From April to October 1999, 40 consecutive patients were prospectively
entered into this trial and underwent parenchymal transection using exclusive-
ly the UD. Of these, 13 patients with a Child A cirrhosis were matched with 15
with normal liver for the surface of liver transection measured on the resect-
ed plane (mean 80 ± 28 cm2). Preoperative haemoglobin, transaminases and
serum bilirubin levels were comparable. Indication for surgery (malignancy
93%), rate of pedicular clamping (82%) and extent of resection (major 64%)
were also comparable. Duration of liver transection was not increased in cir-
rhotics (115 ± 31 vs 105 ± 59 min) and blood loss during transection was com-
parable (939 ± 630 and 935 ± 610 cc).The correlation between blood loss and
transection surface was highly significant and comparable in both groups (13 ±
10 vs 11 ± 7 ml/cm2).A single patient in each group required transfusion. Minor
technical problems easily solved by the nurse occurred in 2 patients in each
group. Overall morbidity was higher in the cirrhotic group (77 vs 33%, p=0.02)
but the incidence of biliary leak was not increased (0 vs 1 patient). In conclu-
sion, the UD is as effective in cirrhotic patients as in patients with normal liver.
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V28.9
Different adhesive materials for hemostasis on the raw liver surface (part I:
general assessement)
A Severtsev, N Mironov, E Brekhov, E Ivanova and I Repin
Medical Centre for Russian Government, Postgraduate Research Centre,
Moscow, Russia
One of the most important stages of liver resection is the final haemostasis on
the raw liver surface and covering of liver remnant. For these purposes many
adhesive haemostatic materials are used. Unfortunately there are no studies
concerning to the comparison of these materials.The aim of this study was the
complete comparison of different adhesive haemostatic materials for final
haemostasis and covering of raw liver surface after liver resection. We com-
pared: Gelfoum (6 cases), TachoComb (27 cases), Tissucol (32 cases),
TissuFleece (10 cases), Surgicel (7 cases), Spongostan (8 cases), Russia collagen
fleece (15 cases).The study was done during the period 1994-2000 on the basis
of clinical results of 117 liver resections. During the study we calculated and
assessed 7 groups of parameters: 1) visual intraoperative analogue scale; 2)
haemostasis time; 3) additional covering after the use of pharmaceutical agents;
4) drainage of the area of resection; 5) postoperative course; 6) cost effective-
ness; 7) laboratory tests.All results were summarized in analogue table with the
score from 1 to 7.The maximal score was for TachoComb (50,5) and Tissucol
(49). Most cost effective was TachoComb. Patients with TissuFleece use had
unclear hyperthermic reaction in postoperative period. CONCLUSION: Our
results showed that now only high tech haemostatic agents could be used for
the purposes of final haemostasis and covering of the raw liver surface after its
resection. Because TachoComb is most cost effective adhesive material, now it
could be recommend for the use in Russia.
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V29.1 Intraductal papillary mucinous tumours of the pancreas: disease entity or epiphenomenon?
E Keus, CJHM van Laarhoven, MEI Schipperand HG Gooszen
V29.2 Clinical and pathological characteristics of small carcinoma of the pancreas
T Manabe, Y Okada, M Tanaka, T Hayakawa
V29.3 Current management of pancreatic carcinoma in a university teaching hospital
A Gilliam, DN Lobo, BJ Rowlands and IJ Beckingham
V29.4 Cost-opportunity of pancreatic resections in elderly
U Boggi, F Vistoli, E Marciano, G Bonari, M Del Chiaro G Turchettiand F Mosca
V29.5 Hypoxic Abdominal Perfusion with TNF, Melphalan and Mitomycin C using minimal inva-
sive balloon catheter techniques: from the laboratory to the clinic
M van IJken, B van Etten, C van Eijck, E de Bruijn, G de Boeck, T ten Hagen, J
Jeekeland A Eggermont
V29.6 Effective suppression of pancreas cancer cell growth in vitro by gemcitabine and inhibitors of
protein isoprenylation
U Boggi, G Bocci, M Del Chiaro, R Danesi, F Moscaand M Del Tacc
V29.7 Intra-arterial oily chemoembolization for unresectable cancer of the pancreatic head: prelim-
inary results
A Pavlovski, P Tarazov and D Granov
V29.8 Second look pancreatectomy
U Boggi, R Bellini, C Moretto, M Del Chiaro, F Vistoli, E Marciano and F Mosca
V29.9 Prophylactic surgical bypass is unnecessary in patients with unresectable pancreatic cancer
AGW Moses, AR Davies, N Dowidar, KK Madhavan, RW Parks and OJ Garden
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V29.1
Intraductal papillary mucinous tumours of the pancreas: disease entity or
epiphenomenon ?
E Keus1, CJHM van Laarhoven1, MEI Schipper2 and HG Gooszen3
1St Elisabeth hospital, Surgery,Tilburg,The Netherlands
2University Medical Centre, Pathology, Utrecht,The Netherlands
3University Medical Centre, Surgery, Utrecht,The Netherlands
Recently a new subdivision of non-inflammatory cystic lesions of the pancreas
has been proposed: intraductal papillary mucinous tumours (IPMT) as opposed
to mucinous cystic neoplasms (MCN). MCN is a local process and IPMT can
spread out through the pancreas. Both lesions are suggested to have malignant
potential and complete removal is advised. Histology of a group of 14 patients
with MCN was reviewed for the presence of IPMT (haematoxylin-eosin stain-
ing). The findings were compared with those of 16 patients with chronic pan-
creatitis (CP) who had a Beger procedure and 16 patients who had a Whipple
procedure for adenocarcinoma.The incidence of IPMT after revision was com-
pared with the initial histological classification. IPMT was observed in 11/14
lesions (78%) initially classified as MCN based on CT findings. IPMT was found
on revision in 10/14 cases of adenocarcinoma (71%) and in 5/16 (31%) cases of
CP. On the initial classification these percentages amounted to 11%, 6% and 8%
respectively (p<0.01). IPMT is not a separate disease entity; IPMT can also be
found in adenocarcinoma and CP and should be regarded as an epiphenome-
non to chronic pancreatic disease.Whether IPMT should be regarded as a pre-
cursor lesion to pancreatic adenocarcinoma and whether the patients with CP
and IPMT are the candidates to develop adenocarcinoma, cannot be concluded
from this retrospective study. If not specially looked for the incidence is under-
estimated.
V29.2
Clinical and pathological characteristics of small carcinoma of the pancreas
T Manabe,Y Okada, M Tanaka,T Hayakawa
First Department of Surgery, Nagoya City University Medical School, Nagoya,
Japan.
The clinical and pathological characteristics of 28 small carcinoma less than
2cm of the pancreas were evaluated.Twenty-seven of 28 tumours were loca-
ted in the head and 1 in the body of the pancreas.Microscopic findings revealed
tubular adenocarcinoma in 22 cases (79%), papillary adenocarcinoma in 6 cases
(21%). Lymph node metastasis was found in 28.6%, capsular invasion in 21.4%,
retroperitoneal invasion in 17.9% and portal invasion in 28.6% and arterial inva-
sion in 3.6% of the patients.The 27 patients underwent standard pancreatico-
duodenectomy or total pancreatectomy and one underwent distal pancreatec-
tomy.The cumulative 5 year survival rate in 13 patients with stage I and II was
54%. In 15 patients with stage III and IV, survival rate was 30% in 2 years and
0% in three years. Among the 5 year survivors papillary adenocarcinoma was
found in 57% (4/7) and tubular adenocarcinoma in 43% (3/7) of the patients. In
the remaining patients who survived less than 4 years, all the tumours were in
tubular adenocarcinoma.These results suggest that more than half of the small
carcinomas of the pancreas have a fairly extensive spread through the extratu-
moural lymphatic , venous, neural networks and histological characteristics, and
have a poor prognosis.These results substantiate the concept that more early
diagnosis is still indispensable for a possible cure of carcinoma of the pancreas.
V29.3
Current management of pancreatic carcinoma in a university teaching hospital
A Gilliam, DN Lobo, BJ Rowlands and IJ Beckingham
University Hospital, Queen’s Medical Centre, Section of Surgery, Nottingham,
United Kingdom
AIMS:The aim of this study was to assess the current diagnostic process and
management of patients with pancreatic cancer in a University Teaching
Hospital. METHODS: All patients diagnosed as having pancreatic carcinoma
from June 1998 to June 2000 were reviewed to determine the time to diagno-
sis, investigations and procedures performed, number of admissions, length of
hospital stay and survival. RESULTS: There were 146 patients in total with a
median (range) age of 71 (38-92) years. 68 (47%) patients were male.117
patients (80%) were jaundiced at referral. Surgeons alone managed two thirds
of the patients. 18 (12%) had resectable lesions, while the remaining 128
patients had 134 palliative interventions (33 surgical; 101 radiological or endo-
scopic). The median number of admissions to hospital for each patient was 2
(range 1-6) with a median length of hospital stay of 9 days (range 1-35 days).
The median (IQR) time to diagnosis was significantly less in the jaundiced
patients [7 (6-10) days vs. 32 (18-46) days, P<0.0001].There was no significant
correlation between age and time to diagnosis (r=0.08, P=0.36). There were
105 (72%) deaths in the study population, 82 in the jaundiced group and 23 in
the non-jaundiced group.There was no significant difference in median (IQR)
duration from referral to death in the jaundiced and non-jaundiced groups
[59.5 (18-175) days vs. 35 (16-137) days, P=0.45]. Conclusions:The presence of
jaundice in patients with pancreatic carcinoma significantly decreases time to
diagnosis, however, jaundiced patients did not have improved survival.
V29.4
Cost-opportunity of pancreatic resections in elderly
U Boggi1, F Vistoli1, E Marciano1, G Bonari1, M Del Chiaro1 G Turchetti2 and
F Mosca1
1Centro Regionale di Riferimento per la Cura delle Malattie del Pancreas,
Regione Toscana, Pisa, Italy
2Scuola Superiore di Studi Universitari e di Perfezionamento, Regione Toscana,
Pisa, Italy
BACKGROUND: Aim of this study was to determine, in time of resource
shortage, whether pancreatic resections (PR) in elderly accrue more hospital
charges or have higher operative risks.This analysis allowed us to sketch some
preliminary considerations on the cost-opportunity of PR and on the criteria
of allocation of resources in health care delivery system in presence of increas-
ing budget constraints. METHODS: We retrospectively reviewed the charges
and pertinent clinical data about 237 patients, operated at our Institution by
elective PR, between January 1995 and December 2000. Charges were analyzed
and normalized to 2000 Euro (Eu). Patients were divided into two groups:
group A, younger than 70 years (n=159); group B, 70 year-old or more (n=78).
No difference was recorded about sex, indications, risk factors and surgical
procedure. RESULTS: Preoperative charges were Eu 2,356 ±Eu1, 147 for group
A versus Eu2, 548 ±Eu1, 320 for group B, p=NS. Intraoperative charges (anes-
thetics and operative units) were Eu3, 761 ±Eu1, 320 for group A versus Eu3,
807 ±Eu1, 227 for group B,p=NS. Postoperative charges (ICU, laboratory, phar-
maceutics) were Eu8, 820 ±Eu3, 939 for group A versus Eu9, 876 ±Eu3, 974 for
group B, p=NS. Total charges were Eu14, 937 ±Eu4, 893 for group A versus
Eu16, 231 Eu4, 671 for group B, p=NS. Mortality was 2% in group A vs 10% in
group B (p<0.02). No difference was noted in morbidity, length of hospital stay,
or survival. CONCLUSION: elderly patients undergoing PR have a slightly
enhanced risk of mortality without increased costs and with equivalent out-
comes when compared to the younger patients.
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V29.5
Hypoxic Abdominal Perfusion with TNF, Melphalan and Mitomycin C using min-
imal invasive balloon catheter techniques: from the laboratory to the clinic
M van IJken1, B van Etten1, C van Eijck1, E de Bruijn2, G de Boeck2,T ten Hagen1,
J Jeekel1 and A Eggermont1
1University Hospital Rotterdam, Surgical Oncology, Rotterdam, The
Netherlands
2University of Leuven, Laboratory for Experimental Oncology, Leuven, Belgium
Hypoxic abdominal perfusion (HAP), using minimal invasive ballooncatheter
techniques, theoretically is an attractive treatment modality for patients with
locally advanced pancreatic tumours. In a pre-clinical study we validated this
methodology and investigated the application potential of Mitomycin C (MMC),
Melphalan and TNF by studying their biodistribution during the procedure.HAP
experiments in pigs demonstrated regional plasma concentration advantages
for all agents. However, the advantage in terms of regional plasma concentra-
tion of TNF reached by this methodology seemed insufficient for TNF-mediat-
ed effects to occur, therefore addition of this cytokine to the clinical procedure
is not feasible. In a phase I-II study patients with locally advanced pancreatic
tumours were treated by HAP with MMC and Melphalan, followed six weeks
later by coeliac artery infusion with the same dose of agents.The maximum tol-
erable dose was assessed as 10 mg/m2 Melphalan and 15 mg/m2 MMC.
Although we demonstrated similar regional concentration advantages of per-
fused agents during HAP as in the animal studies, results regarding tumour and
pain respons were dissapointing. Tumour responses assessed by computer-
tomography 6 weeks after perfusion showed PD 18%, SD 76%, PR 6%, CR 0%.
Of patients experiencing pain prior to treatment, only 35% experienced pain
reduction. In most cases this was of short duration. Moreover, the procedure
was associated with high co-morbidity. Contrary to reports by others,we con-
clude that due to high co-morbidity and dissapointing results regarding tumour
and pain reponses, HAP is not a therapeutic option for patients with pancreat-
ic tumours.
V29.6
Effective suppression of pancreas cancer cell growth in vitro by gemcitabine and
inhibitors of protein isoprenylation
U Boggi1, G Bocci2, M Del Chiaro1, R Danesi2, F Mosca1 and M Del Tacc2
1General surgery and Transplants, Oncology, Transplants and Advanced
Technologies in Medicine, Pisa, Italy
2Pharmacology and Chemotherapy, Oncology, Transplants and Advanced
Technologies in Medicine, Pisa, Italy
Pancreatic cancer displays a high rate of ras mutations that are associated with
tumourigenesis and biologic aggressiveness. Proteins of the ras superfamily are
activated by conjugation with farnesyl and geranylgeranyl isoprenoid moieties.
In order to inhibit the growth of pancreas cancer cells, the present study inves-
tigates in vitro the cytotoxicity of the nucleoside analogue gemcitabine, the
cholesterol-lowering drug fluvastatin and the inhibitor of protein geranylger-
anylation BAL9611. Human pancreas tumour cells MIA PaCa-2 were used since
they harbour a K-ras mutations at codon 12. Cytotoxicity was assessed after
72 h treatment with gemcitabine (1-500 nM), fluvastatin (0.1-200 µM) or
BAL9611 (0.1-25 µM).The effects of fluvastatin and BAL 9611 were examined
on p21ras and p21rhoA isoprenylation and on p42ERK2/MAPK phosphoryla-
tion. Finally, the induction of apoptosis was investigated by the analysis of DNA
fragmentation. Gemcitabine, fluvastatin and BAL9611 dose-dependently
reduced cell proliferation with a 50% inhibitory concentration (mean±S.E.) of
19.7±0.4 nM, 1.07±0.27 µM, and 2.9±0.32 µM, respectively, and all drugs were
able to induce apoptosis. Fluvastatin prevented p21ras and p21rhoA isopreny-
lation as well as phosphorylation of p42ERK2/MAPK, while the administration
of mevalonic acid 100 µM was able to significantly reduce cytotoxicity, apopto-
sis and isoprenylation inhibition of fluvastatin. BAL 9611 suppressed the ger-
anylgeranylation of p21rhoA and phosphorylation of p42ERK2/MAPK but was
ineffective on p21ras farnesylation.The results of this study demonstrate that
gemcitabine, fluvastatin and BAL9611 exert a significant cytotoxic effect in vitro
on MIA PaCa-2 cells; in particular, the effect of fluvastatin and BAL9611 involves
the ras-dependent signal transduction pathway.
V29.7
Intra-arterial oily chemoembolization for unresectable cancer of the pancreat-
ic head: preliminary results
A Pavlovski1, P Tarazov2 and D Granov1
1Research Institute of Roentgenology, Research Institute of Roentgenology,
St.Petersburg, Russia
2Research Institute of Roentgenology, Angio/Interventional, St.Petersburg,
St.Petersburg, Russia
PURPOSE:To analyze the first clinical experience of new treatment for locally
advanced unresectable pancreatic cancer. MATERIAL AND METHODS: We
used oily chemoembolization in 10 patients with histologically proven adeno-
carcinoma of the pancreatic head ( T3-4 N0-X M0 ).The procedure was per-
formed as follows.The angiographic catheter was placed in the gastroduodenal
or dorsal pancreatic artery. Catheterization of arteries supplying the tumour
was then performed, and bolus injection of 200-400mg/sq.m. Gemcitabine,
emulsified in 3-5ml Lipiodol Ultrafluid was made. Subcutaneous injections of
Octreotide 0,1mg x 3/day was used during four days as a prophylactic measure
against possible pancreatic complications. Oily chemoembolizations were
repeated with 1-2 month interval. RESULTS: 10 patients received 32 courses of
oily chemoembolization, 2 to 11 per patient.There were no treatment-related
side effects or complications.At present, 8 patients are alive in 3 to 20 months.
Of them, three patients showed partial response, four stabilization, and only
one tumour progression.The two other patients died from tumour in 4 and 11
months. CONCLUSION: Intra-arterial oily chemoembolization is a well-toler-
ated procedure and can cause partial tumour response in some patients with
locally advanced unresectable pancreatic head carcinoma.
V29.8
Second look pancreatectomy
U Boggi, R Bellini, C Moretto, M Del Chiaro, F Vistoli, E Marciano and F Mosca 
Centro Regionale di Riferimento per la Cura delle Malattie del Pancreas,
Regione Toscana, Pisa,
PISA, Italy
BACKGROUND: Several of the patients diagnosed with nonmetastatic pan-
creatic tumour (PT) may not undergo resection at the time of their initial eval-
uation because of diagnostic difficulties or questioned local resectability. The
outcome of a series of second look pancreatectomies (SLP) is herein described.
MATERIALS AND METHODS: Between November 1987 and September 2000
55 patients who had undergone previous surgery for palliation (n= 39) or diag-
nosis (n= 16) of a PT were re-evaluated for a SLP. Re-evaluation was indicated
when the clinical course was clearly different from that anticipated on the basis
of the initial diagnosis. After a standardized preoperative imaging evaluation
indication to laparotomy was confirmed in 49 patients. RESULTS: SLP was
accomplished in 38 patients (77,5%). 7 (24,1%) patients required extended
resections that included the superior mesenteric vein, right colon, or both.Two
patients died (5,2%) and early complications occurred in 16 (42,1%). Ductal
adenocarcinoma was diagnosed in 17 patients (44,7%), 17,6% of whom had
lymph node metastases. Mean survival time for all patients with ductal adeno-
carcinoma was 16 months. Final diagnoses in the remaining cases were: carci-
noma of the papilla of Vater (3), bile duct carcinoma (3), mucinous (2), silent
neuroendocrine tumour (4), chronic pancreatitis (4), acinar cell carcinoma (1),
and lymph node metastases from a previously resected right colon cancer (1).
CONCLUSIONS: SLP can be performed safely and may prolong survival of
carefully selected patients with localized PT. Occasionally, patients with slow-
growing PT might be regained to cure.
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V29.9
Prophylactic surgical bypass is unnecessary in patients with unresectable pan-
creatic cancer
AGW Moses,AR Davies, N Dowidar, KK Madhavan, RW Parks and OJ Garden
University of Edinburgh, Surgery, Edinburgh, United Kingdom
We have studied whether patients referred for pancreatic cancer resection
who turn out to be unresectable at laparoscopic staging might still potentially
benefit from prophylactic surgical bypass. Patients who were deemed unre-
sectable by laparoscopy combined with laparoscopic ultrasound (and therefore
did not undergo routine surgical bypass) have been compared with those
patients who received a gastric and biliary bypass for unresectable pancreatic
cancer after laparoscopic staging had suggested resectable disease.A complete
record of survival from, hospitalisations, and all procedures occuring following
the date of laparoscopic assessment until death was obtained for 92 patients
who had undergone staging with a view to potential pancreaticoduodenectomy
between Jan 1995 and May 2000. (Data expressed: median with range; compar-
isons between groups were made using Mann-Whitney U test.) 35 patients
underwent surgical bypass (SB), 36 and 21 underwent non-surgical palliation for
stage II (sII) and stage IV (sIV) disease respectively. The rate of late gastroen-
terostomy in the conservatively treated patients was 12%. Patients undergoing
surgical bypass procedures spent significantly more days in hospital (SB 26, 13-
74; sII 15, 1-64; sIV 13, 2-33), SB vs sII: p=0.0045; SB vs sIV p<0.0001, yet had no
improvement in survival (months) (SB 6.8, 1.5-32.7 ; sII 7.6, 0.9-19.6 ; sIV 6.3, 1.0-
32.4), or subsequent hospitalisations (SHo) post bypass or laparoscopy (SB SHo
events 1, 0-12: days 9, 0-53; sII SHo events 1, 0-8: days 12, 0-64; sIV SHo events
2, 0-3: days 10, 0-32). Prophylactic surgical bypass is therefore not indicated in
patients staged as having unresectable pancreatic cancer.
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V31.1
Surgery for benign liver lesions: open and laparoscopic
H Kocher,AG Patel AG 1 and IS Benjamin
King’s College Hospital, King’s Centre for the Surgery of Liver, Bile Ducts and
Pancreas, London, United Kingdom
AIM:The aim of this study was to look at the indications and morbidity for sur-
gery for benign liver lesions. METHODS: Retrospective analysis of all patients
referred with benign liver lesions at a single UK centre over 10 years, where
laparoscopic surgery was introduced in 1999. RESULTS: 91 patients were
referred for surgery with cysts or adenomas of the liver over the past 10 years.
Of these, 50 were managed by non-surgical means. Of the 41 patients (35 open,
6 laparoscopic procedures) operated upon, 10 had simple liver cysts, 4 poly-
cystic disease, 7 hepatic adenomas, 6 hydatid cysts, 6 focal nodular hyperplasias,
3 haemangiomas, 4 biliary cystadenomas and 1 angiomyolipoma. The proce-
dures carried out were 8 deroofing of liver cysts, 25 hepatectomies (10 seg-
mental, 9 left and 6 right), 2 cyst excision and 6 endocystectomies.The main
indication for surgery was pain or suspicion of malignancy.There was 1 death
due to intra-cerebral bleed in a patient with haemangioma, and only 3 major
complications (1 DVT, 1 bile leak: successfully stented, 1 post-op bleed): all in
the open group.The mean (+\- S.D) stay for the open group was 10.4 (+\- 4.4)
days, while that for laparoscopic group was 1.6 (+\- 0.6) days. CONCLUSION:
Liver surgery for benign disease is safe. The mainstay is non-operative treat-
ment but selected patients benefit from surgery. Laparoscopic surgery, recent-
ly introduced, may be the modality of choice for suitable cases, as it shortens
the hospital stay.
V31.2
Virtual hepatic resection and in vivo urea synthesis in patients with colorectal
cancer metastases
C Dejong1,3,N Dowidar3, SJ Wigmore3,DN Redhead2,OJ Garden3, PB Soeters1,
JA Ross3, NEP Deutz1 and KCH Fearon3
1Academic Hospital Maastricht, Surgery, Maastricht,The Netherlands
2Royal Infirmary, Radiology, Edinburgh, United Kingdom
3Royal Infirmary, Surgery, Edinburgh, United Kingdom
We have recently shown that volumetric computerized tomography (CT) scan-
ning accurately predicts liver mass removed during hepatic resection. However,
its relation with liver function is unclear. AIM:To assess liver function in humans
and correlate this to functional liver volume/mass. METHODS: 7 Patients (1
male, 6 female; age 52, range 29-74) undergoing laparotomy with a view to
resect hepatic colorectal metastases were studied. Liver volume and weight
were assessed by three-dimensional reconstructions of CT angioportography
images. During surgery, a primed, constant L-1-13C-Urea infusion was given
intravenously and hourly blood samples were obtained. 24-Hour urine collec-
tions were performed to compare both methods of measuring whole body
urea synthesis. RESULTS:Three patients underwent major hepatic resections, 4
were irresectable. Steady state isotopic conditions were obtained in all patients
within 2 hours from start of infusion. Mean (SEM) liver volume was 1905±280
mL, mean functional liver volume, calculated as liver volume minus tumour vol-
ume, was 1590±264 mL. Urea synthesis was 269±32 µmol/kg bw/h and
11.5±1.4 µmol/gram functional liver/h calculated from the isotope data, and
139±10 µmol/kg bw/h and 6.77±0.82 µmol/gram functional liver/h from 24 h
urine excretion. Urea synthesis per gram liver increased 3-fold (to 34.8±3.3
µmol/gram liver/h) following resections. CONCLUSION: It is possible to assess
liver volume and function in patients using volumetric CT and stable isotopes.
The difference between isotope data and 24-hour urine collections is explained
by intestinal bacterial breakdown.These data open perspectives for estimation
of liver function in patients at risk of developing liver failure following hepatic
resection.
V31.3
Liver dissection using scissors versus water-jet, ultracision and CUSA: a com-
parative study in pigs
R Canelo1, B Sattler2, M Soegel1,A Grosse Beilage2, L Fásezi2 and B Ringe1
1Georg-August-Universität Gottingen, Klinik f?r Trnansplantationschirurgie ,
Göttingen, Germany
2Georg-August- Universität Gottingen, Zentrum Pathologie, Göttingen,
Germany
INTRODUCTION: New devices for dissection of the liver are used to improve
surgical techniques of resection and transplantation. Technical aspects were
evaluated in pigs using scissors,Water-Jet, Ultracision and CUSA. METHODS:
28 pigs (30.8 +- 1.5 kg) were divided into four groups of 7 pigs, and a different
device was used on each group.The organ was divided through the right and
left paramedial lobes. No coagulation tools or clamping were used.The exper-
iments lasted 6 hours, after which the animals were sacrified.Time of dissection
(min), blood loss during operation and the number of sutures and clips were
controlled. Systolic arterial pressure, diastolic arterial pressure, biochemical
parameters (AST), leukozytes count and arterial ketone body ration (AKBR)
were measured before (A) and after 6 hours of liver dissection (B). RESULTS:
Scissors Water-Jet Ultracision CUSA p<.05
Dissection time 42.7 42 44.7 45.7 0.007
Blood loss 785.1 664 550 314.2 0.002
Sutures 4.7 4.7 2.7 3.5 0.001
Clips 19 25.1 2 39 0.000
Hemodynamic changes, leukozyts count and AKBR were n.s. No expression of
IL-Beta and TNF-Alpha was detected. CONCLUSIONS:This study shows that
dissection of the liver using these four devices is feasible. Scissors was the
worst device considering blood loss and sutures needed during operation.The
shortest dissection time was achieved with Water-Jet. Ultracision needed few
sutures and clips because of its incorporated electrocoagulation for dissection
and cutting. CUSA was the best device concerning blood loss during operation,
although it showed the longest time for dissection.
V31.4
The incidence and modern management of liver trauma
G Kyratzis, L Lapidakis, G Papoutsis, B Gougoutas and N Theakos
KAT Hospital, 2nd Dept of General Surgery,Athens, Greece
Hepatic injuries consist a primary surgical problem, both from the point of early
diagnosis and proper management, according to liver trauma degree.The clini-
cal material of this retrospective study consisted of 448 cases (21%) out of
2.132 admissions for serious trauma, the last 30 years. The vast majority of
cases, (almost 50%) as in multicentre series, followed blunt abdominal trauma,
but open wounds presented a real challenge for the surgeon. Classification of
liver trauma score into four degrees was based, on the extent of parenchymal
damage and/or involvement of liver circulation. Analysis was comparatively
made between two periods: a) 1970-1985 (group A, 188 cases 41,9%), b) 1986-
2000 (group B, 260 cases 53,1%).All methods of operative management were
used, from simple arrest of bleeding to more complicated surgical interven-
tions, including internal by-pass of vena cava.Thirty patients (6.6%) underwent
conservative management successfully. The overall mortality rate was 13.1%,
but was much higher in cases of complicated liver trauma (3rd and 4rth degree
injuries), of which almost 70% were cases of group B. Major -lethal- complica-
tions, such as recurrent bleeding or sepsis were developed in 23 patients
(5,1%).A relatively lower mortality rate but a high incidence of only minor com-
plications in multi-injured patients, especially of group B, was recorded due to
due to improved operative interventions and modern post-operative manage-
ment in ICU. It is concluded that mortality and morbidity rates, remain still high
in complicated liver trauma, and this consist a challenge for the future. Non-
operative treatment of selected cases can be safely managed due to modern
diagnostic procedures.
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V31.5
Percutaneous isolated hepatic perfusion for treatment of liver metastases
J Rothbarth1, F Tijl1, J van Dierendonck1,M Pijl2, R Tollenaar1, P Kuppen1,CHJ van
de Velde1 and L Schultze Kool3
1Leiden University Medical Centre, Surgery, Leiden,The Netherlands
2Leiden University Medical Centre, Radiology, Leiden,The Netherlands
3Antoni van Leeuwenhoek Ziekenhuis/The Netherlands Cancer Institute,
Radiology,Amsterdam,The Netherlands
GOAL: To develop a minimally invasive percutaneous technique for isolated
hepatic perfusion. INTRODUCTION: Isolated hepatic perfusion (IHP) has been
developed as a treatment for non-resectable metastases confined to the liver.
In data obtained from phase I/II studies (n=105) we have shown that this pro-
cedure can lead to a significant response resulting in a median life expectancy
of 28 months and even 5 year survivors with good quality of life. IHP however,
is an invasive, technically difficult, non-repeatable demanding operation.A mini-
mally invasive percutaneous method for isolated hepatic perfusion (PIHP) is
under development to broaden the indication and enable widespread use of
this method, in collaboration with the Malmö Medical Centre in Sweden
(Ivancev, Lunderquist) using a porcine model. METHODS:Yorkshire pigs (n=20)
weighting approximately 60 kg were used. Leakage was quantified by adding
Technetium to the isolated circuit. Different perfusion techniques were tested
(antegrade, retrograde, with and without occlusion outflow) and flow charac-
teristics and leak-rates were evaluated. RESULTS: The most promising tech-
nique is retrograde perfusion with inflow from the hepatic veins/artery and
outflow through the portal vein. Flowrates in excess of 300 cc. per minute
could be achieved.By adjusting portal pressures during perfusion, leakage could
be controlled. An update of recent experiments will be presented of experi-
ments in a preclinical phase. CONCLUSION:A percutaneous isolated hepatic
perfusion technique is feasible.
V31.6
Percutaneous treatment of intrahepatic stones or stenoses in patients with a
hepatico-jejunostomy
M Bemelmans1, D Castaing2, D Azoulay2 and H Bismuth2
1Academic Hospital Maastricht, Surgery, Maastricht,The Netherlands
2Hepatobiliary and Liver Transplant Centre, Paul Brousse Hospital, Villejuif ,
France
Intrahepatic stones or stenoses in patients with a hepatico-jejunostomy form a
difficult clinical problem. In our centre a percutaneous transjejunal catherization
is used.With this technique , the jejunum of the hepatico-jejunostomy is punc-
tured under ultrasonic guidance after which a catheter is left behind.One week
later this traject can be dilated, a pediatric endocscope can be introduced and
the necessary treatment performed. From 1978-2000, 71 patients were treat-
ed by this method in 87 procedures. Patients were divided in 3 groups. Group
A: (n=51, 13 transplant patients, 65 procedures) intrahepatic/common bile duct
stones with or without stenoses.Group B: (n=15, 17 procedures) carcinoma or
suspicion of carcinoma. Group C: (n=5, 3 transplant patients) stenosis without
stones or carcinoma. RESULTS: (A) 58 procedures (91%) were successful (all
stones removed), 7 procedures were partially successful (cholangitis cured,
some stones left behind). (B) If the goal was to obtain a diagnosis (n=12, 14 pro-
cedures) success rate was 100%. If the goal was to ameliorate the condition
(icterus), adequate drainage was achieved in 1 out of 3 patients (33%). (C) In all
patients there was a successful dilatation.There was no mortality, and morbid-
ity consisted of pain and fever for 1-3 days. CONCLUSION: Percutaneous
treatment of intrahepatic stones or stenoses in patients with a hepatico-
jejunostomy is a relatively simple, minimal invasive procedure in patients who
require otherwise complex and extensive interventions.
V31.7
Recurrenence of git bleeding after complete obliteration of esophageal varices
in portal hypertensive patients
I Boghdadi I1 , M Osman M2 and M Rashed M-Y3
1Dept. of Medicine, Faculty of Medicine, University of Menoufiya, Egypt
2Dept. of HPB Surgery, National Liver Institute, University of Menoufiya, Egypt
3Dept. of Medicine, Hepatology Unit, University of Alexandria, Egypt
The most catastrophic complication of portal hypertension is variceal bleeding.
The target of different endoscopic techniques is complete eradication of the
varices to decrease the risk of bleeding. However, recurrence of bleeding is still
a problem. AIM: the aim of this work was to study the different causes of bleed-
ing in such a group of patients. PATIENTS AND METHODS: Twenty-seven
patients (20 males and 7 females with a mean age of 47.4 ±15.7 years) with
established complete esophageal eradication by either endoscopic sclerother-
apy and/or band ligation suffered recurrent bleeding at variable time ranging
between 6 to 18 months.All patients were submitted to emergency endoscopic
examination. RESULTS: Portal hypertensive gastropathy of severe degree was
the source of bleeding in 10 (37%) patients, in 4 of them was a history of intake
of NSAID.Bleeding duodenal ulcer was in 5 (18.5%), Duolafoy lesion in 3 (11%),
bleeding newly developed gastric varices in 3 (11%), duodenal bulb varix in 4
(14.8%) patients. Bleeding from anal varix and from esophageal carcinoma was
detected from one (4%) patient each. Patients presented either by hemateme-
sis in 7 (40.7%) patients, melena in (55.5%), and bleeding per rectum in only one
(4%) patient. CONCLUSION: Esophageal variceal obliteration is not the end of
the problem of GIT bleeding in portal hypertensive patients. Recurrence of
bleeding from lesions related to portal hypertension was found in 62.5%, indi-
cating that close endosopic follow-up and treatment of portal hypertension are
mandatory.
V31.8
Small-diameter h-graft portacaval shunt in the treatment of portal hypertension
He Jie Hu, Ge Liang Xu and Jian Sheng Li 
Anhui Provincial Hospital, General Surgery, Hefei, China
OBJECTIVE:To evaluate the clinical effect of small-diameter H-graft portalcav-
al shunt in the treatment of portal hypertension. METHOD: Twenty-three
patients with portal hypertension were treated by small-diameter H-graft of
ePTFE (expanded polytetrafluoroethylene) portalcaval shunt from May 1995 to
November 1999.Thirteen had externally reinforced grafts and 10 had non-rein-
forced one, 20 had 10mm diameter grafts and 3 had 8mm grafts. Left gastric
artery and coronary vein were ligated in all and splenectomy was performed in
22. RESULT:The FPP (free portal pressure, FPP) was reduced from 31.27±4.71
cmH2O before shunt to 16.82±3.28 cmH2O after shunt averagely.The portal
blood flow was reduced by 1/3 of that before shunt.All 23 patients were sur-
vival and no upper gastro-intestinal rebleeding occurred in the follow-up peri-
od (20.2months in average). Color Doppler ultrasonagraphy and/or cavography
revealed that the shunts were patent in 21 cases and occluded in 2 (8.7%).
Encephalopathy was developed in 3 cases (13%). CONCLUSION: Small-diame-
ter ePTFE H-graft portacaval shunt can reduce the portal pressure effectively.
Majority of the hepatic blood flow from portal vein can be maintained. The
shunts with reinforced graft keep higher patency. The morbidity of enceh-
palopathy was lower. It’s effective in preventing recurrent variceal bleeding.
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V32.1
Prognostic factors in liver retransplants
JC Meneu-Diaz1, E Moreno-Gonzalez1, E Vicente-Lopez2, OJ Nuão2, C Loinaz1,
Y Quijano2, R Gomez1 and P Lopez-Hervas2
1University Hospital, General, Digestive and Abdominal Organ Transplantation
Unit, Madrid, Spain
2University Hospital Transplantation Unit, Madrid, Spain
OBJECTIVE:To analyze the impact on survival of a retransplantation and the
role of several factors on early death (first year post retransplantation).
MATERIAL AND METHODS: Between March 1986 and December 1997, a
total of 1087 OLT were performed in 965 patients at three University hospi-
tals in Madrid, accounting for a 32% of the OLT carried out in our country since
the first in 1984. Among them, 122 were retransplants (13% rate), which rep-
resents the focus of this study. RESULTS: A total number of 122 retransplants
were carried out in 104 recipients. Mean age was 53 (SD: 13.52) and a 60.4%
of the sample were male (6.3% were pediatric patients). Median follow up of
33.5 months (1-90) and the procedure was done urgently in up to 42.7%.
Operative mortality (first month) was 17.8% and at the end of the first year,
the rate was 37.5% (63.2% of the total amount of deaths). Actuarial survival
rate at 12, 35 and 61 months was 62%, 53% and 46% respectively. Risk factors
related to early death (first year) were identified on a logistic regression model;
secondary diagnosis, interval, urgent basis, UNOS, mechanical ventilation, diali-
sis, HCV + and ascitis. CONCLUSIONS. In spite of an acceptable actuarial sur-
vival we have to take into account that this may be better for a primary liver
transplant. Early death must be heavely considered when making decisions as
far as organ allocation is concerned.
V32.2
Hepatic retransplantation: the impact of the interval, unos status and emer-
gency on long-term survival.A multicentre study
J Meneu-Diaz1, E Moreno-Gonzalez1, E Vicente-Lopez2, J Nuão2, C Loinaz1, Y
Quijano2, I Garcia1, P Lopez-Hervas2, I Gonzalez-Pinto1 and V Turrion2
1University Hospital 12 De Octubre, General, Digestive and Abdominal Organ
Transplant Unit, Madrid, Spain
2University Hospital 12 De Octubre,Transplant Unit, Madrid, Spain
INTRODUCTION: retransplantation has been reported to be necessary in
11.6%-16.9% of adults and in 15.2%-28.2% in children.The inferior results asso-
ciated with this procedure (a difference of 22.5% in patient survival between pri-
mary and retransplants at 1 year after transplant), have prompted some to
restrict the number of retransplants based on cost-effective parameters.
Material and methods: between March 1986 and December 1997, 1061 patients
underwent 1087 liver transplants at three University Hospitals; there were 122
retransplants.Nine of them performed in 7 patients were excluded (incomplete
follow-up). Results: Rejection was the most frequent indication (35.4%). The
majority of them (85.4%, 95% CI: 81.8%-89.2%) were simple RTX. As many as
44.8% of recipients were UNOS 1. Operative mortality was 18%. Early mortali-
ty rate (within the first year) was 37.5%.After a mean follow-up of 35.8 months
(range, 1-90),median survival rate was 45 months (95% CI: 15-75).Actuarial sur-
vival rate at 12, 36 and 60 months were 62%, 53% and 46% respectively.The log-
rank test showed significant differences on survival based on the interval, the
emergency basis of the retransplant and the UNOS status of the recipients.
Conclusions: It is clear that in spite of an inferior results compared to primary
liver transplants, RTX remains as a useful procedure. Interval of time,UNOS sta-
tus and emergency of the retransplant are variables affecting survival and poten-
tially controlable by the transplant team. For this reason, we conclude that
retransplantation have to be indicated in the optimus situation for the recipient.
V32.3
Surgical complications after liver retransplantation. Impact on operative mor-
tality
J Meneu-Diaz1, E Moreno-Gonzalez1, E Vicente-Lopez2, J Nuão2, Y Quijano2, I
Garcia1, I Gonzalez-Pinto1 and V Turrion2 and P Lopez-Hervaz2
1University Hospital 12 De Octubre, General, Digestive and Abdominal Organ
Transplant Unit, Madrid, Spain
2University Hospital 12 De Octubre,Transplant Unit, Madrid, Spain 
INTRODUCTION: Allocation problems based on results achieved with
retransplantation has prompted us to analyze the presence of surgical compli-
cations after this approach and their impact on operative mortality. MATERIAL
AND METHODS:A total of 1087 OLT were performed in 965 patients at three
University hospitals in Madrid; 122 were retransplants (13% rate), which rep-
resents the focus of this study. OBJECTIVE: To analyze the impact of surgical
complications after retransplantation on operative mortality. RESULTS:A total
number of 122 retransplants were carried out. The majority of the patients
(85.4%; 95% CI: 81.8%-89%) underwent one retransplant; a second retransplant
was carried out in 12.5% and 2% received more than two retransplants. Mean
age was 53 (SD: 13.52) and a 60.4% of the sample were male (6.3% were pedi-
atric patients). Median follow up of 33.5 months (1-90) and the procedure was
done urgently in up to 42.7%. Detected surgical complications were: wound
infection (9.3%); biliary complications (20.4%); vascular complications (7.1%);
fecal peritonitis (2.1%); biliary peritonitis (2.1%); hemoperitoneum (24.5%).The
relaparotomy rate was 51.4% in order to solve surgical complications. At the
end of the study, 59.4% of the patients have died.A 56.1% of deaths were con-
sidered due to septic complications. Relaparotomy did not affect operative
mortality. Five year actuarial survival rate was 45.5%. CONCLUSIONS: In spite
of an acceptable actuarial survival for candidates to retransplantation, surgical
complications are extremely frequent and the rate of relaparotomy is also high.
Sepsis remains to be responsible for operative mortality.
V32.4
A new technique for the assessment of hepatic microcirculation in vivo by dig-
ital videomicroscopy
A Giudiceandrea1, A Seifalian1, H Salacinski1,Y Ogasawara2, B Davidson1 and F
Fajiya2
1Royal Free & University College Medical School, University Department of
Surgery & Liver Transplant, London, United Kingdom
2Kawasaki Medical School, Dept of Medical Eng. System cardiology, Kurashiki,
Japan
INTRODUCTION:The hepatic microcirculation is altered in chronic liver dis-
ese and its assessment is essential to the evaluation of treatment modalities.
This may be possible noninvasively using a videomicroscopy system with a
CCD camera. METHOD: The videomicroscopy system consisted of a pencil
lens, together with light guides, a CCD camera with a monitor and a digital
videocassette recorderhieved b.The time sequential images were digitised by a
Computer workstation. Instantaneous blood velocities were estimated by cross
correlating the profiles of the moving red blood cells.The spatial resolution of
the system is 0.86mm with a temporal resolution of 16.7ms (60 frames a sec-
ond). The focal depth is 20 mm. Mongrel beagle dogs (n = 4) underwent a
laparotomy and liver exposure.The videomicroscopy pencil probe was placed
on the liver surface in order to continuously record changes in sinusoid perfu-
sion. Reduction of hepatic perfusion was acy hepatic vascular inflow occlusion.
RESULTS:The sinusoidal flow was clearly visualised in all animals and velocity of
red blood cell was possible to compute with small variation inter group of ani-
mal (4%). From the colorization images arterial and venous flow could be dis-
tinguish. CONCLUSION: These results indicate that this newly developed
intravital videomicroscope gives a continuous indication of portal venous flow
and hepatic flow and will prove to be a useful tool in the assessment of liver
perfusion and any subsequent disease modalities.
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V32.5
Multiresistant bacteria infections - An emergent issue in liver transplantation
E Balbi, G Santoro-Lopes, M Halpern, EF Gouvea, L Pacheco-Moreira, ME
Oliveira, HSM Coelho, S Martins, G Carreiro and J Ribeiro
Federal University of Rio de Janeiro, Liver Transplantation, Rio de Janeiro, Brasil
OBJECTIVE:To describe the frequency of multiresistant bacteria infections in
liver transplant receptors. METHODS: Patients submitted to liver transplant
between January 1999 and November 2000.The infection diagnosis was con-
firmed by positive cultures from normally sterile sites or by finding more than
100000 CFU (colony forming units) in urine culture or bronchoalveolar lavage.
RESULTS: Among 43 patients submitted to liver transplant in this period, 14
(33%) had 20 infections (3 liver abscesses, 1 cholangitis, 1 pneumonia, 3 peri-
tonitis, 2 urinary tract infecctions, 2 vascular catheter-related infections, 2 skin
infections and 2 bacteremias). More than one etiology was found in 2 cases.
From the 23 identified bacteria 15 (65%) were Gram negative: Pseudomonas
aeruginosa (9), Enterobacteriaceae (5), Acinetobacter (1). Among the Gram
positive bacteria, there were Enterococcus spp (5), Staphilococcus aureus (2),
Staphilococcus epidermidis (1).Ten of the 23 isolated agents (44%) were mul-
tiresistant bacteria: carbapenem-resistant P. aeruginosa (5), extended spectrum
beta-lactamase producing Enterobacteriaceae (3), methicillin-resistant S.aureus
(2). CONCLUSION: In this centre, liver transplant recipients had a high risk of
infection by multiresistant bacteria. Differently from what has been reported
from other centres, where multiresistant Gram positive bacteria predominate,
carbapenem-resistant P. aeruginosa was the most frequent agent isolated.
V32.6
Platelet function is negatively correlated with blood consumption during ortho-
topic liver transplantation independent of platelet count
J Schule am Esch1, A Akyildiz, R Tustas, D Bröring and X Rogiers
University Hospital of Hamburg, Department of Hepatobiliary Surgery,
Hamburg, Germany
INTRODUCTION: Endstage liver failure is paralleled by a severe disturbance
of homeostasis. Despite technical aspects it does largely determine periopera-
tive blood loss of orthotopic liver transplantation (oLTX). In this study we eval-
uated the impact of platelet function for the perioperative blood loss in the
course of oLTX. METHODS: In a prospective study pre-, peri- and postopera-
tive platelet function was measured in 33 consecutive cases of adult oLTX.
Collagen, ristocetin and ADP were utilised as inducers of platelet aggregation.
Partial thrombin time (PTT) and the platelet counts were recorded.The peri-
operative consumption of blood products was recorded. Patients were divided
into a group of more than 80 ml packed erythrocytes per kg body weight (A)
and those with less (B). RESULTS: UNOS destribution did not differ significant-
ly amongst the 2 contrasted collectives. Platelet count and PTT did not pres-
ent with significant differences at any time point between the groups. In con-
trast, in group B the platelet aggregation for all inducers tested did demonstrate
significant lower levels in the anhepatic and reperfusion phase respectively.This
phenomenon presented with ADP-induced aggregation in addition on day 2
after oLTX. CONCLUSION: In this study we demonstrated platelet function as
a major aspect in blood consumption in the course of oLTX largely independ-
ent of the platelet count. These data point to the presence of a qualitative
defect of platelets. To control intraoperative bleeding during oLTX over cor-
rection of platelet counts may be beneficial in selected cases to compensate for
functional platelet defects.
V32.7
Ginkgo biloba (EGB 761) reduces reperfusion injury after warm ischemia in the
fatty rat liver
A Schutte1, S Topp1,WT Knoefel2, S Brilloff1, X Rogiers1 and M Gundlach1
1Clinic of Surgery, Dept. of Hepatobiliary Surgery, Hamburg, Germany
2Clinic of Surgery, Dept. of General Surgery, Hamburg, Germany
INTRODUCTION: Gingko Biloba Extract (EGB 761) is known to be a free rad-
ical scavenger. Since the free radical production has been discussed as one of
the major mechanisms of reperfusion injury after warm ischemia, our study
uses EGB 761 as an antioxidant to prevent the postischemic reperfusion injury
in the fatty liver. MATERIAL AND METHODS: To obtain fatty livers in Lewis
rats, the animals were put on a Cholin and Methionin free diet for 30-40 days.
The rats were subjected to 60 minutes of left hepatic lobar ischemia.After 15
and 90 minutes of reperfusion intravital microscopy, reflectance spectroscopy
and serum transaminase levels were used to assess reperfusion injury. Group B
(n=10) was treated with EGB 761 intravenously 20 minutes before reperfusion.
The non-treated animals of group A (n=10) served as control. RESULTS:After
90 minutes of reperfusion we found a better sinusoidal perfusion rate (peri-
portal/ midzonal/ pericentral) in group B of 87,2%/87,9%/87,1% compared to
group A (75,9%/80,6%/82,5%). During observation time the perfusion rate
decreased in group A and increased in group B. The incidence of rolling and
sticking leukocytes was significantly reduced under the treatment with EGB
761. Serum transaminase levels were higher in group A than in group B.
CONCLUSION: EGB 761 reduces the reperfusion injury after warm ischemia
in the fatty rat liver.The microcirculation is improved and the number of leuko-
cytes is decreased in comparison to control animals.Therefore EGB 761 might
be a useful substance to reduce reperfusion injury in fatty livers.
V32.8
Outcome of lamivudine resistant hepatitis b infection after liver transplantation
D Seehofer1, N Rayes1, AR Müller1, U Naumann2, U Hopf2, R Neuhaus1, T
Steinmueller1 and P Neuhaus1
1Charité Campus Virchow, Department of General-, Visceral- and Transplant-
Surgery, Berlin, Germany
2Charitè Campus Virchow, Department of Gastroenterology and Hepatology,
Berlin, Germany
PURPOSE: Major problem of lamivudine treatment of HBV-infection after liver
transplantation is a relatively fast resistance formation. Lamivudine-resistant
reinfection is supposed to have a milder clinical course, although long-term data
are not available. PATIENTS: 34 patients with hepatitis-B recurrence after liver
transplantation were treated with lamivudine.All patients developed reinfection
despite long-term passive immunoprophylaxis . 22 of them underwent a former
course of famciclovir. All patients were followed up with monthly laboratory
values and regular liver biopsies. RESULTS: 20 of 34 patients (59%) developed
lamivudine-resistance during the follow up period of 12 to 48 months. 1 and 3
year graft survival rates after diagnosis of lamivudine-resistance were 100% and
75%. Lamivudine-resistance presented in most cases with high viral replication
(3012±574 pg/ml one month after lamivudine-resistance) , but liver enzymes
were only slightly elevated (ALT 45±16 U/l). Only 3 patients (15%) presented
with a rapid rise of ALT up to 1500 U/l after 3 months.All others had only mild-
ly elevated liver enzymes within the first 8 months. In case of increased
transaminases patients were switched to lamivudine plus interferone-alpha
(n=8) or lamivudine plus famciclovir (n=6). Most patients tolerated this combi-
nation well, and HBV-DNA and liver enzmes decreased. In total 3 patients with
lamivudine-resistance died (two malignomas, one HBV-reinfection), and two
were retransplanted due to reinfection. CONCLUSION: Lamivudine-resistant
reinfection is mostly characterised by a benign course. In case of lamivudine
resistance combination of different antivirals could diminish viral replication, in
the future new antivirals like adefovir might expand therapeutic options.
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V32.9
Experience with liver transplant program in Prague: first 199 consecutive liver
transplantations
M Ryska, P Trunecka, S Vitko, F Belina, E Pokorna, J Spicak, J Peregrin, R Zazula
and K Filip
Institute for clinical and experimental medicine, Prague 4, Czech Republic
Liver transplant program in Prague we started with Professor Peter Neuhaus
(Berlin) in 1995.The aim of program was to make the availability of this treat-
ment modality in Czech Republic.In 4/1995 until 12/2000 199 OLTx were pro-
vided. Method: Procurement with UW (HTK), full-size graft 195, split 3, graft
reduction 1.Recipient : hepatectomy with retrohepatic IVC resection (piggy
back sporadically), VVS obligatory in 1.-33. pts., later selectively, CHDCHDA
side-to-side with T-tube (1.-50.),later end-to-end without T-tube (51.-199.) , HJA
in case of secondary biliary cirrhosis, PSC and re-OLTx. Induction immunosup-
pression:ATG or Zenapax,Aza or MMF, MP, CyA and maintenance therapy CyA
x FK 506 + MP + Aza x MMF. Results: 1-year patient survival (Kaplan-Meier)
reached 90,33 % (1997) - 80,95 % (1998), total survival 86 %. 7 reOLTx, 1
rereOLTx. Biliary complications 33 % (1. - 50. pts.), 20 % (150. - 199. pts.) with
0 % mortality,AR in 35 %, totally episodes 92 in 70 pts. with 78 % gr.I., 23 pts.
had steroid resistant AR with 0 % of graft loss and mortality. In follow-up: 24,1
% with DM, 70,1 % with hypertension, 52,8 % pts.with hypercholesterolemia ,
HBV de novo in 2 pts. Significant improvement of quality of life (SF36) within
first 5 years after OLTx.Conclusions : Liver transplantation started in Prague as
the standard procedure under several cautions: co-operation with well estab-
lished transplant centre (Berlin), prudent selection of recipients, good quality of
liver grafts, the good potency to solve biliary complications. OLTx improves the
life quality of most patients.
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